Zurueck zur Suche

Reporte zur Charge 016J21_2A

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

349Reporte angezeigt
3Todesfaelle
28Hospitalisiert
6Lebensbedrohlich
5Bleibende Schaeden
NE 69 CA 42 VA 38 AL 31 SC 13 MA 12 WA 11 TN 10 NY 10 MI 9 TX 9 IL 7

VAERS 2710791

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j212a

kritisch
Staat
-
Alter
34,0
Geschlecht
F
Eingang
07.11.2023
Impfdatum
15.01.2022
Beginn
05.11.2023
Tage bis Beginn
659,0
Dosis
3
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Abdominal pain Alanine aminotransferase increased Angiogram normal Angiogram pulmonary normal Anion gap Aspartate aminotransferase increased Asthenia Back pain Bacterial test positive Basophil count decreased Basophil percentage decreased Bilirubin urine Blood albumin decreased Blood alkaline phosphatase increased Blood bilirubin normal Blood calcium decreased Blood chloride normal Blood creatinine normal

Symptomtext

Document Type: History and Physical Document Subject: History & Physical Note Performed By: MD on November 05, 2023 20:35 EST Verified By: MD on November 05, 2023 20:35 EST Encounter Info: Hospital, Inpatient, 11/05/23 - * Final Report * Chief Complaint Abdomen pain History of Present Illness/Subjective 36-year-old female with past medical history COPD here with diffuse abdomen painx3 days of mild of moderate severity, radiating to the back, no relieving or exacerbating factors. Reports fever to 101. Also complaining of generalized weakness and malaise. Denies nausea, vomiting, abdomen pain.No shortness of air or diaphoresis. Does report a mild cough productive of scant amounts of white sputum with some pleuritic chest pain. White blood cell count 14,000, increased absolute neutrophil count.Mildly elevated D-dimer. Potassium 2.8, alkaline phosphatase 164, minimal elevation of AST and ALT, total bilirubin is normal, she has prior cholecystectomy. Serum lactate is 0.7, cardiac enzymes are negative. Urine shows bacteria, pyuria ,microhematuria, nitrite positivity. COVID-19 positive as well. Normotensive with mean arterial pressure in the 70s but systolic blood pressure on the soft side in the high 90s and low 100s. Mildly tachycardic.No hypoxia. CT of the abdomen pelvis shows decreased cortical perfusion in a patchy distribution as well as perinephric stranding bilaterally. CT angiography shows no acute abnormality including pulmonary embolus. Review of Systems Complains of mild nonproductive cough, pleuritic chest pain, fever,abdomen pain. Denies shortness of air. No nausea vomiting or diarrhea hematochezia or melena. Remaining 10 point review of systems negative except as noted above. Physical Exam/Objective Vitals & Measurements most recent past 24 hours T: 37.5 ?C (Oral) BP: 98/65 HR: 112 (Monitored) HR: 110 (Peripheral) RR: 17 SpO2: 96% Oxygen Therapy: Room air WT: 50.30 kg (WFC) Hemodynamics Neurologic Glasgow Coma Score: 15 Patient Weight Current Daily Weight: 50.3 kg 11/05/23 Patient Height Current Height: 162.6 cm 11/05/23 Constitutional: No acute distress, well-nourished Eyes: PERRLA, EOMI, normal conjunctiva ENMT: Moist oral mucosa Neck: Supple, non-tender, intact range of motion Respiratory: Lungs CTAB Cardiovascular: Regular rate and rhythm Gastrointestinal: Soft, non-tender, non-distended Musculoskeletal: No joint swelling, no deformity, bilateral CVA tenderness to palpation Integumentary: Intact, warm, dry no rashes Neurologic: Alert & Oriented x 3, no cognitive impairment, no focal deficits Psychiatric: Cooperative, appropriate mood and affect Assessment/Plan 1. Acute pyelonephritis N10 The patient has no multidrug-resistant risk factors thus will prescribe ceftriaxone 1 g every 24 hours, pain control, as needed antiemetics, follow cultures, follow procalcitonin levels. 2. COVID-19 virus infection U07.1 Not sure we can call this asymptomatic with fever, however, no hypoxia. Supportive care. 3. Sepsis A41.9 Present on admission secondary to urinary tract infection. Follow bolus guidelines and then administer maintenance IV fluids to maintain a mean arterial pressure of 65 and urine output of 50 mL/h. Recheck on physical examination shows appropriate capillary refill and peripheral tissue perfusion. We will follow urine and blood cultures. Antibiotics as described above. This is a urinary tract infection in a young female with nitrite positivity, no indication for gram-positive coverage at this point. 4. Elevated liver enzymes R74.8 Chronic, stable, follow 5. Hypokalemia E87.6 Replete and follow Orders: albuterol, 2 Puff, Inhalation, MDI/DPI Inhaler Treatment, 4 Times Daily, 11/05/23 21:00:00 EST Sodium Chloride 0.9% 500 mL, Total Volume (mL) = 500, IV Continuous, 11/05/23 19:50:00 EST, Other - See Comments, Clinical Weight Sodium Chloride 0.9% 500 mL, Total Volume (mL) = 500, IV Continuous, 11/05/23 19:50:00 EST, Other - See Comments, Clinical Weight Full code Lovenox Code Status Full Code Chronic Problem List Extensive tattoos History of conization of cervix History of depression History of migraine headaches Request for sterilization Procedure/Surgical History ?Laparoscopic cholecystectomy (01/11/2023) ?Oral surgery (02/2016) ?Pap smear for cervical cancer screening.... (06/16/2015) ?Colposcopy (06/09/2006) ?Abnormal pap smear (03/07/2006) ?Extraction of wisdom tooth (2003) ?Conization of uterine cervix (12/18/2001) ?cholesystectomy Surgical History Internal 01/11/2023 Cholecystectomy Laparoscopic MD 08/14/2020 Tubal Ligation Laparoscopic MD Medications Home Medications (3) Active Benadryl 25 mg oral tablet 25 mg = 1 Tablet, PRN, Orally, At Bedtime Ventolin HFA 90 mCg/inh inhalation aerosol 180 mCg = 2 Puff, Inhalation, 4 Times Daily, May use up to 3-4 puffs four times a day. Wixela Inhub 500 mCg-50 mCg inhalation powder , Inhalation, BID Active Scheduled Inpatient Medications albuterol (Albuterol (Eqv-Ventolin HFA) 90 mCg/inh inhalation aerosol), Aerosol, 2 Puff, Inhalation, 4 Times Daily, Start: 11/05/23 21:00:00 potassium chloride (potassium chloride extended release), Tab, Extended Rel, 20 mEq, Orally, ONCE, Start: 11/05/23 17:00:00 Sodium Chloride 0.9% 500 mL IV Continuous Other - See Comments Sodium Chloride 0.9% 500 mL IV Continuous Other - See Comments One-Time Medications Given 11/04/23 00:00:00 TO 11/05/23 20:34:49 ceftRIAXone, Injection, 1 GM, IV Push, ONCE, (1 DOSE 11/05/23 16:02:00) HYDROmorphone (HYDROmorphone Inj ED (1 mg/mL)), Injection, 1 mg, IV Push, ONCE, (1 DOSE 11/05/23 15:06:00) ondansetron, Injection, 4 mg, IV Push, ONCE, prn, Nausea/Vomiting IV - Use First, (1 DOSE 11/05/23 15:06:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% - ED Bolus), Infusion, 500 mL, IVPB, ONCE, (1 DOSE 11/05/23 15:04:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% - ED Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 11/05/23 18:09:00) Sodium Chloride 0.9% (Sodium Chloride 0.9% - ED Bolus), Infusion, 1,000 mL, IVPB, ONCE, (1 DOSE 11/05/23 18:09:00) PRN Medications (0600 - 0559) from 11/04 - 11/05 HYDROmorphone, 1 mg, IV Push, Q10min, 0 Dose(s) Allergies morphine (Itching, Hives) Social History Alcohol Denies Electronic Cigarette/Vaping E-Cigarette Use Never. Employment/School Employed, Work/School description: GM x 10 years. Highest education level: Some college. Home/Environment (Married, has been together since 2013), Lives with Children, Spouse. Nutrition/Health Diet: Regular. Other Sexual Sexually active: Yes. History of sexual abuse: Yes. Other sexual concerns: Pt states she was sexually abused at age 10 by brother's friend. She states her first husband was physically abusive. ACE Score-5 Declines any counseling at present. States she had counseling in the past.. Substance Abuse Denies Tobacco Tobacco Use: Never (less than 100 in lifetime). Family History Alcoholism /alcohol abuse...: Mother and Father. Anxiety: Mother. Blood clot: Aunt. Breast cancer: Grandmother (M). COPD (chronic obstructive pulmonary disease)...: Mother. DVT (deep venous thrombosis)....: Aunt. Depression: Mother. Drug abuse: Father and Brother. Drug dependency...: Brother. Hepatitis c, chronic...: Father. Hypertension: Mother. Hypertension..: Father. Lung cancer..: Grandfather (P). Migraines..: Mother. Miscarriage: Mother. Myocardial infarction...: Grandfather (M). Rheumatoid arthritis: Mother. Skin cancer: Grandfather (M). Grandmother (P): History is negative Lab Results All Labs Last 24 hours (No Micro or Pathology) Hematology: WBC: 14.4 k/cumm High (11/05/23 14:51:00) RBC: 3.4 million/cumm Low (11/05/23 14:51:00) Hgb: 10.1 GM/dL Low (11/05/23 14:51:00) Hct: 29.7 % Low (11/05/23 14:51:00) MCV: 88 fL (11/05/23 14:51:00) MCH: 29.6 pg (11/05/23 14:51:00) MCHC: 33.9 GM/dL (11/05/23 14:51:00) RDW: 13.7 % (11/05/23 14:51:00) Platelet: 238 k/cumm (11/05/23 14:51:00) MPV: 8 fL (11/05/23 14:51:00) Neutrophils %: 84 % (11/05/23 14:51:00) Lymphocytes %: 4 % (11/05/23 14:51:00) Monocytes %: 12 % (11/05/23 14:51:00) Eosinophils %: 0 % (11/05/23 14:51:00) Basophils %: 0 % (11/05/23 14:51:00) Absolute Neutrophil: 12.1 k/cumm High (11/05/23 14:51:00) Absolute Lymphocyte: 0.5 k/cumm Low (11/05/23 14:51:00) Absolute Monocyte: 1.8 k/cumm High (11/05/23 14:51:00) Absolute Eosinophil: 0 k/cumm (11/05/23 14:51:00) Absolute Basophil: 0 k/cumm (11/05/23 14:51:00) Chemistry: Sodium SerPl QN: 138 mmol/L (11/05/23 14:51:00) Potassium SerPl QN: 2.8 mmol/L Critical (11/05/23 14:51:00) Chloride SerPl QN: 103 mmol/L (11/05/23 14:51:00) Carbon Dioxide SerPl QN: 24 mmol/L (11/05/23 14:51:00) Anion Gap: 11 mmol/L (11/05/23 14:51:00) BUN SerPl QN: 12 mg/dL (11/05/23 14:51:00) Creatinine SerPl QN: 0.84 mg/dL (11/05/23 14:51:00) Estimated GFR (CKD-EPI, no race): >90 (11/05/23 14:51:00) Estimated CRCL (CG): 74 mL/min (11/05/23 14:51:00) Glucose SerPl QN: 93 mg/dL (11/05/23 14:51:00) Calcium Total SerPl QN: 8.2 mg/dL Low (11/05/23 14:51:00) Alkaline Phos SerPl QN: 164 Units/L High (11/05/23 14:51:00) ALT SerPl QN: 75 Units/L High (11/05/23 14:51:00) AST SerPl QN: 53 Units/L High (11/05/23 14:51:00) Bilirubin Total SerPl QN: 1 mg/dL (11/05/23 14:51:00) Total Protein SerPl QN: 6.4 GM/dL (11/05/23 14:51:00) Albumin SerPl QN: 3.4 GM/dL Low (11/05/23 14:51:00) Lipase SerPl QN: 12 Units/L (11/05/23 14:51:00) Troponin-I High Sensitivity: 7 ng/L (11/05/23 15:57:00) Lactate Venous Pl QN: 0.7 mmol/L (11/05/23 14:51:00) Coagulation: D-Dimer Pl QN: 304 ng/mL DDU High (11/05/23 14:51:00) Urine Studies: Pregnancy Test Urine: Negative (11/05/23 14:34:00) Color: Yellow (11/05/23 14:34:00) Clarity: Slightly Cloudy (11/05/23 14:34:00) Specific Gravity: 1.022 (11/05/23 14:34:00) pH: 6 (11/05/23 14:34:00) Protein: 100 Abnormal (11/05/23 14:34:00) Glucose: Normal (11/05/23 14:34:00) Ketones: 20 Abnormal (11/05/23 14:34:00) Bilirubin: NEGATIVE (11/05/23 14:34:00) Hgb Ur: TRACE. Abnormal (11/05/23 14:34:00) Nitrite: Positive 2+ Abnormal (11/05/23 14:34:00) Urobilinogen: 2.0 2 Abnormal (11/05/23 14:34:00) Leukocyte Esterase Ur: Large500 Abnormal (11/05/23 14:34:00) WBC: >100 Abnormal (11/05/23 14:34:00) RBC: 11-20 Abnormal (11/05/23 14:34:00) Bacteria: Many Abnormal (11/05/23 14:34:00) Squamous Epithelial: Few (11/05/23 14:34:00) Mucous: PRESENT. (11/05/23 14:34:00) Hyaline Casts: 3-5 (11/05/23 14:34:00) All Other Labs: COVID 19 Specimen Source: Nasal (11/05/23 14:34:00) Coronavirus SARS-CoV2 Rapid: Detected Abnormal (11/05/23 14:34:00) Micro - Last 7 days Rapid Influenza Method: PCR - Liat (11/05/23 14:34:00) Rapid Influenza A PCR: Not Detected (11/05/23 14:34:00) Rapid Influenza B PCR: Not Detected (11/05/23 14:34:00) Diagnostics Radiology Results - Last 24 hours Across Visits 11/05/2023 16:55 - CTA Abd/Pelvis WO/W IV Contrast IMPRESSION:1. Negative for aortic dissection.2. Findings most consistent with RIGHT worse than LEFTpyelonephritis. No evidence of ureteral obstruction.3. Small volume free fluid in the pelvis may be physiologic in areproductive age female.4. Borderline splenomegaly.Thank you for consulting our team of subspecialty radiologists at Physicians Radiology. 11/05/2023 16:55 - CTA Chest WO/W IV Contrast IMPRESSION:1. No acute findings in the chest. Abdominopelvic findings reportedseparately.Thank you for consulting our team of subspecialty radiologists at Physicians Radiology. Signature Line Electronically Signed on 11/05/23 20:35 EST ________________________________________________________ MD

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma scale
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2668603

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
-
Alter
72,0
Geschlecht
M
Eingang
09.08.2023
Impfdatum
14.01.2022
Beginn
12.01.2023
Tage bis Beginn
363,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Cerebral artery occlusion Cerebrovascular accident Reversible ischaemic neurological deficit

Symptomtext

ACUTE STROKE DUE TO OCCLUSION OF LEFT MIDDLE CEREBRAL ARTERY REVERSIBLE ISCHEMIC NEUROLOGIC DEFICIT SYNDROME

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebrovascular accident
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2667706

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
-
Alter
48,0
Geschlecht
F
Eingang
08.08.2023
Impfdatum
02.02.2022
Beginn
23.01.2023
Tage bis Beginn
355,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Symptom recurrence

Symptomtext

ACUTE RESPIRATORY FAILURE 1/30/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2659342

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

kritisch
Staat
-
Alter
83,0
Geschlecht
F
Eingang
21.07.2023
Impfdatum
31.01.2022
Beginn
14.09.2022
Tage bis Beginn
226,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute myocardial infarction Acute respiratory failure Aortic arteriosclerosis Colitis

Symptomtext

ACUTE NON ST ELEVATION MI 4/24/2023 COLITIS ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/24/2023 COLITIS ACUTE NON ST ELEVATION MI 4/24/2023 ATHEROSCLEROSIS OF AORTA ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/24/2023 ATHEROSCLEROSIS OF AORTA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2645284

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
-
Alter
81,0
Geschlecht
M
Eingang
14.06.2023
Impfdatum
25.01.2022
Beginn
21.12.2022
Tage bis Beginn
330,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute myocardial infarction

Symptomtext

ACUTE NON ST ELEVATION MI ACUTE MI

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute myocardial infarction
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2634896

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

kritisch
Staat
FL
Alter
85,0
Geschlecht
F
Eingang
22.05.2023
Impfdatum
30.12.2021
Beginn
05.06.2022
Tage bis Beginn
157,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Blood culture negative COVID-19 Chronic kidney disease Condition aggravated Constipation Encephalopathy Endotracheal intubation Essential hypertension Hyperlipidaemia Hypotension Intensive care Mechanical ventilation Pancreatic disorder Pleural effusion SARS-CoV-2 test positive Senile dementia Septic shock

Symptomtext

BREAKTHROUGH COVID: PT FULLY VACCINATED. 85-year-old female admitted to intensive care unit during a septic shock, necessitating mechanical ventilation and vasopressors for the 1st 48 hours of the hospitalization, when she was extubated successfully and vasopressors were able to be discontinued, antibiotic therapy with fosfomycin and doxycycline. Subsequent blood cultures follow-up were negative. Patient diagnosed with COVID 19 infection, possible the triggered the acute respiratory failure necessitating mechanical ventilation at the time of admission. Patient was treated with Decadron, as well as with 5 days of remdesivir, which she completed both treatments here in the hospital. On June 16th patient was considered non infectious and will be able to transition to the skilled nurse facility. Primary Discharge Diagnosis: Acute Hypoxemic Respiratory Failure, requiring intubation. Extubated 6/7, COVID-19 Positive, Bilateral Pleural Effusions,Severe sepsis with shock, Acute encephalopathy secondary to sepsis, Senile Dementia, Nonspecific radiographic changes on pancreas, Chronic kidney disease, Essential hypertension, Hypotension upon admission, Hyperlipidemia, AND Constipation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
13,0
Labordaten
-
Aktuelle Erkrankungen
UNKNOWN
Vorgeschichte
DEMENTIA, Chronic kidney disease, ESSENTIAL HYPERTENSION,
Andere Medikamente
UNKNOWN
Allergien
EGGS
Vorherige Impfungen
-

VAERS 2634400

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

kritisch
Staat
-
Alter
55,0
Geschlecht
M
Eingang
19.05.2023
Impfdatum
04.02.2022
Beginn
18.10.2022
Tage bis Beginn
256,0
Dosis
3
Route/Site
UN / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Acute respiratory failure Pneumonia

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE 10/18/2022 PNEUMONIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2624832

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

kritisch
Staat
-
Alter
79,0
Geschlecht
M
Eingang
02.05.2023
Impfdatum
22.01.2022
Beginn
05.06.2022
Tage bis Beginn
134,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Hypoxia Respiratory failure

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY HYPOXIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2624015

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

kritisch
Staat
-
Alter
24,0
Geschlecht
M
Eingang
01.05.2023
Impfdatum
01.02.2022
Beginn
18.07.2022
Tage bis Beginn
167,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure

Symptomtext

PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE ACUTE RESPIRATORY FAILURE HYPOXIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2617547

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
-
Alter
84,0
Geschlecht
F
Eingang
19.04.2023
Impfdatum
14.09.2022
Beginn
26.10.2022
Tage bis Beginn
42,0
Dosis
5
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Acute respiratory failure Hypoxia

Symptomtext

ACUTE HYPOXEMIC RESPIRATORY FAILURE HYPOXIA

Weitere VAERSDATA-Felder
Praegender Schweregrund
Acute respiratory failure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2523210

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

kritisch
Staat
SD
Alter
86,0
Geschlecht
F
Eingang
05.12.2022
Impfdatum
07.04.2022
Beginn
21.09.2022
Tage bis Beginn
167,0
Dosis
4
Route/Site
SYR / RA
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
COVID-19 Death Decreased appetite Fatigue Hypoxia Malaise Oropharyngeal pain Pneumonia Pyrexia SARS-CoV-2 test positive Unresponsive to stimuli Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Moderna product on 03/04/2021, 04/01/2021, 11/11/2021, and 04/07/2022. They first tested positive via antigen test at the long term care facility at which they were a resident on 09/21/2022. They presented to emergency department on 09/25/2022 with sore throat, fever, malaise, decreased appetite, and fatigue. They were admitted to hospital and found to have bronchopneumonia and to be hypoxic. They were discharged back to the long term care facility on 09/28/2022. They then presented to emergency department on 10/10/2022 with a chief complaint of "a brief episode of unresponsiveness while eating" which was possibly attributed to choking. They were discharged back to the long term care facility, on hospice on 10/11/2022. They were seen by the LTCF provider on 10/12/2022 and hospice status was confirmed. They died on 10/17/2022. Even with the length of time between the positive COVID-19 test and the death, COVID-19 is on the death certificate.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
8,0
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Type II Diabetes, Dyslipidemia, Vascular Dementia, Hypertension The individual was a resident of the long-term care facility indicated in the Address portion of this form.
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2296282

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
-
Alter
83,0
Geschlecht
F
Eingang
26.05.2022
Impfdatum
08.04.2022
Beginn
14.04.2022
Tage bis Beginn
6,0
Dosis
UNK
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute kidney injury Death Morganella infection Proteus infection

Symptomtext

DEATH N17.9 - Acute kidney failure, unspecified B96.4 - Proteus (mirabilis) (morganii) as the cause of diseases classified elsewhere

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2257142

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
-
Alter
58,0
Geschlecht
M
Eingang
28.04.2022
Impfdatum
27.01.2022
Beginn
28.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
- / -
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Agonal respiration COVID-19 Death Endotracheal intubation Loss of consciousness Mental status changes Pulse absent Resuscitation SARS-CoV-2 test positive

Symptomtext

pt brought to ED (Hospital) via EMS; pt lost consciousness while transferring to bed at home; acute change in mental status; pt with agonal respirations; positive for COVID; intubated then found to be pulseless; CPR but no rhythm ever obtained; pt passed away in the ED; pt received COVID booster vaccine the day before her death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Anemia, COPD, DM, HTN, obesity
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2171098

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
VA
Alter
44,0
Geschlecht
M
Eingang
10.03.2022
Impfdatum
25.01.2022
Beginn
26.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Asthenia Computerised tomogram head Electroencephalogram Feeling cold Impaired work ability Magnetic resonance imaging Nausea Pallor Postictal state Respiratory arrest Scan with contrast Seizure Tongue biting Vomiting

Symptomtext

Patient complained of feeling cold, nauseated when getting up in the morning and stated that he had felt cold all night long and could not get warm. Appearance was pale. Dressed in multiple layers of clothing. Rode with me in the car as to not leave him alone. While sitting in the car he became more nauseated and vomited. When he leaned back onto the car seat he began to seize biting his tongue and then stopped breathing. Pulse was present. 911 called. Breathing gradually returned. EMS took him to the hospital where he remained for 4-6 hours. He was released from the hospital after the post distal stage passed and he could function. He was so weak that he did not return to work for 10 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Respiratory arrest
Hospital-Tage
-
Labordaten
Laboratory test CT of the Head Follow up with Neurologist Additional tests MRI with and without contrast /. And EEG. /. Increase in Seizure medication to 300 mg bid Follow up with Primary Care Physician
Aktuelle Erkrankungen
None
Vorgeschichte
Epilepsy
Andere Medikamente
Lamictal 250 mg bid Atorvastatin 40 mg daily MVI
Allergien
No Known food allergies Environmental - caterpillars
Vorherige Impfungen
-

VAERS 2087717

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j212a

kritisch
Staat
KY
Alter
54,0
Geschlecht
M
Eingang
04.02.2022
Impfdatum
26.01.2022
Beginn
04.02.2022
Tage bis Beginn
9,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Brain operation Cerebral haemorrhage Haemorrhagic stroke

Symptomtext

Report of patient hemorragic stroke with brain bleed, patient is reportedly in surgery at the moment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cerebral haemorrhage
Hospital-Tage
2,0
Labordaten
unknown
Aktuelle Erkrankungen
NONE REPORTED
Vorgeschichte
BLOOD PRESSURE, ACID REFLUX
Andere Medikamente
NONE REPORTED
Allergien
NONE REPORTED
Vorherige Impfungen
-

VAERS 2087181

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
AZ
Alter
75,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
24.01.2022
Beginn
01.01.2022
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bone pain Chills Fear of death Feeling abnormal Insomnia Pain Pain in extremity Vaccination site erythema Vaccination site infection Vaccination site pain

Symptomtext

Potential infection at injection site; More pain at injection site; Redness around the injection area that is about 4.5 inches long and 4.5 inches wide/ The redness appears to be spreading too; Chills and shivering; Felt strange; Arm felt like hammer; Unable to sleep at night; Pain like getting stabbed with pins was really bad; Aches and pain in her bones; she's scared to death; This spontaneous case was reported by a consumer and describes the occurrence of INSOMNIA (Unable to sleep at night), PAIN (Pain like getting stabbed with pins was really bad), BONE PAIN (Aches and pain in her bones), VACCINATION SITE INFECTION (Potential infection at injection site) and FEAR OF DEATH (she's scared to death) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Previously administered products included for COVID-19 vaccination: Johnson & Johnson (First dose (Primary series)) on 10-Jul-2021. Past adverse reactions to the above products included No adverse event with Johnson & Johnson. On 24-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced FEAR OF DEATH (she's scared to death). On 25-Jan-2022, the patient experienced INSOMNIA (Unable to sleep at night), PAIN (Pain like getting stabbed with pins was really bad), BONE PAIN (Aches and pain in her bones), FEELING ABNORMAL (Felt strange), PAIN IN EXTREMITY (Arm felt like hammer) and CHILLS (Chills and shivering). On 26-Jan-2022, the patient experienced VACCINATION SITE INFECTION (Potential infection at injection site), VACCINATION SITE PAIN (More pain at injection site) and VACCINATION SITE ERYTHEMA (Redness around the injection area that is about 4.5 inches long and 4.5 inches wide/ The redness appears to be spreading too). At the time of the report, INSOMNIA (Unable to sleep at night), PAIN (Pain like getting stabbed with pins was really bad), BONE PAIN (Aches and pain in her bones), VACCINATION SITE INFECTION (Potential infection at injection site), FEAR OF DEATH (she's scared to death), FEELING ABNORMAL (Felt strange), PAIN IN EXTREMITY (Arm felt like hammer), VACCINATION SITE PAIN (More pain at injection site), VACCINATION SITE ERYTHEMA (Redness around the injection area that is about 4.5 inches long and 4.5 inches wide/ The redness appears to be spreading too) and CHILLS (Chills and shivering) outcome was unknown. No concomitant and treatment medications were reported. Patient put a large bandaid around the redness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fear of death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2046292

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

kritisch
Staat
MN
Alter
65,0
Geschlecht
M
Eingang
19.01.2022
Impfdatum
15.01.2022
Beginn
18.01.2022
Tage bis Beginn
3,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Pulmonary embolism SARS-CoV-2 test positive

Symptomtext

hospitalization, pulmonary emboli

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary embolism
Hospital-Tage
1,0
Labordaten
COVID-19 positive test result 1/18/22
Aktuelle Erkrankungen
-
Vorgeschichte
HTN, COPD
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2328990

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

schwer
Staat
AL
Alter
72,0
Geschlecht
M
Eingang
23.06.2022
Impfdatum
17.01.2022
Beginn
01.02.2022
Tage bis Beginn
15,0
Dosis
3
Route/Site
SC / AR
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Amnesia Blood testosterone decreased Central nervous system lesion Confusional state Endocrine disorder Intensive care Lethargy Lumbar puncture Magnetic resonance imaging head abnormal Nausea Noninfective encephalitis Ultrasound scan

Symptomtext

Began as slight nausea and progressed to lethargy and memory loss followed by symptoms related to endocrine system, e.g., drastic drop in testosterone determined by primary care physician. Symptoms progressed within days to drastic memory loss and confusion and within approximately three to four weeks to mri diagnosing inflammation of the brain presenting as 3 lesions positioned in center of brain positioned directly on hypothalamus. Initial diagnosis as potential lymphoma or neurosarcoidosis to completely "rare" as described hematologist/oncologist, Dr., and eventually neuro oncologist, Dr., Hospital. Hospitalization on April 27, 2022 into Hospital Neuro Critical Care with complete shutdown of endocrine system stemming from brain inflammation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Intensive care
Hospital-Tage
18,0
Labordaten
MRI's, ultrasounds, 4 lumbar punctures. Dates ranging from February 2022-April 17, 2022.
Aktuelle Erkrankungen
December, 2021 diagnosed with Covid-19
Vorgeschichte
High blood pressure
Andere Medikamente
Lasinipril (high blood pressure med) Supplements: Multivitamin, Vitamin D,
Allergien
none known
Vorherige Impfungen
-

VAERS 2231634

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

schwer
Staat
TN
Alter
41,0
Geschlecht
F
Eingang
13.04.2022
Impfdatum
28.01.2022
Beginn
02.03.2022
Tage bis Beginn
33,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein
Amnesia Chest pain Computerised tomogram Dysphemia Electrocardiogram Electroencephalogram Gait disturbance Heart rate decreased Hypotension Laboratory test Loss of personal independence in daily activities Magnetic resonance imaging Muscle spasms Repetitive speech Speech disorder Syncope X-ray

Symptomtext

After 1st vaccine-hypotension, low heart rate, generalized fatigue, muscle aches and spasms After 2nd vaccine-increased hypotension, low heart rate, syncopal episodes, severe muscle spasms, stuttering, short term memory loss, unable to ambulate without assistance, unable to complete ADLs without assistance., chest pain, unable to speak correctly, repeative speech

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
26,0
Labordaten
MRI. CT scans, lab work, eegs, xrays, ekgs
Aktuelle Erkrankungen
Covid 19 positive Jan 18, 2022
Vorgeschichte
fibromyalgia bipolar I with PTSD hypothyroidism menapause-complete hysterectomy 8/2016 narcolepsy
Andere Medikamente
Levothyroxine 0.125mcg daily Thiamine 100mg daily Bariatric multivitamin daily gabapentin 400mg three times a day xanax 1mg twice a day prn trintellex 10mg daily imitrex prn collagen tab daily estradiol 1mg daily Nuvigil 200mg daily
Allergien
trileptal, phenergan, demerol, stadol, toradol, tamiflu
Vorherige Impfungen
-

VAERS 2209099

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

schwer
Staat
VA
Alter
44,0
Geschlecht
F
Eingang
31.03.2022
Impfdatum
01.02.2022
Beginn
08.02.2022
Tage bis Beginn
7,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Anticoagulant therapy Computerised tomogram thorax abnormal Condition aggravated Hypertension Imaging procedure Oxygen saturation decreased Pulmonary thrombosis Respiratory rate increased Syncope

Symptomtext

A week after vaccination, patient was leaving a restaurant with family, she raced kids to the car where she collapsed. Emergency was called, BP was high respiration rate was high but O2 was low. Patient's vitals recovered after rest, she went home then symptoms came back when she went up the 7 stairs to get in her house, she called the squad and was taken to the ER at hospital. ER took vitals then did a CT that showed a blood clot in her right lung. ER started medication in IV and patient was admitted due to size of clot. She was airlifted to another hospital . More images were taken at hospital to determine if DVT was present. Patient was at hospital until 02/11/2022. Patient is currently on Eliquis 5mg every 12 hours until August and will follow-up with Dr. and pulmonology at the hospital

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pulmonary thrombosis
Hospital-Tage
3,0
Labordaten
CT scan in ER and multiple imaging studies at hospital
Aktuelle Erkrankungen
none
Vorgeschichte
high blood pressure; high cholesterol
Andere Medikamente
hctz 12.5mg po qam; life multivitamins 1 po qam; hair, skin and nails 2 gummies po qam; flaxseed cap 1 po qam; fish oil 500?mg 1 po qam ;
Allergien
none known
Vorherige Impfungen
-

VAERS 2099336

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

schwer
Staat
-
Alter
20,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Syncope

Symptomtext

Description of Event Pt received vaccination at 1205. Experienced dizziness with syncopal episode at 1224. Interventions:Patient given water, instructed to lie recumbent, vital signs taken, observed for 30 mins. Medications administered: none Response to interventions and/or medications given: Patient status improved. Disposition:Home Treatment Pt accompanied by mother.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2083060

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

schwer
Staat
SC
Alter
53,0
Geschlecht
F
Eingang
02.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Anaphylactic reaction Interchange of vaccine products Pharyngeal swelling Pruritus Swollen tongue

Symptomtext

Anaphylactic allergic reaction to the shot. Pt began with itching. Was given 25 mg liquid Benadryl, symptoms progressed to tongue swelling, then throat swelling, Epipen given and EMS called to the facility. Pt was treated with steroids' and a second Epipen

Weitere VAERSDATA-Felder
Praegender Schweregrund
Anaphylactic reaction
Hospital-Tage
-
Labordaten
Blood pressure and Pulse OX measurements were taken , not sure what other tests were performed at the hospital or by EMS
Aktuelle Erkrankungen
No
Vorgeschichte
High Blood Pressure, High cholesterol
Andere Medikamente
None
Allergien
Allergies to sudafed, doxycycline, moxifloxacin, azithromycin - has some food allergies also
Vorherige Impfungen
covid vaccine - janssen - mild itching, rash in mouth

VAERS 2079848

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

schwer
Staat
KS
Alter
21,0
Geschlecht
M
Eingang
01.02.2022
Impfdatum
01.02.2022
Beginn
01.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Blood glucose normal Fall Syncope

Symptomtext

Patient fainted and fell out of chair within 5 minutes of receiving vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
blood pressure (normal ) blood sugar (normal)
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
nka
Vorherige Impfungen
-

VAERS 2055477

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

schwer
Staat
IL
Alter
22,0
Geschlecht
M
Eingang
21.01.2022
Impfdatum
21.01.2022
Beginn
21.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Loss of consciousness Syncope

Symptomtext

Patient received COVID booster and fainted about 1 minute afterward while still sitting in the chair when pharmacist was cleaning arm and applying bandaid. Patient did announce he was feeling light headed to warn pharmacist before losing consciousness. Pharmacist called for help from the pharmacy and then patient was assisted to the floor to lay down when he regained consciousness during the process. Patient was given a jacket to rest his head on, an ice pack to place on his forehead and a bottle of water to drink. He remained laying down for 5 minutes, then tried sitting up but still felt lightheaded so laid back down. It took patient about 20 minutes to feel better and be able to get up and walk to a chair in front of the pharmacy for further observation. Patient sat in front of pharmacy for 10 more minutes and then left on his own after feeling better. He did not have any injuries and EMS was not contacted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
bipolar disorder
Andere Medikamente
Divalproex ER 500mg
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2054480

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

schwer
Staat
NC
Alter
49,0
Geschlecht
F
Eingang
21.01.2022
Impfdatum
18.01.2022
Beginn
20.01.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Bell's palsy Lacrimation increased

Symptomtext

Bell's Palsy - left eye began watering on Thursday, left side of mouth does not move when I smile, went to doctor on Friday (today) and he diagnosed me with Bell's Palsy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/A
Vorgeschichte
diabetes, HPB
Andere Medikamente
metformin, Synthroid, Zoloft, amlodipine, verapamil, fosinopril, Jardiance
Allergien
penicillin, Reglan, latex
Vorherige Impfungen
-

VAERS 2039263

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

schwer
Staat
MA
Alter
53,0
Geschlecht
F
Eingang
19.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Amnesia Dizziness Electrocardiogram normal Fall Fatigue Bradycardia Flushing Hyperhidrosis Hyporesponsive to stimuli Hypotension Depressed level of consciousness Dyskinesia Nausea Posture abnormal Gait disturbance Head injury Headache Illness

Symptomtext

Systemic: Fainting / Unresponsive-Severe, Systemic: Flushed / Sweating-Medium, Systemic: Hypotension-Medium, Additional Details: This NP was called to pharmacy waiting area after a pt reportedly passed out after a vaccine. Upon arrival at PT's side BP was 102/52 with a pulse of 52, Pt was alert but minimally verbal and would not clearly answer questions, EMS activated. No cervical tenderness noted, no seizure-like activity present, unsure of head strike. Pt was diaphoretic and lying supine, BP 2 min after arrival was 92/60 with a HR of 68. PT was intermittently bradycardic. Transported to Hospital by EMS.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2038450

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

schwer
Staat
KS
Alter
25,0
Geschlecht
M
Eingang
16.01.2022
Impfdatum
16.01.2022
Beginn
16.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Condition aggravated Seizure

Symptomtext

pt had a seizure around 15 minutes after vaccination while waiting in observation area

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
seizure disorder
Andere Medikamente
divalproex, levetiracetam
Allergien
-
Vorherige Impfungen
-

VAERS 2025750

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

schwer
Staat
VA
Alter
19,0
Geschlecht
F
Eingang
11.01.2022
Impfdatum
11.01.2022
Beginn
11.01.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Loss of consciousness Pain Pain in extremity

Symptomtext

patient received vaccine, was fine sitting in chair, stated she moved her arm and felt pain and passed out

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none noted
Vorgeschichte
none noted
Andere Medikamente
none noted
Allergien
nkda
Vorherige Impfungen
patient stated she had previously had this issue with other vaccines

VAERS 2015105

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

schwer
Staat
PA
Alter
22,0
Geschlecht
F
Eingang
07.01.2022
Impfdatum
07.01.2022
Beginn
07.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Blood glucose normal Dizziness Face injury Loss of consciousness Nausea Syncope

Symptomtext

PATIENT WAS SITTING AT STATION AND PASSED OUT AND BANGED LEFT SIDE OF FACE AND FAINTED ON TO THE FLOOR. 911 WAS CALLED, PATIENT ASKED "WHERE AM I?" AND COULD NOT RECOGNIZE MOM. AFTER ABOUT 30 SECONDS PATIENT RECOGNIZED MOM AND THEN SAID SHE REMEMBERED FEELING LIGHTHEADED BUT NOTHING ELSE FROM THE INCIDENT. EMS TOOK BLOOD PRESSURE AND GLUCOSE READING WHICH WERE NORMAL BUT THE PATIENT FELT NAUSEA SO SHE WAS PUT ON STRETCHER AND

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
NORMAL BLOOD PRESSURE AND GLUCOSE READING
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
GLUTEN
Vorherige Impfungen
-

VAERS 2667746

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
-
Alter
45,0
Geschlecht
F
Eingang
08.08.2023
Impfdatum
28.01.2022
Beginn
23.02.2022
Tage bis Beginn
26,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Hypotension Symptom recurrence

Symptomtext

HYPOTENSION 3/11/2022, 8/21/2022, 11/21/2022, 11/29/2022, 3/14/2023, 2/4/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypotension
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2617608

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
MI
Alter
71,0
Geschlecht
F
Eingang
19.04.2023
Impfdatum
15.04.2022
Beginn
14.09.2022
Tage bis Beginn
152,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Ageusia Anosmia COVID-19 Cough Migraine Oropharyngeal pain SARS-CoV-2 test positive

Symptomtext

9/14/22 I had a bad sore throat, low in the neck. It lasted for four hours, then disappeared. I began coughing. Then I got a migraine for four hours, then it went away. My sense of taste and smell were gone. I took an at home COVID test that was positive. I emailed my doctor?s office and the doctor said I did not need an anti-viral for this type of COVID. The cough was horrible, and I could not stop coughing. In January the doctor prescribed a cough medication, pills, and warm honey that did not work. I continue to have the cough, but it is better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Migraine
Hospital-Tage
-
Labordaten
14SEPT23-At Home COVID Test-Positive
Aktuelle Erkrankungen
None
Vorgeschichte
High Blood Pressure
Andere Medikamente
Vitamin E, Hydrochlorothiazide, Multi Vitamin, Bio Complete Probiotic
Allergien
Penicillin, Sulfa Drugs
Vorherige Impfungen
-

VAERS 2570042

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
AL
Alter
52,0
Geschlecht
F
Eingang
29.01.2023
Impfdatum
30.03.2022
Beginn
01.06.2022
Tage bis Beginn
63,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Acoustic stimulation tests abnormal Condition aggravated Deafness unilateral Electronystagmogram Impaired work ability Meniere's disease Speech disorder Tinnitus Vertigo

Symptomtext

Approximately 3 months after receiving the booster Covid vaccine, I developed an echo in my left ear resulting in significantly reduced speech discernment. I also had a significant increase in meneires vertigo attacks resulting in missed work. As of December 16th, 2022 I am completely deaf in my right ear.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
Hearing test- 09/06/2022, 10/07/2022, 01/13/2023 VNG- 10/12/2022
Aktuelle Erkrankungen
-
Vorgeschichte
Meneires disease
Andere Medikamente
Yes
Allergien
Sulpha drugs, augmentum
Vorherige Impfungen
Jansen Covid vaccine 03/12/2021, age 51

VAERS 2564482

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
NJ
Alter
51,0
Geschlecht
M
Eingang
20.01.2023
Impfdatum
24.01.2022
Beginn
05.02.2022
Tage bis Beginn
12,0
Dosis
1
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anxiety Asthma Dyspnoea Histamine level increased Parosmia Pruritus Rash

Symptomtext

My immune system went into overdrive and produced an overwhelming amount of histamines. I had a rash for weeks, developed asthma, itched on my scalp and other parts of my body. Developed severe anxiety. Developed ghost smells of things that were not present in my environment. I was prescribed some OTC and prescription strength medications including: METHYLPREDNISOLONE 4 MG DOSEPK, LEVALBUTEROL TAR HFA 45MCG INH HFA AEROSOL INHALER, WIXELA 100-50 INHUB BLISTER WITH DEVICE, MONTELUKAST SOD 10 MG TABLET, QVAR REDIHALER 80 MCG HFA AEROSOL BREATH ACTIVATED, SYMBICORT 160-4.5 MCG INHALER HFA AEROSOL INHALER, Pepcid AC and Benadryl. My severe symptoms lasted for more than 90 days and I still suffer from time to time with itching all over my body and some difficulty breathing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Had Omnicron from 12/26/21 to 12/31/21
Vorgeschichte
Borderline high blood pressure and cholesterol
Andere Medikamente
Atorvastatin, Lisinopril, Multivitamin
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2477943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
CA
Alter
33,0
Geschlecht
M
Eingang
13.10.2022
Impfdatum
31.03.2022
Beginn
31.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: ja Erholt: nein
Blood test Cough Dysphonia Dyspnoea Gait disturbance Limb injury Oropharyngeal pain Pain Pulmonary congestion Pulmonary function test Rheumatoid factor SARS-CoV-2 test negative Sleep study Sputum discoloured Vocal cord paresis X-ray

Symptomtext

Frequent severe coughing attacks, at one point I damaged my shoulders and experienced excruciating pain walking between May and June Difficulty breathing. I have shortness of breath, overproduction of thick green phlegm, change in voice (likely some form of vocal paresis), regular severe pain in throat, and regular lung congestion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
April 15th, Negative Covid-19 Test at Private Provider April 19th, 2022, Went to Hospital Over Difficulty Breathing, Medical Examination plus X-Rays at local Hospital. May 4th, 2022, General Blood Test May 31st, 2022, X-rays at Imaging center. June 2nd, 2022, Sleep Lab Done at local Sleep Clinic. June 5th, Negative Covid-19 Test at Private Provider August 17th, 2022, Lung Breathing Exam in Doctor Office September 1st, 2022, Rheumatology Panel
Aktuelle Erkrankungen
None.
Vorgeschichte
Mild allergies to dust, pollen and certain nuts.
Andere Medikamente
None.
Allergien
Mild allergies to dust, pollen and certain nuts.
Vorherige Impfungen
-

VAERS 2414811

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

moderat
Staat
GA
Alter
56,0
Geschlecht
M
Eingang
18.08.2022
Impfdatum
07.04.2022
Beginn
01.05.2022
Tage bis Beginn
24,0
Dosis
1
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Condition aggravated Hypertension

Symptomtext

Hypertension has risen since last booster shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Hypertension
Vorgeschichte
Hypertension
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2303496

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
WA
Alter
72,0
Geschlecht
F
Eingang
31.05.2022
Impfdatum
17.04.2022
Beginn
21.04.2022
Tage bis Beginn
4,0
Dosis
4
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Anticoagulant therapy Atrial fibrillation Blood potassium decreased Blood test abnormal Chest X-ray normal Dyspnoea exertional Echocardiogram normal Electrocardiogram abnormal Extra dose administered Fatigue Feeling cold Feeling jittery Heart rate increased Mobility decreased Nasopharyngitis Pain Pyrexia SARS-CoV-2 test negative

Symptomtext

On the morning of April 21, 2022, around 9-10 AM, I felt very jittery like I had too much caffeine. At some point in the morning, I put on my pulse oximeter and checked my oxygen saturation and heart rate. My rate was between 113-140. Every time I checked it would be slightly different. My oxygen was in the normal range between 94-96. I thought that was very odd that my heart rate was that fast. I didn't have any other symptoms other than feeling jittery, feeling fatigued, and having a rapid heart rate. I called my doctor's office to see if I could be seen and they didn't have an appointment for that day. I told them I needed to be seen sooner and they said to go to the urgent care facility. It was around 3pm when I went over there and a nurse practitioner examined me and did an EKG. When he returned, he noted that I was in afib and he recommended to go to the ER at the near by hospital. It was a little alarming to me because he said I shouldn't go home and I needed someone to take me there. My husband came back and picked me up and drove me to the emergency room at Medicine Hospital. We walked in and I had a print out from the urgent care that had determined I was in afib. They told me it was going to be a long wait. I got into a room within 5 minutes, had an IV and another EKG, Chest x-ray, and COVID swab. I saw the emergency doctor and there was discussion about being in afib and they noted it would be better to be seen by a cardiologist. I was there for about 5 hours. 5pm-10pm. they determined that I was handling my heart rate well and started me on a blood thinner Eliquis 5mg twice daily. They started me on a beta blocker Metoprolol 25mg twice daily. They also did give me some potassium as well because the potassium was low on my blood work. They administered those to me in the hospital and watched me. When they got my heart rate down to 100 and lower, and testing to see if I was actively having a heart attack. They determined I didn't have one and I wasn't having one. About 10pm, my husband came back and got me. They gave me a referral to see a cardiologist and told me to take the Eliquis and metoprolol at home. They told me to make an appointment with the cardiologist in their department. My heart rate managed to stay around 100 or lower. The next day I called their cardiology department and made the appointment for April 28. At that appointment, we did another EKG and I was still in afib and talked about my treatment. They recommended an echocardiogram which I did on May 13, 2022. I am scheduled to have a cardioversion on June 10, 2022. She talked about what the cardioversion would do and what other options there were if the cardioversion did not work. I do have an appointment for July 29 with another cardiologist for a procedure called an ablation if the cardioversion does not work. I've continued to take the blood thinner and beta blocker twice daily. My symptoms are that I get short of breath if I exert myself exercise, climbing stairs, etc. I have to stop and I'm just tired all the time. My cardiologist said that the symptoms of the beta blocker is fatigue. So between the afib and the treatment, I can't tell which is making me tired. But I'm just tired. I'm active with walking 3 times a week, gardening ? all of that stuff has been left to the side for the mean time. On top of this, just recently caught a cold on May 21.The day I got the 4th vaccine, I didn't have any reaction that day. But the next day, I was in bed all day. Chills, fever aches. The 19th those effects were gone I was still fatigued. 20th I was fatigued. 21st I was still fatigued as well and that's when I decided to put on the pulse oximeter. I could have gone into afib earlier, but I wasn't sure. The doctor told me that the echocardiogram could tell if there was any heart damage, but luckily there has been no damage.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea exertional
Hospital-Tage
-
Labordaten
04/21/2022 - EKG Urgent Care - Afib, 04/21/2022 - EKG ER - Afib, 04/21/2022 - Chest X-ray ER - nothing indicated, 04/21/2022 - COVID Test ER - negative, 05/13/2022 - Echocardiogram - Cardiologist - Heart function normal, no damage indicated from afib
Aktuelle Erkrankungen
None
Vorgeschichte
Hx of skin cancers ? Basal cell carcinomas, Hx of kidney stones
Andere Medikamente
Hydrochlorothiazide 12.5mg daily, Vitamin D3 1000mg daily, Vitamin B12 25,000mcg daily, Premarin 0.625mg twice weekly, Possibly Aleve as needed
Allergien
Erythromycin - hives
Vorherige Impfungen
-

VAERS 2278126

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
MI
Alter
41,0
Geschlecht
F
Eingang
16.05.2022
Impfdatum
20.01.2022
Beginn
15.05.2022
Tage bis Beginn
115,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Dyspnoea Influenza A virus test positive Influenza B virus test positive Oropharyngeal pain SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough COVID infection. Sore throat and some SOB

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Positive SARS-CoV-2 (COVID-19) and Influenza AB by Nucleic Acid Amplification on 5/15/2022
Aktuelle Erkrankungen
-
Vorgeschichte
Morbid obesity, chronic kidney disease, congestive heart failure, anemia of chronic disease, hyperkalemia, end stage renal disease, hyperlipidemia
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2260620

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
CA
Alter
71,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
16.03.2022
Beginn
17.03.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Computerised tomogram head normal Confusional state Dysarthria Pyrexia Tremor

Symptomtext

Confusion, slurred speech, fever, both hands with tremor

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
Pt left ER AMA on the day she developed symptoms. CT head done as outpatient 3/29/2022 was normal
Aktuelle Erkrankungen
had appointments for chronic pain from lumbar spinal stenosis. bilat carpal tunnel syndrome approximately within 1mo prior
Vorgeschichte
chronic pain from lumbar stenosis, osteoarthritis. bilat carpal tunnel syndrome, hypertension, gallstones, osteoporosis, chronic anemia, peripheral edema, hx poliomyelitis, hx gastritis, hx anemia, vitamin D deficiency
Andere Medikamente
Morphine, Oxycodone, Gabapentin, Albuterol, Hyzaar, Magesium- Oxide, Alendronate, MVI, Tylenol
Allergien
Cymbalta (rash)
Vorherige Impfungen
-

VAERS 2260344

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
NY
Alter
67,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
16.03.2022
Beginn
25.04.2022
Tage bis Beginn
40,0
Dosis
4
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Anosmia COVID-19 Dyspnoea Fatigue Headache Malaise Oropharyngeal pain Pain in extremity Productive cough SARS-CoV-2 test positive Sinus pain Sputum discoloured

Symptomtext

AE- sore arm for 36 hours and a headache for about 2 days. I did not have fever. 04/25/2022 - I started feeling sick, sore throat, then I had a barking sort of cough, but it was productive, originally was clear and then started getting yellowish-tint. Loss of sense of smell. Pain in my left maxillary sinus and frontal sinus. The symptoms prompted me to take a COVID-19. I took a home test, one in the morning BinaxNow was negative. I did Flo fax at home that night- negative. I took the PCR test-04/27/2022, I got the results, 04/28/2022- it was positive. I talked to the nurse, given my diagnosis, I was given Paxlovid- 4/28/2022, I started it on late afternoon. I am not totally better, but I am feeling better than 2 days. I have noticed overwhelming tiredness. I have been sleeping for like 10 hours and I never sleep for 10 hours. Unknown because I noticed I was feeling better one night and I was feeling worse when I woke up. I have also noticed I am more short of breath than I usually am. I am getting better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
PCR COVID-19 Test 04/27/2022 - results 04/28/2022 -positive
Aktuelle Erkrankungen
no
Vorgeschichte
lung cancer- I never smoked - diagnosed 04/2018, asthma, 6 sinus surgeries in hospitals and a lot of minor procedures over the years, history of sinus infections, hyperactive gall bladder - bladder surgery 02/2021
Andere Medikamente
Levo albuterol inhaler, Singulair, Allegra, Memantine, Sunosi, Warfarin, Crestor, Alprazolam, Bupropion, Dexilant, Co-Q-10, Folgard, Preservision vitamins, vitamin B-2, Vitamin D-3, grape seed extract, Pepcid, L-arginine
Allergien
nutmeg - anaphylactic reaction, opioids - I throw up within seconds
Vorherige Impfungen
-

VAERS 2244071

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
CO
Alter
36,0
Geschlecht
F
Eingang
20.04.2022
Impfdatum
22.12.2021
Beginn
27.01.2022
Tage bis Beginn
36,0
Dosis
2
Route/Site
SYR / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Colitis ulcerative Colonoscopy abnormal Condition aggravated Diarrhoea Diarrhoea haemorrhagic

Symptomtext

Diarrhea starting 1/6/2022 that hasn't stopped. Got substantially worse after 2nd dose with blood and mucus. Diagnosed as Ulcerative Colitis.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
Colonoscopy at facility.
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
Zyrtec
Allergien
Celebrex
Vorherige Impfungen
-

VAERS 2228602

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
FL
Alter
65,0
Geschlecht
F
Eingang
12.04.2022
Impfdatum
28.07.2021
Beginn
10.04.2022
Tage bis Beginn
256,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 Chest X-ray normal Chest pain Dizziness Dyspnoea Productive cough Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection Wheezing

Symptomtext

Covid19 breakthrough. 1st vaccine received on 07/06/2021. 66 y/o female with PMHX of ESRD on hemodialysis MWF, Asthma, CAD s/p PCI 2017, HTN, gastritis, DM, Hypothyroidism, scolosis presents to ED with c/o SOB, wheezing, productive cough, dizziness and chest pain x1 day. Room air sat 97%, CXR with no focal consolidation and pt with low grade temps. Treated with IV steroids. Covid severity score=0 per Admitting MD.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
SARS CoV 2 PCR Covid19- Detected on 04/10/2022
Aktuelle Erkrankungen
-
Vorgeschichte
ESRD on Hemodialysis MWF, Asthma, CAD s/p PCI 2017, HTN, Gastritis, DM, Hypothyroid, scolosis
Andere Medikamente
-
Allergien
Azithromycin, Dust
Vorherige Impfungen
-

VAERS 2213979

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
TX
Alter
69,0
Geschlecht
F
Eingang
04.04.2022
Impfdatum
03.03.2022
Beginn
01.04.2022
Tage bis Beginn
29,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
Asthenia Differential white blood cell count Full blood count Laboratory test Mobility decreased Muscular weakness Red blood cell sedimentation rate Urine analysis

Symptomtext

Patient was on her knees accessing a drawer last night and then she acutely could not get up and felt profound weakness to her feet and legs. She had to "scooch" herself across the room which took a couple of hours. She denied any loss of bladder or bowel control. She basically lost her motor strength to her legs but she reports she could feel sensation to her legs. She denied any vision or swallowing problems.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
CBC and Dif on 04/2/22 ESR, Westergreen on 04/2/22 Routine Chemistry on 04/2/22 Cardiac markers on 04/2/22 UA macroscopic on 04/2/22
Aktuelle Erkrankungen
Pt. report having a head cold 3 weeks ago.
Vorgeschichte
Past medical history: HTN Sciatica HLD Hypothyroid
Andere Medikamente
carvedilol 6.25 mg PO BID clonidine 0.1 mg PO QID Duloxetine 60 mg PO HS gabapentin 300 mg PO TID hydralazine 25 mg 2.5 tabs PO BID lisinopril 40 mg (2 tabs) PO Daily nystatin topical 1 app TID Levothyroxine 112 mcg PO qday Atorvastatin 40
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2193029

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
CA
Alter
37,0
Geschlecht
M
Eingang
22.03.2022
Impfdatum
15.03.2022
Beginn
16.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest discomfort Chest pain Chills Discomfort Headache Hyperhidrosis Injection site pain Lethargy Limb discomfort Muscle spasms Oedema peripheral Pain Pain in extremity Paraesthesia Pyrexia

Symptomtext

After the shot I experienced severe pain in my arm where the shot was administered which did not cease for 5 days after and felt like it slowly spread into the rest of my arm which lessened but felt uncomfortable for more than 5 days. It felt like my left arm was experiencing muscle spasms and aches from my shoulder down to my pinky. During the night around 8 p.m. I also began to feel the symptoms that were said to be normal after a COVID-19 vaccination such as fever, chills, lethargy, headaches, sweats, and body aches. What I didn't expect and what alerted me the most was what I began to feel at about 6:30 am on the following morning which was the inflammation under my armpits, I'm aware that my lymphatic sacs are located there. They swelled up until I was unable to put my arms to my sides and the discomfort was unbearable, I researched and called walk in clinics for help but I currently do not have insurance and I've been waiting to be approved for health care program. Simultaneously, I started to fill a sharp pain and tingling sensation in my chest around the area where my heart is. I felt a heavy pressure on my chest for several days and the swelling under my arms did not start to lessen for 5 straight days. I'm still feeling some discomfort and slight swelling under my arms and it has now been over a week since I was vaccinated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
None because I have no coverage or income to pay for a walk-in clinic.
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2178447

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

moderat
Staat
KY
Alter
38,0
Geschlecht
F
Eingang
14.03.2022
Impfdatum
24.01.2022
Beginn
21.02.2022
Tage bis Beginn
28,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Discomfort Heart rate increased Hypertension

Symptomtext

Late Jan started getting a crushing feeling and fast feeling heart rate. Ignored. In March, I had a health check up for my health insurance and my blood pressure was 170/110. I went to my doctor to confirm and I was 180/120 there. I have NEVER had high blood pressure before.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Hypertension
Hospital-Tage
-
Labordaten
3/10/2022 tests at doctor and full blood panel done to see if it was anything else.
Aktuelle Erkrankungen
Cold in early January, was not covid. Family members did have covid the week of the vaccination.
Vorgeschichte
None
Andere Medikamente
Zoloft, vitamin D, Allegra, multi vitamin, milk thistle
Allergien
None
Vorherige Impfungen
-

VAERS 2158329

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
04.03.2022
Impfdatum
05.02.2022
Beginn
07.02.2022
Tage bis Beginn
2,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Cardiomegaly Chest discomfort Dyspnoea Goitre Lung disorder SARS-CoV-2 test negative Splenomegaly Vaccination site reaction

Symptomtext

First COVID arm then started devolving tightness in chest and shortness of breath. Took CT scan went to the hospital 2/24 was told I had enlarged heart ground glass opacity of left lung. Left side of thyroid is enlarged. Spleen is enlarged.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
PCR- Negative
Aktuelle Erkrankungen
None
Vorgeschichte
High blood pressure
Andere Medikamente
Cardicemer, Hydrochlorothiazide, Lipitor, Xanax, Nexium Zyrtec
Allergien
None
Vorherige Impfungen
-

VAERS 2147171

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j212a

moderat
Staat
CA
Alter
54,0
Geschlecht
U
Eingang
26.02.2022
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dyspnoea Hypoaesthesia Lip swelling Swelling Swelling face

Symptomtext

Wife came in yesterday and said that her husband got the moderna booster at around 12pm and he started to have symptoms at 9pm that same day. He had swelling of the chin, face, lips and neck, sob, diff breathing, and numbness started from the right face to the left face. She took him to the urgent care and now he is all better and back to normal. Apologized to the wife that happened to her husband but she was fine she just wanted to let us know. She also said he got 2 moderna vaccines and he was fine just the 3rd dose he got really bad reactions. put in database and vaers

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2141079

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2A

moderat
Staat
CT
Alter
24,0
Geschlecht
F
Eingang
25.02.2022
Impfdatum
07.02.2022
Beginn
10.02.2022
Tage bis Beginn
3,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Asthenia Chest X-ray Computerised tomogram Full blood count Gait disturbance Laboratory test Magnetic resonance imaging Metabolic function test Speech disorder Tremor

Symptomtext

Tremors Speech abnormality Gait disturbance Weakness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
4,0
Labordaten
Mri C-X-ray Ct scan BMP CBC Drug withdrawal panel 2/10
Aktuelle Erkrankungen
None
Vorgeschichte
Depression
Andere Medikamente
Zoloft 100 Trazadone 100
Allergien
None
Vorherige Impfungen
-

VAERS 2140483

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
AL
Alter
34,0
Geschlecht
F
Eingang
25.02.2022
Impfdatum
23.02.2022
Beginn
23.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Erythema Fatigue Injected limb mobility decreased Pain Pain in extremity Peripheral swelling Tenderness

Symptomtext

Vaccine given on the afternoon of February 23, 2022 via intramuscular route in right deltoid. Waited 15 minutes with no immediate reaction or soreness. Arm soreness developed later that evening. On February 24, 2022, right arm became red and increasingly sore. Co-workers were able to visibly notice the area. That evening (24 hours after vaccine received), her arm became extremely sore, as well as experiencing body aches, chills and fatigue. The injection site arm became raised at this time. She was unable to lift arm above shoulder height without extreme pain. Took Tylenol Cold & Flu to help with aches and chills. On the morning of February 25, 2022, she can lift her arm somewhat better but is still very sore. She took four Advil 200 mg (800 mg total) and it helped some. Presently, arm is still very tender, sore, red, and raised. Area feels almost like a knot in the muscle.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injected limb mobility decreased
Hospital-Tage
-
Labordaten
None at this time
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
No known allergies
Vorherige Impfungen
-

VAERS 2139810

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
VA
Alter
61,0
Geschlecht
F
Eingang
25.02.2022
Impfdatum
18.02.2022
Beginn
19.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Impaired work ability Injection site warmth Mobility decreased Oedema peripheral Peripheral swelling Tenderness

Symptomtext

On Friday my left arm was swollen twice the normal size. Then on Saturday morning started around my left arm pit on left arm was swollen (described as small orange). The injection site was hot and had fever of 100.2. I stayed in bed all day Saturday and most of day on Sunday. My joint was aching and left arm was sore to touch. On Monday I stayed home from work due to the swelling contacted my doctor. I went to see my doctor on Tuesday he stated might was a draining from my lymph node advised me to take Aleve and apply cold compress. The swelling has gone down to normal.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
No
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
Shrimp, NatLax
Vorherige Impfungen
-

VAERS 2114243

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
PR
Alter
54,0
Geschlecht
M
Eingang
15.02.2022
Impfdatum
08.01.2022
Beginn
10.01.2022
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood pressure increased Palpitations

Symptomtext

Strong heart palpitations, increased blood pressure despite taking medications.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Enalapril 10mg, Pepcid 20mg, Simvastatin 40 mg.
Allergien
NO
Vorherige Impfungen
-

VAERS 2109663

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
CA
Alter
26,0
Geschlecht
M
Eingang
13.02.2022
Impfdatum
27.01.2022
Beginn
11.02.2022
Tage bis Beginn
15,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest pain Costochondritis Echocardiogram normal Electrocardiogram normal Laboratory test normal Oesophagitis Polyarthritis Troponin normal

Symptomtext

Polyarthritis without swelling/warmth/edema, chest pain worse with swallowing and movement (esophagitis, costochondritis?) Given NSAIDS, checked labs, EKG, troponin, all negative and reassuring. Echo of heart showed normal wall motion, no effusion. EKG normal. Discharged home with NSAIDS and pepcid.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
See above
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2098823

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
CA
Alter
45,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Chest discomfort Dizziness Dyspnoea Erythema Hyperhidrosis Interchange of vaccine products Throat irritation

Symptomtext

Provider was called to the Vaccine Clinic for possible reaction to find patient with mild labored breathing, diaphoretic and redness to bilateral upper extremities and chest. Patient began feeling SOB, chest tightness, and dizziness reported ~10 minutes following vaccine administration. O2 sat 100% RA, pulse upper 90s to low 100s, BP 120/82. After a few minutes, symptoms unchanged and patient reporting scratchiness to throat starting. Benadryl 50mg given PO, EMS called given worsening SX of SOB and new throat concerns. Patient received J&J x1 Oct 2021, no prior Moderna vaccine before today. Patient denied prior known allergic reactions to vaccines. Paramedics transported patient to ER for further evaluation/monitoring.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
None done.
Aktuelle Erkrankungen
Was being treated for possibly asthma/pneumonia via telephone appt.
Vorgeschichte
-
Andere Medikamente
albuterol inhaler, loratadine,
Allergien
lidocaine
Vorherige Impfungen
-

VAERS 2091660

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
CA
Alter
31,0
Geschlecht
F
Eingang
05.02.2022
Impfdatum
13.01.2022
Beginn
16.01.2022
Tage bis Beginn
3,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest pain Chills Fatigue Insomnia Menstruation delayed Muscular weakness Neuralgia Urinary tract infection

Symptomtext

Late menses, insomnia, UTI, chronic fatigue, body chills, muscle weakness, chest pain, extreme fatigue and nerve pain.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Shingles, narcolepsy, insomnia and chronic fatigue, frequent UTIs from Moderna #2 vaccine
Vorgeschichte
Chronic Epstein Barr, chronic Lyme disease
Andere Medikamente
Vyvanse 30mg
Allergien
-
Vorherige Impfungen
Shingles; narcolepsy; insomnia; UTI; BV; age 30; April 2021; Moderna vaccine #2.

VAERS 2087776

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2a

moderat
Staat
OK
Alter
29,0
Geschlecht
M
Eingang
04.02.2022
Impfdatum
01.02.2022
Beginn
02.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Angina pectoris Anxiety Blood test Chest X-ray Chest pain Dyspnoea Electrocardiogram Gait disturbance Hypoaesthesia Metabolic function test Migraine Pain in extremity Pyrexia

Symptomtext

Extremy left arm pain after Injection. Fever(lowgrade), migrane(extreme), heart and chest pain(went to er) difficulty breathing, numbness in lower right leg, difficulty waking, extreme anxiety/feeling of impending doom.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
2/3/22 ecg. Complete metabolic panel blood test. Chest x-ray.
Aktuelle Erkrankungen
Streptococcus Jan 17th 2022
Vorgeschichte
Hypertension
Andere Medikamente
None
Allergien
Sulfa allergy
Vorherige Impfungen
-

VAERS 2082425

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
-
Alter
53,0
Geschlecht
F
Eingang
02.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Paraesthesia

Symptomtext

Pt states they have tingles going down their arm. It happened right away pt states.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2079121

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
SC
Alter
34,0
Geschlecht
F
Eingang
01.02.2022
Impfdatum
06.01.2022
Beginn
07.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Body temperature increased Chills Dyspnoea exertional Fatigue Headache Hyperhidrosis Impaired work ability Injection site haemorrhage Injection site rash Injection site warmth Malaise Musculoskeletal stiffness Pain Pain in extremity Pruritus Pyrexia Rash

Symptomtext

1/6/22 8:30 pm- received booster at drug store, bled a lot. 1/7/22 7 am- sore arm; 10 am- slight headache; 12:30 pm- took Tylenol; 3:30 pm- tired leaving work; 4:30 pm- not feeling well with chills; 6:15 pm- temperature rose to 101.2 with body aches, took Tylenol; 11:45 pm- temperature 101.8 1/8/22 7 am- temperature at 101.3, took Tylenol; 9:30 am-fever went down, but lymph node under left arm pit was swollen, and sore to move arm; 11:30 am- joints ached, hurt to walk, headache/teeth ache; 12:45 pm- temperature was at 101.5, took Advil; 1:30 pm- temperature still at 101; 8:30 pm- fever down to 100.1 but sweating at night 1/9/22 9 am- no fever but rash on L arm from the injection area; 11:30 am- did not attend church, thought fever broke at 98.3 with no achiness but just a slight headache, harder breathing when walking; 5:00 pm- fever back with sweating, took Advil, rash went further down arm towards elbow 1/10/22 6am- rash from left arm spread to front neck area with low grade fever, rash on left arm holding heat, permitted to go into work; 7:30 am- sweating just sitting down; 12:45 pm- stiff neck, rash going to right arm area, called into family doc office; 1:45 pm- doc via phone visit instructed me to use Benadryl and if it didn?t improve/worsened then I would have to go to Urgent Care, 2pm- left work early, from doctor?s advice; 2:45 pm- took Benadryl; 7:30 pm- took another Benadryl, body itching 1/11/22 6:30 am- rash still with heat but no stiff neck; 4:30 pm- tired and resting at home, not better but not worse, VERS rep called to advise me to report concerns Continued to feel tired and have small rash on left arm near injection site for rest of the week

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea exertional
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension.
Andere Medikamente
Junel; Hydrochlorothiazide; Multi-vitamin; Cranberry supplement; Zyrtec; Fsh oil; Vitamin C and D; Zinc.
Allergien
-
Vorherige Impfungen
Moderna shot 2, less than Booster but rash was bad

VAERS 2075639

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

moderat
Staat
NY
Alter
52,0
Geschlecht
F
Eingang
31.01.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Back pain Chest discomfort Condition aggravated Fatigue Nausea Palpitations

Symptomtext

Heaviness in my chest, racing heart, back and shoulder pain, fatigue, and nausea.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
tested positive for Covid-19, first symptoms on 12/31/21 tested on 1/2/22 results back 1/6/22.
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
Morphine
Vorherige Impfungen
racing heart, rash, fatigue, fever body aches.

VAERS 2074870

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
TX
Alter
69,0
Geschlecht
F
Eingang
30.01.2022
Impfdatum
22.01.2022
Beginn
22.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chest discomfort Dyspnoea Heart rate abnormal Heart rate increased Hypopnoea

Symptomtext

Severe shortness of breath lasting several hours. Chest pressure lasting several hours. Extremely rapid heartbeat lasting over 12 hours. The following days heart became very shallow and could not detect heart beat at any pulse area. Breathing also became shallow. Shortness of breath also returned off and on during following 7 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
In progress now will be receivjng echocardiogram and Holter monitor to study heart progress.
Aktuelle Erkrankungen
Heart valves damage
Vorgeschichte
Heart valves damage since 1981. Also heart attacks and ventricular fibrillation.
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2073117

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

moderat
Staat
WA
Alter
35,0
Geschlecht
F
Eingang
28.01.2022
Impfdatum
27.01.2022
Beginn
28.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tremor Vaccine positive rechallenge

Symptomtext

Per patient, tremors occurred in left arm (just like after the first and second Moderna dose).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tremor
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Anxiety, ADD, depression, insomnia
Andere Medikamente
Lorazepam, Citalopram, Hydroxyzine, Lithium, Propranolol, Doxazosin, Prazosin, Vyvanse
Allergien
Ketorolac
Vorherige Impfungen
Similar tremor occurred with the first and second dose of Moderna COVID-19 vaccine.

VAERS 2059194

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
AK
Alter
26,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
19.01.2022
Beginn
19.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Paraesthesia oral Pharyngeal paraesthesia Swelling

Symptomtext

C/O throat and tongue feeling tingly and slightly swollen. This is the same symptoms she gets when she eats shellfish. Usually Benadryl will resolve shellfish symptoms. Alert and oriented. VSS. No outward signs of swelling. No difficulty swallowing or breathing. Prefers not to have 911 called. Explained our policy and that she can refuse transport after ambulance is here. Agrees to transport to Hospital ER by ambulance after EMTs arrive. Sent to ER at 1436 with symptoms unchanged.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia oral
Hospital-Tage
-
Labordaten
Unknown. Was observed in ER and discharged home.
Aktuelle Erkrankungen
None known
Vorgeschichte
Reports that she will occasionally get similar allergic reactions to unknown sources that present with oral numbness and sense of tongue swelling. Shellfish cause this reaction every time but has so far resolved with benadryl.
Andere Medikamente
Unknown
Allergien
Reports allergy to shellfish
Vorherige Impfungen
-

VAERS 2045473

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

moderat
Staat
WA
Alter
39,0
Geschlecht
F
Eingang
19.01.2022
Impfdatum
18.01.2022
Beginn
18.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Balance disorder Chest discomfort Chest pain Cough Dyspnoea Erythema Pharyngeal swelling Urticaria Wheezing

Symptomtext

Within 60 seconds of receiving the shot, I felt chest compression and pain and my throat swelled so that I had to wheeze and struggle for breath. I was able to talk, although I would cough as I spoke. My face turned very red and I had hives on my neck. The pharmacist gave me an injection of Benadryl 50 mg and the shortness of breath subsided. After about 15 minutes, I could breathe normally although my chest still felt tight. When I stood to go, I realized that I could not balance and I was at risk of falling. This felt different than low blood pressure or blacking out. I simply could not understand which way was "up." I wasn't thinking very clearly. 90 minutes after the vaccine, I felt well enough to drive home. 7 hours later, my chest still feels a bit tight and I had a little wheezing an hour ago, but it went away.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
OTC MEDICATIONS: Cetirizine Hydrochloride Tablets, 10 mg (generic). PRESCRIPTIONS: Spironolactone Tabs, 50 mg (generic); Mirena Intra-Uterine Device. DIETARY SUPPLEMENTS: B12 Microlozenge, 500 mcg; Vitamin C; 400 mg; Vitamin D3, 45 mcg; Zin
Allergien
Sensitive to acrylates (adhesives, such as in bandages), propylene glycol, and chlorhexidine.
Vorherige Impfungen
-

VAERS 2612352

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
AZ
Alter
69,0
Geschlecht
M
Eingang
10.04.2023
Impfdatum
06.04.2022
Beginn
14.11.2022
Tage bis Beginn
222,0
Dosis
4
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Allergy test positive Blood immunoglobulin E increased C-reactive protein increased Haematocrit increased Haemoglobin increased Histone antibody positive Immunoglobulins normal Rash Red blood cell sedimentation rate normal Thyroid function test normal Vitamin D decreased

Symptomtext

I broke out in a rash in several different areas of my body. I had some allergy testing done at the dermatologist and was treated with cetirizine and famotidine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
31JAN2023 Immunoglobulin Panel normal; 15DEB2022 Erythrocyte Sedimentation rate normal; 15DEC2022 CRP high; 15DEC2022 IGE high; 15DEC2022 Histone antibodies high; 15DEC2022 latex sensitivity high; 15DEC2022 vitamin D low; 15DEC202 Hematocrit high; 15DEC2022 Hemoglobin high;15DEC2022 Thyroid, small but normal
Aktuelle Erkrankungen
N/A
Vorgeschichte
Type 2 Diabetes
Andere Medikamente
NOVOLOG; TRESIBA; vitamin D
Allergien
Penicillin; codeine; MEFOXIN
Vorherige Impfungen
-

VAERS 2582811

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
MA
Alter
38,0
Geschlecht
M
Eingang
16.02.2023
Impfdatum
18.01.2022
Beginn
01.06.2022
Tage bis Beginn
134,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Malaise Pain in extremity SARS-CoV-2 test positive

Symptomtext

I had a sore arm for about 24 hours after receiving the vaccine. I tested positive for COVID-19 in 06/2022. I had symptoms for about 24 hours prior to testing positive. On day five I contacted my doctor, and it was decided that I do not take Paxlovid. I didn't take anything for my symptoms and just dealt with it.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Malaise
Hospital-Tage
-
Labordaten
JUN2022 COVID-19 Test - Positive
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
Prednisone
Allergien
N/A
Vorherige Impfungen
-

VAERS 2568660

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
MD
Alter
59,0
Geschlecht
F
Eingang
26.01.2023
Impfdatum
25.01.2022
Beginn
26.01.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test normal COVID-19 Computerised tomogram normal Fatigue Headache SARS-CoV-2 test positive

Symptomtext

The day after I took the vaccine, I had the worst headache I have ever had in my life and fatigue. I thought it was a reaction to the shot, even though the first shot I had. I always have a reaction to the flu shot so I thought it was just that. However, the fatigue and headaches kept coming and going. I had blood work done and nothing came of it, it showed nothing wrong. I contracted COVID in December of 2022 as well. We are now in January and I still get the headaches and fatigue. I did have a chiropractor appointment for my back and they did a CT scan of my back and neck but also found nothing.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
CT scan of the neck and back with no results. Full blood panel with nothing abnormal.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
ZOLOFT; CRESTOR; multivitamin
Allergien
Mushrooms
Vorherige Impfungen
Flu vaccines give me the feeling of having the flu

VAERS 2473509

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
60,0
Geschlecht
M
Eingang
10.10.2022
Impfdatum
08.04.2022
Beginn
16.07.2022
Tage bis Beginn
99,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia COVID-19 Cough Exercise tolerance decreased Fatigue Headache Hyperhidrosis Nasal congestion Pain in extremity Pyrexia SARS-CoV-2 test positive

Symptomtext

I was extremely tired. I had a low-grade fever. Strangely my thighs and my hips ached; lasting 2-3 days. I had some nasal congestion WITHOUT a cough. I sort of had a come and go headache. The feeling of exhaustion lasted about 2-3 weeks. I noticed since testing positive; I can't tolerate exercise as well as I did before. I excessively sweat now and get tired a lot easier. Surprising my asthma did not trigger while being positive.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
at home COVID-19 rapid test; Paxlovid: stepped up my asthma treatment to Alvesco twice and day for 2weeks
Aktuelle Erkrankungen
no
Vorgeschichte
Asthma; mild Hepatic Steatosis; HPV related dysplasia; History of heart dysrhythmia;
Andere Medikamente
Famotidine; Clomiphene citrate; Aspirin 81mg; Vitamin D3; Centrum; Allergy shots; Xolair (asthma injection);
Allergien
Erythromycin; Meloxican; Augmentin(possibly); History of latex allergy Buckwheat;
Vorherige Impfungen
Influenza, 1997

VAERS 2426521

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
AL
Alter
60,0
Geschlecht
F
Eingang
01.09.2022
Impfdatum
01.06.2022
Beginn
23.06.2022
Tage bis Beginn
22,0
Dosis
4
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Fatigue Nasal congestion SARS-CoV-2 test positive Therapy change

Symptomtext

On 06/23/2022 in the morning I experienced nasal congestions; fatigue; and elevated body temperature of 99.06. I did a tele health on the same day with my doctor she only gave me vitamins most of them I already took before seeing my doctor. I started feeling better after 4 days. After 2 months of the vaccine I got hypertension. I went to the doctors office where she increased the dose of my hypertension medication.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
COVID-19 home test - positive
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension
Andere Medikamente
Hydrochlorothiazide; COREG; multivitamins; vitamin D; zinc; vitamin C; CLARITIN
Allergien
None
Vorherige Impfungen
-

VAERS 2397726

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
MA
Alter
58,0
Geschlecht
F
Eingang
31.07.2022
Impfdatum
17.01.2022
Beginn
01.04.2022
Tage bis Beginn
74,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia X-ray

Symptomtext

pain in right wrist, especially when lifting anything heavy or bending the hand backwards. This began sometime in April 2022, I don't remember exactly. I listed this on the V-Safe check-in to be thorough.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
Visual and manual examination of my wrist, followed by X-rays. Referral to occupational therapy, treatment started July 2022.
Aktuelle Erkrankungen
-
Vorgeschichte
multiple sclerosis, arthritis, depression
Andere Medikamente
gabapentin, bupropion, mirtazapine, Ritalin, lisinopril, Ocrevus, naproxen, vitamin D
Allergien
Bactrim, cephalosporins, possibly stevia or erythritol
Vorherige Impfungen
-

VAERS 2391035

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CO
Alter
75,0
Geschlecht
F
Eingang
26.07.2022
Impfdatum
15.04.2022
Beginn
25.06.2022
Tage bis Beginn
71,0
Dosis
4
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Dysphonia Nasal congestion Nasopharyngitis Oropharyngeal pain SARS-CoV-2 test positive Upper-airway cough syndrome

Symptomtext

On June 25, 2022 I began to have a head cold with a sore throat. I never had a fever. I did a home test on the 26th and it was negative. On June 30th since I was not getting better I went in to have a PCR and it was positive. I began taking Claritin and the inhaler prescribed and symptoms began to decrease. On July 7th I had a home test and it was negative. On July 24th I had another PCR test and it was negative. As of today, the only symptoms I have are stuffy feeling in my head and nasal drip with a slight cough. I also have a hoarse voice.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oropharyngeal pain
Hospital-Tage
-
Labordaten
Home COVID-19 test, negative; PCR test, positive
Aktuelle Erkrankungen
N/A
Vorgeschichte
Asthma; Shoulder replacements
Andere Medikamente
Metamucil; Osteobiflex; Lutein; Fish Oil; Cranberry; Vitamin D3; Pepto Bismol; Visviome; CoQ10; Vitamin B Complex; Baby Aspirin; Atorvastatin; Viest; ProAir SHA
Allergien
Penicillin; Chromium
Vorherige Impfungen
-

VAERS 2388790

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
VA
Alter
58,0
Geschlecht
F
Eingang
25.07.2022
Impfdatum
21.01.2022
Beginn
14.06.2022
Tage bis Beginn
144,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Fatigue Oropharyngeal pain SARS-CoV-2 test positive Sinus congestion Sinus operation

Symptomtext

On 06/14/2022 I woke up and felt my sinus were full. I took a home test 06/17/2022 and it was positive. The next day I went to urgent care and had a PCR test that also showed positive. I had drainage, cough, sore throat and fatigue. It was too late to start any medications but I did take a steroid. As of today I am only having a lingering cough that does continue to get better and less frequent.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Home COVID-19 test 06/17/2022 positive. PCR COVID-19 test 06/18/2022 positive.
Aktuelle Erkrankungen
None
Vorgeschichte
High Blood Pressure; High Cholesterol
Andere Medikamente
Sertraline; simvastatin; pantoprazole; losartan with hydrochlorothiazide
Allergien
Shellfish
Vorherige Impfungen
-

VAERS 2370492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
CA
Alter
66,0
Geschlecht
F
Eingang
15.07.2022
Impfdatum
04.02.2022
Beginn
10.03.2022
Tage bis Beginn
34,0
Dosis
2
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Aphonia Blood test Computerised tomogram Computerised tomogram normal Deafness Ear infection Ear pain Fungal infection Headache Hypersensitivity Infection Laboratory test Muscle tension dysphonia Pain Pruritus Urinary tract infection

Symptomtext

She got her vaccine (booster), she had no reaction at first, then around 3/10/22 she started getting sick with an ear ache. She went to the UC she had an ear infection. They gave her antibiotics. Then after the ear infection she lost her hearing for 2 weeks, so she went back to the doctor and they gave her more antibiotics. The next thing she remembers is she went to the ENT and they checked her vocal cords as she had lost her voice, and they were strained. They gave her some antibiotics too. Then after that she went back to UC because she had a really bad headache that would not go away, possibly due to the infection. She went to Hospital as she was hurting so bad, and they gave her a CT scan if the infection had gone to her brain but it had not done that. They gave her more antibiotics. Her head kept hurting and she went back to UC and found out that she had a UTI, so she was put on more antibiotics. Then, she went back to the UC again and they recommended a different antibiotic and she started taking those. She finished the antibiotics and went back to the UC as she had a yeast infection and was given more antibiotics. As of today, she hasn't been back to the UC but believe the UTI is still there. Her skin is itching really really bad, so they gave her some Benadryl to take, which is not working. She has been scratching her skin up so bad because she is having the allergic reaction to the booster shot. She has been itching since 3/10/22. She kept getting back to back infections and nobody knew why and just kept getting sicker and sicker. They kept asking her what she did differently and last Friday she figured out that it was the booster shot that she had done differently, and thinks this was related to all of her infections. She feels the booster shot did not agree with her system.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ear pain
Hospital-Tage
-
Labordaten
As above, CAT scan, blood work, lab work.
Aktuelle Erkrankungen
None.
Vorgeschichte
Diabetes, high blood pressure.
Andere Medikamente
Ambien 10 mg.
Allergien
Tetracycline.
Vorherige Impfungen
7 years ago she got a flu shot and got really sick from that, and has not taken that since.

VAERS 2368769

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
MD
Alter
61,0
Geschlecht
M
Eingang
14.07.2022
Impfdatum
08.04.2022
Beginn
02.06.2022
Tage bis Beginn
55,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Dysphonia Feeling abnormal Feeling cold Nasopharyngitis Oropharyngeal pain Pain SARS-CoV-2 test positive

Symptomtext

On 06/02/2022 I began to experience a mild throat soreness around noon. The next day I woke up and my throat felt like I had a whole bunch of little incisions all around my throat and it was really painful. Toward the middle of the day it began to feel more like a head cold. These events normally occur when I get minor illnesses so I thought it was just a cold. By Saturday, my symptoms had progressed and I was having body aches and I was feeling really cold. By the time I was going to bed that night, I felt like my symptoms were less than normal so I took an at home COVID-19 test which was very obviously positive. When I woke up on Sunday, I was still feeling badly but was feeling slightly better than the day before. Since my primary care doctor is not available on Sundays, I called a local urgent care type facility. I was informed that I could not take Paxlovid due to a medication that I am currently prescribed so they suggested that I could receive a Monoclonal Antibody infusion. On Monday, when I heard from them about the monoclonal antibody therapy, I was already feeling better to the point that I did not feel that it was needed. It took 4 or 5 more days for my throat to begin feeling normal again but at this point, all of my symptoms have subsided with the exception of some changes to my voice that may have been caused by my extremely sore throat.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Oropharyngeal pain
Hospital-Tage
-
Labordaten
At home COVID-19 test-positive-06/04/2022
Aktuelle Erkrankungen
None.
Vorgeschichte
Benign Enlarged Prostate; High Cholesterol; Osteoarthritis; Sleep Apnea; Obesity.
Andere Medikamente
Lipitor; Finasteride; Alfuosin; Tadalafil; Zyrtec; Multivitamin; Vitamin B; Potassium; Probiotic.
Allergien
Walnuts; Artificial Cheese; Jello.
Vorherige Impfungen
Anthrax Vaccines-Extreme redness and soreness at injection site. COVID-19 vaccines-head fog.

VAERS 2368748

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
-
Alter
26,0
Geschlecht
F
Eingang
14.07.2022
Impfdatum
28.02.2022
Beginn
01.03.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
- / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chronic spontaneous urticaria Immune system disorder Lip swelling Peripheral swelling Swelling face Urticaria

Symptomtext

I developed a Chronic Spontaneous Urticaria for the first time, a few days later of getting the booster shot, presenting swelling of my lips , facial area, hands and feet and hives all over my body. Several doses of steroids were administered as well as high doses of antihistamines for more than a week. Symptoms have been controlled by taking cetirizine 10mg daily. However, symptoms becomes severe if I stop the medication for one day. I have been seen an allergist/immunologist who concludes that based on my health history and evaluation; that my immune system was over-stimulated by the 3rd booster shot of the Moderna Covid-19 Vaccine, thus causing this chronic condition.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chronic spontaneous urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Covid 19 a month prior to vaccination.
Vorgeschichte
None
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2367838

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
WA
Alter
55,0
Geschlecht
M
Eingang
13.07.2022
Impfdatum
12.04.2022
Beginn
31.05.2022
Tage bis Beginn
49,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Fatigue Malaise Pain Rhinorrhoea SARS-CoV-2 test positive Throat irritation

Symptomtext

I contracted COVID-19 on 05/31/2022 with symptoms of scratchy throat, runny nose, body aches, and fatigue. I was not prescribed any medications for my symptoms. I was ill for 12 days before my symptoms began to resolve. I am fully recovered with no lingering symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
COVID-19 rapid nasal swab home test was positive on 06/02/2022.
Aktuelle Erkrankungen
N/A
Vorgeschichte
Sleep Apnea
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2366578

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
65,0
Geschlecht
M
Eingang
13.07.2022
Impfdatum
08.04.2022
Beginn
28.05.2022
Tage bis Beginn
50,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Back pain COVID-19 Dizziness Fatigue Headache SARS-CoV-2 test positive

Symptomtext

Although I had two initial Pfizer vaccinations, one Pfizer booster and one Moderna booster, I still caught COVID-19. I did not have a bad cough or fever, but I was dizzy, extremely fatigued, had a bad headache and developed severe lower back pain. I took Paxlovid for five days and was generally better after that, but my lower back pain has continued.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
Tested positive using home test for six days.
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension
Andere Medikamente
Olmesartan, HCTZ, Baby Aspirin
Allergien
Pennicillin
Vorherige Impfungen
-

VAERS 2361033

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
CA
Alter
73,0
Geschlecht
F
Eingang
07.07.2022
Impfdatum
16.04.2022
Beginn
04.07.2022
Tage bis Beginn
79,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Fatigue Headache Pyrexia SARS-CoV-2 test positive Sinus pain Upper-airway cough syndrome

Symptomtext

Monday, July 4, I began running a fever and got up to take home COVID-19 test and it was positive. My symptoms were mostly sinus head pain and just really tired. Post nasal drip caused me to cough. I had a tickle in my throat that caused me to cough. Fever only lasted one day.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
Home COVID-19 test, positive; PCR COVID-19, positive.
Aktuelle Erkrankungen
N/A
Vorgeschichte
Ocular Melanoma
Andere Medikamente
OCUVITE; turmeric; multivitamin; B complex; calcium; vitamin D3
Allergien
N/A
Vorherige Impfungen
-

VAERS 2361024

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
GA
Alter
55,0
Geschlecht
F
Eingang
07.07.2022
Impfdatum
06.04.2022
Beginn
04.07.2022
Tage bis Beginn
89,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
COVID-19 Discomfort Dysphonia Fatigue Headache Illness Impaired work ability Nasal congestion Rhinorrhoea SARS-CoV-2 test positive Tenderness Throat irritation

Symptomtext

I received my second Moderna booster for COVID-19 on 4/6/2022. On the night of 7/4/2022, I developed a runny nose, a very slight headache, nasal congestion, a slightly scratchy throat, and a tenderness in both inner ears. When I woke up the morning of 7/5/2022, the symptoms were pretty much the same, though the headache was gone. I went ahead and went to work, because it just felt like I was getting a cold. As the day progressed at work, though, I noticed that my voice wasn't the same, as I sounded congested. That evening, the nasal congestion worsened. On the morning of 7/6/2022, the symptoms were pretty much the same, though slightly worse. As I was getting ready for work that day, it occurred to me that I had heard that COVID-19 symptoms are similar to those of a cold, so I took an at-home test, and the result was positive. I immediately called in sick to work and went to the urgent care clinic and underwent a PCR test. The PCR test also yielded a positive result. The NP or PA at the urgent care recommended that I treat my symptoms with OTC medicines like nasal spray and CLARITIN or ZYRTEC, which I did. She also told me to isolate at home for 5 days and told me I could leave the house afterwards as long as I wore a mask for 5 more days afterwards. On the night of 7/6/2022, I again had a slight headache, but it was nothing major. It was so mild that I didn't even take medicine for it. During my illness, I haven't felt especially bad. I'm slightly more tired than usual and aside from the discomfort caused by the abovementioned symptoms, I feel mostly fine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None.
Vorgeschichte
None.
Andere Medikamente
None.
Allergien
None.
Vorherige Impfungen
-

VAERS 2356001

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
59,0
Geschlecht
F
Eingang
03.07.2022
Impfdatum
25.01.2022
Beginn
01.01.2022
Tage bis Beginn
-
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Headache Vaccination site pain

Symptomtext

headache; sore arm; This spontaneous case was reported by a patient and describes the occurrence of HEADACHE (headache) and VACCINATION SITE PAIN (sore arm) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 prophylaxis. Previously administered products included for Drug use for unknown indication: JNJ (received JNJ vaccine initially). Past adverse reactions to the above products included No adverse event with JNJ. On 25-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced VACCINATION SITE PAIN (sore arm). On 25-Jan-2022, the patient experienced HEADACHE (headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. In January 2022, HEADACHE (headache) and VACCINATION SITE PAIN (sore arm) had resolved. No concomitant medication was reported. Patient got the Moderna booster dose. A couple hours after administration when she came home, she experienced the headaches. Both side effects lasted about a day. This case was linked to MOD-2022-595774 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2342462

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
WA
Alter
68,0
Geschlecht
F
Eingang
29.06.2022
Impfdatum
29.03.2022
Beginn
29.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Blood pressure decreased Blood pressure increased Feeling hot Pain Pain in extremity Pharyngeal swelling Pyrexia SARS-CoV-2 test negative

Symptomtext

05/2022 Within 12 hours of vaccination, I woke up in middle of night I was running a fever, felt like throat was swelling, achy, hot. Arm was sore. This continued to run fevers. I had husband take me for 2 COVID-19 tests. Blood pressure kept spiking to over 200's and then dipping real low below the 100's. I started wearing my cuff daily. Regular Dr. said to go to the ER. Adjusted some medicines at the ER. Put on prednisone, high doses. Almost for 2 1/2 weeks. My blood pressure continued being off the charts. It only recently started to go back to normal digits. The worst was 216/116. Dr and ER said to never to take the vaccinations again. It delayed me getting my breasts MRI and biopsy, delaying my health care after the vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain
Hospital-Tage
-
Labordaten
COVID-19; negative
Aktuelle Erkrankungen
N/A
Vorgeschichte
Hashimoto's disease; Breast cancer survivor; Reflux; Vertigo; Tinnitus; Micardis
Andere Medikamente
Vitamin D; Calcium; Magnesium; Zinc; Colace
Allergien
Cipro; Daypro; Suplosporone; Ace inhibitors; Statin Sensitive; Mobic; Compazine; Nickel; Latex; Codeine; Mold; Bee; Lactose and Dairy Intolerance
Vorherige Impfungen
COVID-19 feeling sick after for about 3-5 days after

VAERS 2303011

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
65,0
Geschlecht
M
Eingang
31.05.2022
Impfdatum
30.03.2022
Beginn
01.03.2022
Tage bis Beginn
-
Dosis
4
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Eye pain Fatigue Headache Inappropriate schedule of product administration Insomnia Myalgia Oropharyngeal pain

Symptomtext

sore throat; eye aches; difficulty sleeping; Extreme fatigue; body aches; chills; headaches; Patient took Pfizer dose 3 on 19-Mar-2022 and Moderna dose 4 on 30-Mar-2022; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient took Pfizer dose 3 on 19-Mar-2022 and Moderna dose 4 on 30-Mar-2022), OROPHARYNGEAL PAIN (sore throat), EYE PAIN (eye aches), INSOMNIA (difficulty sleeping) and FATIGUE (Extreme fatigue) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Previously administered products included for Drug use for unknown indication: Pfizer/BioNTech (Dose Number: 1 Batch/Lot No: EN6201 Location of injection: Arm Right Vaccine Administration Time: 11:15 AM) on 26-Feb-2021, Pfizer/BioNTech (Dose number: 2 Batch/Lot No: EW0187 Location of injection: Arm Right Vaccine Administration Time: 02:30 PM) on 27-Aug-2021 and Pfizer/BioNTech (Dose number: 3 Batch/Lot No: EN6208 Location of injection: Arm Right Vaccine Administration Time: 11:45 AM) on 19-Mar-2022. Past adverse reactions to the above products included No adverse event with Pfizer/BioNTech, Pfizer/BioNTech and Pfizer/BioNTech. Concurrent medical conditions included Drug allergy (Unknown drug). On 30-Mar-2022 at 2:45 PM, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In March 2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient took Pfizer dose 3 on 19-Mar-2022 and Moderna dose 4 on 30-Mar-2022). On 18-May-2022 at 11:00 AM, the patient experienced OROPHARYNGEAL PAIN (sore throat), EYE PAIN (eye aches), INSOMNIA (difficulty sleeping), FATIGUE (Extreme fatigue), MYALGIA (body aches), CHILLS (chills) and HEADACHE (headaches). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Patient took Pfizer dose 3 on 19-Mar-2022 and Moderna dose 4 on 30-Mar-2022), OROPHARYNGEAL PAIN (sore throat), EYE PAIN (eye aches), INSOMNIA (difficulty sleeping), FATIGUE (Extreme fatigue), MYALGIA (body aches), CHILLS (chills) and HEADACHE (headaches) outcome was unknown. No concomitant medications were reported. The patient previously received a COVID-19 Vaccine. It was unknown that the patient was taking any other medications/products within 2 weeks of starting COVID-19 treatment. The patient had treatment for COVID-19 (unspecified). Device Date: 21-May-2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Drug allergy (Unknown drug)
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2260583

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
MN
Alter
72,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
19.01.2022
Beginn
06.02.2022
Tage bis Beginn
18,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Gait disturbance Movement disorder Musculoskeletal stiffness Myalgia Pain Pain in extremity Swelling

Symptomtext

It came on as soon as I woke up. I was very stiff and sore. I couldn't move my hands. My feet were sore especially the balls of my feet, it was painful to walk. My leg and arm muscles were very painful. For about a week I thought it would get better on its own. After two weeks I decided to contact my doctor, I wasn't able to get in until a month later. I took Tylenol and Ibuprofen to help with the swelling but it just kept coming back. When I finally saw the doctor, he gave me a 3-day supply of prednisone which worked well but a couple days after I had to start taking the Tylenol and ibuprofen to help the pain. As of today, I am still taking the medications for the pain and swelling.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Myalgia
Hospital-Tage
-
Labordaten
Blood work
Aktuelle Erkrankungen
None
Vorgeschichte
Depression; Heart disease
Andere Medikamente
Aspirin Multivitamin Vitamin D3 Venlafaxine Omeprazole
Allergien
None
Vorherige Impfungen
-

VAERS 2252277

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
CT
Alter
52,0
Geschlecht
F
Eingang
26.04.2022
Impfdatum
14.01.2022
Beginn
15.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Dysstasia Fatigue Joint effusion Joint stiffness Magnetic resonance imaging joint Peripheral swelling

Symptomtext

Within 8-10 hours after the vaccine I had an onset of extreme Fatigue and Joint Pain, I have no recollection of 72 hours post vaccine. After which my left knee blew up with fluid, swollen fingers, wrist pain and stiff ankles. I was given glutathione injection to help with stiffness. In addition I tried Homeopathic therapy and nothing has helped. It takes me a long time to get up from a sitting position and I cannot stand for long periods of time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
MRI conducted on Right Knee.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Synthroid, Progesterone, Claritin, Zyrtec, Vitamin D, Calcium
Allergien
Clindamycin
Vorherige Impfungen
-

VAERS 2249695

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
MA
Alter
19,0
Geschlecht
F
Eingang
24.04.2022
Impfdatum
27.02.2022
Beginn
27.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Urticaria

Symptomtext

PT STATES THEY HAVE LONG TERM TRANSIENT DERMALOGIC SIDE EFFECTS INCLUDING TRANSIENT LONG TERM HIVES, WELTS AND RASHES

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2248063

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
CO
Alter
81,0
Geschlecht
M
Eingang
22.04.2022
Impfdatum
15.04.2022
Beginn
16.04.2022
Tage bis Beginn
1,0
Dosis
4
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Asthenia Chills Fatigue Myalgia Pain

Symptomtext

The day after my booster vaccine that I started to feel symptoms of sore muscles, joint pain, chills, weakness, fatigue. No fever. The day after I was starting to feel better, however I still had body aches, muscles pain and fatigue. As of now I am feeling good and back to normal with a little bit of fatigue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Diabetic
Andere Medikamente
Pradaxa 150mg; Lisinopril twice a day 20 mg; Insulin Apidra 3x daily 5mg; Tojaio once daily 300mg; Cabergoline once a month
Allergien
Previnar-13; 65+ flu shot
Vorherige Impfungen
Previnar-13 2017-2018: ER visit due to rash, chills, muscle aches. 65+ flu shot: Rash development and itching.

VAERS 2243746

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
SC
Alter
61,0
Geschlecht
F
Eingang
20.04.2022
Impfdatum
13.04.2022
Beginn
13.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Back pain Head discomfort Headache Injection site warmth Insomnia Neck pain Pain Pain in extremity Peripheral swelling Pyrexia Vomiting

Symptomtext

Dear Dr and Staff, I just wanted to report my reaction to the 2nd booster shot since it was remarkable. I need no further care, I just want to let you know. I am just fine now, however approximately 8-9 hours after I received the booster shot, my arm began to swell, hurt, and fell hot to the touch at the injection site. About 10-11 hours after, I began running a fever, and an excruciating headache set in. I get migraines and this "headache" was worse then a migraine - I felt similar pain to when I was 13 with mumps/encephalitis - it felt like there was increasing pressure all around my head, but especially on the left side of my head, the same side I received the booster on. I also felt pain on the left side of my neck, upper back, and left leg. My fever increased to 102 degrees, and at some point during the night I began vomiting, and continued to do so I think 3-4 times. I finally was able to return to bed, but the fever did not break until about 11:00 am the next day. Feeling like the vomiting had passed, I took an ibuprofen in the early morning (6 am), and the pain decreased to a dull pain feeling, and then disappeared by about 2 pm. I did not sleep during the night - it wasn't possible. I just wanted someone there to know. Ironically, I had received my last check-in from v-safe the day before this injection. My best to all,

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
-
Andere Medikamente
?Propranolol HCl 10 MG Tablet 1 tablet Orally Twice a day prn palpitations or elevatedbp ?Vyvanse 60 MG Capsule 1 capsule in the morning Orally Once a day ?Amphetamine Sulfate 10 MG Tablet 1 tablet in the morning Orally Once a day
Allergien
Codeine Sulfate and Percocet
Vorherige Impfungen
-

VAERS 2241714

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
KS
Alter
69,0
Geschlecht
M
Eingang
19.04.2022
Impfdatum
12.04.2022
Beginn
13.04.2022
Tage bis Beginn
1,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Burning sensation Lymph node pain Pain in extremity

Symptomtext

I experienced pain in my right arm, and I experienced swollen painful/burning lymph nodes under my arm, which lasted for 4 or 5 days.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymph node pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
No
Vorgeschichte
Spinal Stenosis; Ruptured Disc C3; Asthma; TMJ on the right
Andere Medikamente
Gabapentin, Cyclobenzaprine, Pravastatin Sodium, Montelukast Sodium, Ventolin Inhaler, Benzonate, Baby Aspirin, Vitamin B Complex, Men's Multivitamin, Metamucil, CoQ10
Allergien
Minocycline; Peanuts
Vorherige Impfungen
Covid19 Moderna dose 2 with body aches and fatigue 2/12/21

VAERS 2238169

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
VA
Alter
49,0
Geschlecht
F
Eingang
17.04.2022
Impfdatum
09.02.2022
Beginn
09.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity Peripheral swelling Rash Swelling of eyelid

Symptomtext

This was a booster as I am immunocompromised. I received the Pfizer vaccines (2 doses and 1 booster) without any notable reactions before this dose of Moderna. My arm became very swollen and sore, I had a rash on my trunk and arms, and my eyelid became very swollen. My care provider prescribed a low dose of prednisone for another condition. I believe that this Rx also helped alleviate the adverse reaction to the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
asplenia
Andere Medikamente
88 mcg levothyroxine for hypothyroidism
Allergien
-
Vorherige Impfungen
I have had widespread rash after Pneumonococcal vaccine

VAERS 2208769

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
WA
Alter
28,0
Geschlecht
F
Eingang
31.03.2022
Impfdatum
23.03.2022
Beginn
24.03.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Pyrexia Somnolence Vaccination site discolouration Vaccination site erythema Vaccination site pruritus

Symptomtext

black spots at injection site; red spots started to appear at the injection site; fever; tiredness; slept the whole day; itching at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE DISCOLOURATION (black spots at injection site), SOMNOLENCE (slept the whole day), VACCINATION SITE PRURITUS (itching at the injection site), VACCINATION SITE ERYTHEMA (red spots started to appear at the injection site) and PYREXIA (fever) in a 28-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J212A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (patient tested positive) in December 2021. Previously administered products included for Product used for unknown indication: Pfizer (Dose Number: 1, Lot number: EN6201, Expiration date: 30-Jun-2021) on 05-Mar-2021, Pfizer (Dose Number: 2, Lot number: EN6201 and Expiration date: 30-Jun-2021) on 26-Mar-2021. Past adverse reactions to the above products included No adverse event with Pfizer and Pfizer. On 23-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 24-Mar-2022, the patient experienced SOMNOLENCE (slept the whole day), VACCINATION SITE PRURITUS (itching at the injection site), PYREXIA (fever) and FATIGUE (tiredness). On 25-Mar-2022, the patient experienced VACCINATION SITE ERYTHEMA (red spots started to appear at the injection site). On 28-Mar-2022, the patient experienced VACCINATION SITE DISCOLOURATION (black spots at injection site). On 25-Mar-2022, SOMNOLENCE (slept the whole day), PYREXIA (fever) and FATIGUE (tiredness) had resolved. At the time of the report, VACCINATION SITE DISCOLOURATION (black spots at injection site) and VACCINATION SITE PRURITUS (itching at the injection site) had not resolved and VACCINATION SITE ERYTHEMA (red spots started to appear at the injection site) had resolved with sequelae. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that patient is not on any concomitant medications. It was reported that the black spots are about an inch in diameter. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19 (patient tested positive)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2197549

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
-
Alter
24,0
Geschlecht
M
Eingang
25.03.2022
Impfdatum
24.03.2022
Beginn
24.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Axillary pain Oedema peripheral

Symptomtext

Subjective left axillary swelling and soreness, not appreciated on exam.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Axillary pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Lower back pain
Vorgeschichte
None
Andere Medikamente
Celebrex 100mg PO QDay
Allergien
None
Vorherige Impfungen
-

VAERS 2192230

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
MN
Alter
32,0
Geschlecht
F
Eingang
22.03.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Blindness Burning sensation Deafness Dizziness Dysstasia Feeling hot Gait disturbance Musculoskeletal stiffness Pain Pain in extremity Pruritus Pyrexia Rash macular Tenderness

Symptomtext

3/18 - shot given- slight burning and hot feeling pain/ tender in arm 3/19 - body aches/pains manageable with ibuprofen 3/20 - Severe body aches/pains and weakness. Unable to walk a short distance. Walking from bedroom to living room felt faint, everything went black and couldn't hear. Laid on floor until senses came back. Felt faint upon trying to walk for remainder of day. 102 fever throughout day, down to 101.5 with meds. So weak needed help sitting up from floor. Fever broke around 8pm. Then noticed injection site arm was red/blotchy and hot. 3/21 - Still weak and achy but no fever. Arm still blotchy, hot, itchy and sore/stiff 3/22 - Arm still blotchy, hot, itchy and sore/stiff

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Small Meningioma brain tumor
Andere Medikamente
Pre Natal vitamin 1x daily
Allergien
Celiac disease - No gluten or dairy
Vorherige Impfungen
-

VAERS 2192230

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
MN
Alter
32,0
Geschlecht
F
Eingang
22.03.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Asthenia Blindness Burning sensation Deafness Dizziness Dysstasia Feeling hot Gait disturbance Musculoskeletal stiffness Pain Pain in extremity Pruritus Pyrexia Rash macular Tenderness

Symptomtext

3/18 - shot given- slight burning and hot feeling pain/ tender in arm 3/19 - body aches/pains manageable with ibuprofen 3/20 - Severe body aches/pains and weakness. Unable to walk a short distance. Walking from bedroom to living room felt faint, everything went black and couldn't hear. Laid on floor until senses came back. Felt faint upon trying to walk for remainder of day. 102 fever throughout day, down to 101.5 with meds. So weak needed help sitting up from floor. Fever broke around 8pm. Then noticed injection site arm was red/blotchy and hot. 3/21 - Still weak and achy but no fever. Arm still blotchy, hot, itchy and sore/stiff 3/22 - Arm still blotchy, hot, itchy and sore/stiff

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Small Meningioma brain tumor
Andere Medikamente
Pre Natal vitamin 1x daily
Allergien
Celiac disease - No gluten or dairy
Vorherige Impfungen
-

VAERS 2185943

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
CA
Alter
26,0
Geschlecht
F
Eingang
17.03.2022
Impfdatum
17.01.2022
Beginn
31.01.2022
Tage bis Beginn
14,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Burning sensation Pruritus Urticaria chronic

Symptomtext

Chronic urticaria from January 31, 2022 to present. Scalp, face and body covered in hives every day; multiple times a day. Excessive itching/burning sensation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Penicillin and Sulfa drugs
Vorherige Impfungen
-

VAERS 2170757

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
-
Alter
63,0
Geschlecht
F
Eingang
10.03.2022
Impfdatum
16.02.2022
Beginn
01.03.2022
Tage bis Beginn
13,0
Dosis
3
Route/Site
OT / OT
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Abdominal pain Nausea Pyrexia Vomiting

Symptomtext

fever, abd pain, n/v

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2163503

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
67,0
Geschlecht
F
Eingang
07.03.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Photopsia Pyrexia Vitreous detachment Vitreous floaters

Symptomtext

White flashes in left eye, starting in the night of the booster (with fever), and subsequent dark floaters in left visual field. Symptoms did not resolve, and saw an ophthalmologist on February 3. Physician diagnosed a left vitreous detachment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
Exam by ophthalmologist.
Aktuelle Erkrankungen
None
Vorgeschichte
High Lipoprotein(a) levels
Andere Medikamente
Clopidogrel
Allergien
None
Vorherige Impfungen
-

VAERS 2160521

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
NJ
Alter
28,0
Geschlecht
F
Eingang
05.03.2022
Impfdatum
15.02.2022
Beginn
23.02.2022
Tage bis Beginn
8,0
Dosis
3
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Mechanical urticaria Pruritus Urticaria

Symptomtext

On Feb 23rd I began experiencing intense itching and hives all over my body. It has been over 1 week and I am still experiencing itching throughout my body and dermatographia. The welts caused by light touch are very uncomfortable and add on to the already intense itching. Called my doctor and was ordered 5 days of prednisone, but experienced no relief. Started taking allegra and it makes the itching less intense and my skin less reactive touch.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mechanical urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2154828

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
AL
Alter
64,0
Geschlecht
M
Eingang
03.03.2022
Impfdatum
02.03.2022
Beginn
03.03.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Pain Urticaria

Symptomtext

HIVES, REDNESS AT THE INJECTION SITE AND BODY ACHES

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151402

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

mild
Staat
TX
Alter
41,0
Geschlecht
F
Eingang
01.03.2022
Impfdatum
01.03.2022
Beginn
01.03.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Discomfort Fatigue Hypersensitivity Lip pruritus Swelling of eyelid Throat irritation Tongue pruritus

Symptomtext

Patient had an allergic reaction to vaccine approximately 20-30 minutes from administration. Pt c/o itchy tongue, throat, lips and had visible swelling to eyelids. Denied difficulty breathing. Administered 50 mg/ml of Dipenhydramine IM and followed up with patient at 12:20 pm, she denied trouble breathing, stated she was no longer itching and only felt her tongue slightly heavy. C/o fatigue from the dipenhydramine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Vicodin
Vorherige Impfungen
-

VAERS 2149534

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
NJ
Alter
23,0
Geschlecht
F
Eingang
28.02.2022
Impfdatum
25.01.2022
Beginn
05.02.2022
Tage bis Beginn
11,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Histamine intolerance Mechanical urticaria Pruritus Sleep disorder

Symptomtext

Severe histamine intolerance. Onset of dermatographia and other dermatological concerns. Cannot sleep a full night because of itching skin with no rash or main point of irritation. Only reporting this here because the booster is the only thing I have taken that might have caused this. I don't take ibuprofen or other medications ever (I'm mostly into just letting my body run its course unless there's a pandemic!)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mechanical urticaria
Hospital-Tage
-
Labordaten
Will be going to the dermatologist tomorrow to get blood work and possibly a biopsy on the affected areas to see if this is fungal. Will update you.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2138183

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
CA
Alter
39,0
Geschlecht
F
Eingang
25.02.2022
Impfdatum
31.01.2022
Beginn
12.02.2022
Tage bis Beginn
12,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Blood test Eye pruritus Mechanical urticaria Pruritus Sleep disorder Urticaria

Symptomtext

Extremely itchy eyes, scalp, body. Very itchy hives on several area of my body randomly appearing on different areas all times of the day and night. At night it is worst. Dermographia that Itches and causes hives. It wakes me up during the night. Zyrtec does not help, Benadryl does not help, Claritin helped a little but not enough. My Doctor prescribed hydroxyzine HCl 10mg tonight will be my first time taking it. I also received a referral for an allergist. I'm awaiting approval.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Eye pruritus
Hospital-Tage
-
Labordaten
Today 2/24/22 my doctor had blood drawn to run tests.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2124861

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
VA
Alter
36,0
Geschlecht
M
Eingang
19.02.2022
Impfdatum
05.02.2022
Beginn
17.02.2022
Tage bis Beginn
12,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthropod bite Erythema Pruritus Rash macular Skin discolouration Skin irritation Urticaria

Symptomtext

2 weeks later; I have developed hives all over my body. Lesser on my arms but a few individual hives on wrists, arms, hands. Some on the back on my scalp. A few have ranged under my chin and neck area but the primary location tends to be the base of my spine, my hips, the back of my legs, groin/pelvic region, and thighs. A few noted on calves, especially in the joint areas, behind the knees, elbows etc. The largest masses of hives tend to be along the belt area and extend down the legs from there. All are itchy and white/red depending on irritation. Hives appear splotchy and grouped in satellites; few are individual hives. Unbearably itchy. Note: I don't see anywhere requesting blood type. I am A+. This feels much like my severe reactions to mosquito bites. Same hives, same itch, just at a much larger scale. I am postulating there is a correlation of people experiencing these same reactions with those of a certain blood type; and I'm guessing it's type A.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No
Vorgeschichte
No
Andere Medikamente
No
Allergien
No
Vorherige Impfungen
-

VAERS 2118965

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
NJ
Alter
59,0
Geschlecht
F
Eingang
17.02.2022
Impfdatum
17.01.2022
Beginn
19.01.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein
Blood test normal Borrelia test negative Dizziness Ear pain Headache Impaired driving ability Pain of skin Pruritus Pyrexia Tinnitus Urticaria Vision blurred

Symptomtext

Fever. Large, painful, itchy skin hives all over scalp, forehead, cheeks, chin, neck, shoulders, abdomen and legs. Dizzy. Headaches. Earaches, ringing in the ear. Blurry vison. Difficulty driving. Started 01/17/2022 and still going on today 02/17/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
Blood work done checking for Lyme's disease. Result - Negative.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Crestor (Rosuvastatin) 5 mg once daily. Started taking this on 01/04/2022 but stopped as of 01/31/2022 on doctor's advise due to reaction from Moderna COVID booster shot administered on 01/17/2022.
Allergien
-
Vorherige Impfungen
Flu vaccine administered on 10/24/2019. Age 57. side effects: Flu like symptoms (chills) lasted for 6 months.

VAERS 2112827

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21_2A

mild
Staat
MA
Alter
19,0
Geschlecht
F
Eingang
15.02.2022
Impfdatum
22.01.2022
Beginn
08.02.2022
Tage bis Beginn
17,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Urticaria

Symptomtext

Began w/urticarial rash on torso, upper and lower extremities, and scalp, on-going x4 days at time of evaluation. Symptoms began 17days after booster dose of COVID moderna vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
Physical exam
Aktuelle Erkrankungen
NA
Vorgeschichte
None
Andere Medikamente
NA
Allergien
shellfish, seasonal allergies
Vorherige Impfungen
-

VAERS 2110788

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
AL
Alter
56,0
Geschlecht
F
Eingang
14.02.2022
Impfdatum
11.02.2022
Beginn
12.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Headache Pruritus Rash Rash erythematous Rash papular Skin irritation Urticaria

Symptomtext

Rash covering about half the body that's red, raised, and hives-like in certain areas. Areas included patient's arms, axillary area, breasts, sides, stomach, and back. The rash began the morning after administration of the vaccine and is extremely itchy and irritating. The patient sough emergency treatment for it. She also said she had a pounding headache that began the night of vaccine administration and had persisted for 3 days. Patient states she did not have any type of rash following the first or second doses of the vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension, High cholesterol, heart murmur, sleep apnea
Andere Medikamente
Finasteride 1mg, Amlodipine 5mg, Valsartan 320mg, Atorvastatin 40mg, Estradiol 0.025mg/day patch, Vitamin D2 50,000 unit
Allergien
Pregabalin, methimazole, peanuts
Vorherige Impfungen
-

VAERS 2109295

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j212a

mild
Staat
NJ
Alter
79,0
Geschlecht
M
Eingang
12.02.2022
Impfdatum
07.02.2022
Beginn
09.02.2022
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Hypoaesthesia Nausea

Symptomtext

Patient chief complaints were nausea, chills and numbness in finger tips and feet

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
NO
Vorgeschichte
DIABETES
Andere Medikamente
-
Allergien
NONE
Vorherige Impfungen
-

VAERS 2104736

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

mild
Staat
-
Alter
31,0
Geschlecht
M
Eingang
11.02.2022
Impfdatum
24.01.2022
Beginn
05.02.2022
Tage bis Beginn
12,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Erythema Mechanical urticaria Pruritus Urticaria

Symptomtext

Got 3 covid shots - First shot 04/23/2021 - Second shot 05/21/2021 - Booster shot 01/24/2021 About 12 days after my booster shot, I got extremely itchy. This led to redness and hives. Running my nail softly over skin will cause a red mark to appear a couple minutes later and will disappear eventually. I believe I have developed Dermatographia. I have been using Claritin and using Cortizone on extreme spots.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mechanical urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
Penicillin
Vorherige Impfungen
-

VAERS 2099701

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

mild
Staat
OH
Alter
33,0
Geschlecht
M
Eingang
09.02.2022
Impfdatum
07.02.2022
Beginn
08.02.2022
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Feeling abnormal Headache Muscle rigidity Skin burning sensation

Symptomtext

per pt. had severe headache and feeling of "skin burning sensation" and he sensed feeling of muscle rigidity . was told go to er he called them and they told him that could take some time for reaction to subside and they were 6 hour wait so he chose not to go in took allergy medication . we called pt. 2/9 and pt. said still didnt feel right but was better

Weitere VAERSDATA-Felder
Praegender Schweregrund
Headache
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
no
Vorgeschichte
none disclosed by pt.
Andere Medikamente
unknown
Allergien
pcn
Vorherige Impfungen
-

VAERS 2099318

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
VA
Alter
40,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
05.02.2022
Beginn
05.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Fatigue Headache Pyrexia Rash Rash pruritic

Symptomtext

Patient received the COVID-19 vaccine #1 (Moderna; Lot: 016J212A) on 5 February 2022 on her R upper arm a medical facility. She received the vaccine around 0930. She noted in 10 minutes feeling lightheaded. She was monitored by medical staff at the facility with reported systolic BP of 92. She remained in the clinic for one hour and was discharged. She reported no loss of consciousness or immediate rash or swelling. She went home and to bed at noon and awoke at 1400 and noticed rash on both upper arms and on the R side of her neck. The rash was itching and persisted on her arms and gradually resolved by 7 Feb 2022 without treatment given. She also noted after awakening at noon on 5 February 2022, persistent feeling of lightheadedness, fatigue and headache. She noted the evening of 5 February a low grade fever of 99.8. These symptoms persisted through 8 February 2022 with all symptoms resolved by 9 February 2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
Fibromyalgia, migraines, insomnia
Andere Medikamente
Pregalalin, Rimegepant as needed for migraines, Botox for migraines
Allergien
allergic reaction to past influenza vaccine
Vorherige Impfungen
influenza in 2003, fatigue, shortness of breath, vomiting, passed out

VAERS 2099081

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
WI
Alter
36,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
29.01.2022
Beginn
29.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Chest discomfort Chills Dizziness

Symptomtext

Patient presented for a vaccine at our clinic. According to her husband, three years ago, she underwent stem cell treatment for lymphoma and has had a history of reactions after obtaining various vaccines. According to LPN, patient appeared anxious and asked several questions prior to being vaccinated. After the administration, patient asked what she should do if she felt post-vaccine sideaffects and expressed concern about going to a hospital due to COVID census being reported in the news. She ambulated to the observation area of the clinic under her own power and did not appear to have any problems. Beginning approximately 15 minutes in the observation area, she notified clinic observation staff that she felt dizzy. Staff assisted her to a treatment cot and obtained vital signs. Patient as given juice and water to drink which she did, and rested. Serial vital signs were obtained. At least another 15 minutes later, patient later complained of "a weight on her chest", and chills. She had her eyes closed and was slower to answer questions. EMS was notified and patient required assistance to be lifted onto the stretcher by EMS and clinic staff. Patient was transported to Hospital for further treatment.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
Transported to Hospital for further evaluation
Aktuelle Erkrankungen
Lymphoma
Vorgeschichte
Lymphoma Received stem cell treatments approximately 3 years prior
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2096016

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
MA
Alter
27,0
Geschlecht
M
Eingang
08.02.2022
Impfdatum
06.02.2022
Beginn
07.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Fatigue Nausea

Symptomtext

Improving abdominal pain, fatigue, and nausea

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
-
Andere Medikamente
none
Allergien
penicillin
Vorherige Impfungen
-

VAERS 2092454

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
AL
Alter
47,0
Geschlecht
M
Eingang
07.02.2022
Impfdatum
31.01.2022
Beginn
01.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

Pt reported only experiencing generalized rash to back. No acute respiratory problem and/or complaints voiced during assessment. Advised to notify PCP immediately. Also advised the CDC/ADPH recommendation to take OTC Benadryl as directed to alleviate symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
N/A.
Aktuelle Erkrankungen
Gout, HTN.
Vorgeschichte
Patient reported none.
Andere Medikamente
Client state gout and HTN medication. Unable to recall names during assessment.
Allergien
NKDA, NKEA.
Vorherige Impfungen
-

VAERS 2092094

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
ID
Alter
28,0
Geschlecht
F
Eingang
07.02.2022
Impfdatum
05.02.2022
Beginn
06.02.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Erythema Fatigue Headache Injection site induration Nausea Neck pain Nodule Pain in extremity Peripheral swelling Skin warm Vision blurred

Symptomtext

The morning after I received the Covid vaccine my arm was super sore which was to be expected. But as I?m going about my day, I start to notice the pain was increasing more and more to where it felt like I had a rock or something under my skin. I looked and felt my arm and it was VERY HOT to the touch, super red, and it was the biggest knot ever! Plus my whole upper arm was like a huge hump and extremely swollen. But at the injection site, it felt like a hard medium sized rock was under my skin and when I moved my arm at all or got dressed even, the pain was very extreme. Following the rest of the day, I start noticing that my back and neck began to get sore. I thought nothing of it until it became a nagging pain and I had to sit down and rest and try to relieve the pain. I also have been slightly nauseas and very tired since the day after I received the vaccine. Last thing I noticed was my head pounding. I got such a severe headache that my eyes started to get blurry and they still are. My arm is still very sore as well, but my nausea has subsided for now. It?s only been going on two days post vaccine so we?ll see how long these symptoms last.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
Covid 19 positive 3 weeks before administered vaccine
Vorgeschichte
Chronic Kidney stones Asthma Spinal stenosis Barrett?s esophagus
Andere Medikamente
Bupenorphine IB profin Albuterol Inhaler Pantoprazole Venlafaxine
Allergien
Tetracycline Doxycycline Cipro
Vorherige Impfungen
-

VAERS 2091665

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
AL
Alter
42,0
Geschlecht
F
Eingang
05.02.2022
Impfdatum
01.02.2022
Beginn
04.02.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Injection site pain Pain Pyrexia

Symptomtext

Fever, chills, generalized body aches and intense pain at injection site.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
N/A.
Aktuelle Erkrankungen
No
Vorgeschichte
None
Andere Medikamente
None
Allergien
PCN; Sulfa
Vorherige Impfungen
-

VAERS 2091598

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
NY
Alter
52,0
Geschlecht
F
Eingang
05.02.2022
Impfdatum
19.01.2022
Beginn
20.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Arthralgia Asthenia Fatigue Headache Pain Pain in extremity Tinnitus

Symptomtext

Moderna booster was administered 1/19/22 around 530 pm. Body pain and fatigue started approximately 4 hours later. Within the first 24 hours headache, tinnitus, body pain, joint pain, fatigue, weakness and arm pain at injection site.. These symptoms lasted approximately 48-72 hours. HOWEVER, THE TINNITUS HAS CONTINUED ON A DAILY BASIS AND HAS NOT RESOLVED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
Asthma
Andere Medikamente
Albuterol MDI (PRN) Breo Inhaler (PRN)
Allergien
none
Vorherige Impfungen
-

VAERS 2089216

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
-
Alter
40,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
04.02.2022
Beginn
04.02.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Dizziness

Symptomtext

IT WAS ADDITIONAL DOSE FOR MODERNA, AFTER 10 MINUTES PT FELT DIZZY, BLOOD PRESSURE WAS 220/100, PT WENT TO ER, BUT AFTER 2 TO 3 HOURES PT WAS OK

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2087277

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
IL
Alter
77,0
Geschlecht
F
Eingang
04.02.2022
Impfdatum
19.01.2022
Beginn
01.01.2022
Tage bis Beginn
-
Dosis
3
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Incorrect route of product administration Vaccination site erythema Vaccination site pain Vaccination site pruritus Vaccination site warmth

Symptomtext

a little bit tired; a little sore, still sore; vaccine not given in the right place, injection site half way between elbow and shoulder; huge bright red band of about 3 inches, huge bright red band across the injection site and the back of her arm, it?s fading, it?s more pink; hot; it itches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (it itches), VACCINATION SITE PAIN (a little sore, still sore), VACCINATION SITE ERYTHEMA (huge bright red band of about 3 inches, huge bright red band across the injection site and the back of her arm, it?s fading, it?s more pink) and FATIGUE (a little bit tired) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. Concomitant products included PROPRANOLOL, SIMVASTATIN, ASCORBIC ACID, ERGOCALCIFEROL, NICOTINAMIDE, RETINOL, RIBOFLAVIN, THIAMINE HYDROCHLORIDE (VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]), ESOMEPRAZOLE MAGNESIUM (NEXIUM [ESOMEPRAZOLE MAGNESIUM]), ASPIRIN [ACETYLSALICYLIC ACID], BIFIDOBACTERIUM LONGUM, LACTOBACILLUS ACIDOPHILUS, LACTOBACILLUS RHAMNOSUS (PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACIDOPHILUS;LACTOBACILLUS RHAMNOSUS]) and CELECOXIB (CELEBREX) for an unknown indication. On 19-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2022, the patient experienced VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (it itches) and VACCINATION SITE ERYTHEMA (huge bright red band of about 3 inches, huge bright red band across the injection site and the back of her arm, it?s fading, it?s more pink). On 19-Jan-2022, the patient experienced INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccine not given in the right place, injection site half way between elbow and shoulder). On 20-Jan-2022, the patient experienced VACCINATION SITE PAIN (a little sore, still sore). On an unknown date, the patient experienced FATIGUE (a little bit tired). On 19-Jan-2022, INCORRECT ROUTE OF PRODUCT ADMINISTRATION (vaccine not given in the right place, injection site half way between elbow and shoulder) had resolved. At the time of the report, VACCINATION SITE WARMTH (hot), VACCINATION SITE PRURITUS (it itches), VACCINATION SITE ERYTHEMA (huge bright red band of about 3 inches, huge bright red band across the injection site and the back of her arm, it?s fading, it?s more pink) and FATIGUE (a little bit tired) outcome was unknown and VACCINATION SITE PAIN (a little sore, still sore) had not resolved. Treatment medications were not reported. It was a little sore the next day, and then had a huge bright red band of about 3 inches across the injection site and the back of her arm, it was hot. The patient went to the doctor, who told her that the vaccine was not given in the right place. The injection site was half way between the elbow and the shoulder, and the doctor told her it was supposed to be higher up. Now the arm was still sore, it was not red but was fading, more pink, and it itches and was a little bit tired. No medical history were reported. This case was linked to MOD-2022-466487, MOD-2022-466488 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
PROPRANOLOL; SIMVASTATIN; VITAMINS [ASCORBIC ACID;ERGOCALCIFEROL;NICOTINAMIDE;RETINOL;RIBOFLAVIN;THIAMINE HYDROCHLORIDE]; NEXIUM [ESOMEPRAZOLE MAGNESIUM]; ASPIRIN [ACETYLSALICYLIC ACID]; PROBIOTICS [BIFIDOBACTERIUM LONGUM;LACTOBACILLUS ACID
Allergien
-
Vorherige Impfungen
-

VAERS 2085570

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
WI
Alter
68,0
Geschlecht
F
Eingang
03.02.2022
Impfdatum
02.02.2022
Beginn
03.02.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache Malaise Muscle spasms Oropharyngeal pain Somnolence Taste disorder

Symptomtext

Woke up during the night with cramps in my legs (calf) and left arm. In the am, I was extremely tired, ~ sore throat ~ bad headache ~, sleeping on and off ~ muscles still cramping up ~ odd taste in my mouth. Just not feeling well ~ daughter (nurse) suggested it was from the vaccine and should report this

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Allergies, seasonal and some sents
Andere Medikamente
Sertraline 20mg Pantoprazole SOD 40mg Cyclobenzapr 10 mg, 30 tablets last 6 months Bayer 81 mg Stool Softener Magnesium D3 1000iu Zinc 50 mg
Allergien
Pencillin Sulfa sour cream, mayo
Vorherige Impfungen
-

VAERS 2085295

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
-
Alter
48,0
Geschlecht
M
Eingang
03.02.2022
Impfdatum
14.01.2022
Beginn
26.01.2022
Tage bis Beginn
12,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Rash pruritic

Symptomtext

Seen at ER on 1/28/22 Dr with itchy rash on wrists bil up to upper arms bil and under arm pit region, rash began on 1/26/22, no resp. distress, afebrile, received 3rd dose COVID-19 vaccine on 1/14/22 , MR notes rash appears to be consistent with uticaria multiforme vs serum sickness, recommended refraining from getting future boosters. IM Benadyl 50mg given in ER, prescribed Cetirizne PO 10 mg daily, discharged home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash pruritic
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2083298

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2a

mild
Staat
CO
Alter
22,0
Geschlecht
M
Eingang
02.02.2022
Impfdatum
02.02.2022
Beginn
02.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

Patient develops a moderate to severe dizziness after five minutes receiving the shot for 15 minutes

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
NA
Allergien
None
Vorherige Impfungen
-

VAERS 2076878

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
AZ
Alter
44,0
Geschlecht
F
Eingang
31.01.2022
Impfdatum
29.01.2022
Beginn
29.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Induration Rash Skin warm Swelling

Symptomtext

SWOLLEN/HARD AREA, WARM TO TOUCH AND RASH

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NA
Vorherige Impfungen
-

VAERS 2074944

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
54,0
Geschlecht
F
Eingang
30.01.2022
Impfdatum
28.01.2022
Beginn
29.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lymph node pain Lymphadenopathy

Symptomtext

Swollen, painful lymph node under left arm pit.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymph node pain
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Obesity (BMI >41), anemia, sciatica, arthritis in both knees and ankles, Desmoid tumor at C3-C4, and seasonal allergies
Andere Medikamente
Ferrous iron infusion (intraveneous drip) on 1/27/22 at 3pm due to chronic anemia 1/28/2022 at 7am: 40mg prilosec, 20mg Claritin, 17.5mg Phentermine
Allergien
None
Vorherige Impfungen
-

VAERS 2074698

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
LA
Alter
51,0
Geschlecht
F
Eingang
29.01.2022
Impfdatum
27.01.2022
Beginn
29.01.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Headache Pruritus

Symptomtext

extreme fatigue, headache and Itching all over he body

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
none yet
Aktuelle Erkrankungen
none known
Vorgeschichte
none known
Andere Medikamente
unknown
Allergien
no known drug allergies
Vorherige Impfungen
-

VAERS 2069023

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
57,0
Geschlecht
F
Eingang
27.01.2022
Impfdatum
18.01.2022
Beginn
19.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site rash Injection site swelling Injection site warmth

Symptomtext

Received Moderna booster (1/18/22) and next day (1/19/22) rash noticed on left upper arm. In a.m. 1/20/22, patient came to Health office. Solid redness with slightly darker pin point dots covered left upper arm; area measured 7 inches X 8 Inches, warm to touch and slightly swollen, itchy. Patient took 25 mg tab Benadryl evening of 1/19/22 with no improvement. No other symptoms reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2066932

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
38,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Abdominal pain Blood pressure increased Heart rate increased Nausea Vomiting

Symptomtext

At approximately 1310 patient returned to vaccine clinic after being discharged. Patient came in reporting an onset of symptoms that included an episode of emesis X1, abdominal pain and nausea 20 min post vaccination. Patient reported pain level of a 9 from pain scale of 0 to 10. Upon arrival patient vitals were taken. Refer to chart. Patient was assessed for signs and symptoms of anaphylaxis. Patient was alert and oriented X4, patient denied shortness of breath dizziness and lightheadedness. SpO2 at 100% at Room Air. Doctor, allergist on call was called to report the patient's symptoms. Doctor recommended patient be monitored for worsening symptoms for an additional 30 min. After being monitored for 30 min patient reported a decrease in pain from a 9 to a 3. Although patient pain level decreased patient continued to have elevated BP and HR. Patient was referred to NP on site to be more closely evaluated. Dr. was notified that patient was referred to NP on site for further evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Abdominal pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
latex and keflex
Vorherige Impfungen
-

VAERS 2066875

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
PA
Alter
19,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
14.01.2022
Beginn
15.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Oedema peripheral Pruritus Tenderness Urticaria

Symptomtext

DAY 2 AFTER VACCINE SIGNIFICANT SWELLING/TENDERNESS OF LEFT AXILLA. ON DAY 9 SIGNIFICANT HIVES/ITCHING STARTED ALL OVER BODY (HEAD,NECK,CHEST,ABDOMEN,LOWER EXTREMITIES) UNRELIEVED BY OVER THE COUNTER ANTIHISTAMINES. SEEN BY PRIMARY CARE TODAY.PRESCRIBED 10 DAY COURSE OF ORAL STEROIDS AND ADDITIONAL ANTIHISTAMINES. NO RECENT CHANGES IN HEALTH,MEDICATIONS,PRODUCTS OR DIET. NO KNOWN ALLERGIES.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Ocella (oral contraceptive)
Allergien
None
Vorherige Impfungen
-

VAERS 2066197

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
CA
Alter
28,0
Geschlecht
F
Eingang
26.01.2022
Impfdatum
26.01.2022
Beginn
26.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Dizziness Headache Pruritus Skin warm

Symptomtext

Patient had complaints of headache, dizziness, slight itching and feeling warm. Pt was taken to ED for further assessment. Reaction occurred <15min after COVID vaccine administration

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
Bipolar disorder, hypertension, hypothyroidism, migraine, IBS,
Andere Medikamente
n/a
Allergien
amoxicillin, azithromycin, Pfizer COVID vaccine, Moderna COVID Vaccine (added today 1/26/22), erythromycin, latex, morphine, pencillins, sulfa
Vorherige Impfungen
Headache, Dizziness, feeling warm, itchiness, and swollen arm

VAERS 2062007

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
PA
Alter
73,0
Geschlecht
F
Eingang
25.01.2022
Impfdatum
20.01.2022
Beginn
01.01.2022
Tage bis Beginn
-
Dosis
3
Route/Site
OT / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental underdose Arthralgia Fatigue Feeding disorder Headache Hyperhidrosis Inappropriate schedule of product administration Myalgia Nausea Pain

Symptomtext

patient is immunocompromised and received booster dose of vaccine; Inappropriate schedule of vaccine administered; Sweating in bed for 24 hours; Terrible terrible pain; Could not eat; Headache; Nausea so she could not eat; Joint pain; Muscle pain; woke up very tired but still went to work, big mistake; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Sweating in bed for 24 hours), PAIN (Terrible terrible pain), FEEDING DISORDER (Could not eat), HEADACHE (Headache) and NAUSEA (Nausea so she could not eat) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. The patient's past medical history included COVID-19 (Patient felt worse when had COVID.) in October 2021. Previously administered products included for Product used for unknown indication: Johnson and Johnson (Lot Number (206A21A) and Arm of injection: Right) on 11-May-2021. Past adverse reactions to the above products included No adverse event with Johnson and Johnson. Concurrent medical conditions included Thyroid disorder, Cancer and Depression. Concomitant products included VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for Antidepressant therapy, CANDESARTAN for Blood pressure, TAMOXIFEN for Cancer, LEVOTHYROXINE for Thyroid disorder, VITAMIN D3 and MULTIVITAMIN [VITAMINS NOS] for an unknown indication. On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2022, the patient experienced HYPERHIDROSIS (Sweating in bed for 24 hours), PAIN (Terrible terrible pain), FEEDING DISORDER (Could not eat), HEADACHE (Headache), NAUSEA (Nausea so she could not eat), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and FATIGUE (woke up very tired but still went to work, big mistake). On 20-Jan-2022, the patient experienced ACCIDENTAL UNDERDOSE (patient is immunocompromised and received booster dose of vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) at an unspecified dose and frequency. On 20-Jan-2022, ACCIDENTAL UNDERDOSE (patient is immunocompromised and received booster dose of vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved. At the time of the report, HYPERHIDROSIS (Sweating in bed for 24 hours), PAIN (Terrible terrible pain), FEEDING DISORDER (Could not eat), ARTHRALGIA (Joint pain), MYALGIA (Muscle pain) and FATIGUE (woke up very tired but still went to work, big mistake) had resolved and HEADACHE (Headache) and NAUSEA (Nausea so she could not eat) had not resolved. Patient got the antibodies which is why Patient waited 90 more days before getting booster.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Cancer; Depression; Thyroid disorder.
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19 (Patient felt worse when had COVID.)
Andere Medikamente
CANDESARTAN; LEVOTHYROXINE; TAMOXIFEN; EFFEXOR; VITAMIN D3; MULTIVITAMIN [VITAMINS NOS.]
Allergien
-
Vorherige Impfungen
-

VAERS 2058010

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

mild
Staat
NJ
Alter
31,0
Geschlecht
F
Eingang
23.01.2022
Impfdatum
21.01.2022
Beginn
24.01.2022
Tage bis Beginn
3,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Chills Exposure via breast milk Fatigue Headache Injection site pain Muscular weakness Oropharyngeal pain Pyrexia

Symptomtext

Fever: 105F going up and down; chills; sore throat; headache; muscle weakness; pain at site of the shot; fatigue. I?m breastfeeding and my baby got fever too.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2057565

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
MO
Alter
77,0
Geschlecht
F
Eingang
22.01.2022
Impfdatum
19.01.2022
Beginn
19.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Peripheral swelling Pruritus

Symptomtext

Pt received Moderna booster and complains of swelling and itching around her entire upper arm. She has used hydrocortisone cream to help with the itching.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2050269

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
MI
Alter
81,0
Geschlecht
F
Eingang
20.01.2022
Impfdatum
14.01.2022
Beginn
15.01.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Vaccination site erythema Vaccination site pruritus Vaccination site reaction

Symptomtext

Injection site reaction; injection site on her upper arm is red, itchy, big and round; injection site on her upper arm is red,itchy, big and round; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE REACTION (Injection site reaction), VACCINATION SITE PRURITUS (injection site on her upper arm is red, itchy, big and round) and VACCINATION SITE ERYTHEMA (injection site on her upper arm is red,itchy, big and round) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. Previously administered products included for Product used for unknown indication: Flu vaccine. Past adverse reactions to the above products included No adverse event with Flu vaccine. On 14-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2022, the patient experienced VACCINATION SITE REACTION (Injection site reaction), VACCINATION SITE PRURITUS (injection site on her upper arm is red, itchy, big and round) and VACCINATION SITE ERYTHEMA (injection site on her upper arm is red,itchy, big and round). At the time of the report, VACCINATION SITE REACTION (Injection site reaction), VACCINATION SITE PRURITUS (injection site on her upper arm is red, itchy, big and round) and VACCINATION SITE ERYTHEMA (injection site on her upper arm is red,itchy, big and round) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. No concomitant medication was reported. No treatment medication was reported. Patient had not applied anything on the site of reaction. Patient never had a reaction to the flu vaccine. Patient was scared to proceed. Second dose due on 11 Feb 2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Vaccination site pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2047979

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2A

mild
Staat
VA
Alter
46,0
Geschlecht
F
Eingang
19.01.2022
Impfdatum
15.01.2022
Beginn
16.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pain in extremity

Symptomtext

patient reported soreness in her arm.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
no
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
no
Allergien
no
Vorherige Impfungen
-

VAERS 2047918

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
CA
Alter
20,0
Geschlecht
F
Eingang
19.01.2022
Impfdatum
17.01.2022
Beginn
18.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Lymph node pain Lymphadenopathy

Symptomtext

Given Moderna Booster Shot. About a day after I received the booster shot, my left armpit lymph nodes had become swollen and painful. I am currently letting the swelling go down naturally, and will get medical treatment if it doesn't recover.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Lymph node pain
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
n/a
Vorgeschichte
n/a
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2047479

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
MI
Alter
52,0
Geschlecht
F
Eingang
19.01.2022
Impfdatum
18.01.2022
Beginn
18.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Chills Dizziness Headache Injection site pain Pain

Symptomtext

This was a booster. Area for the booster sore, headache, then full body aches, severe chills and dizziness

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chills
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Sinus issue
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2045481

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j212a

mild
Staat
MA
Alter
32,0
Geschlecht
F
Eingang
19.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

Systemic: Dizziness / Lightheadness-Mild, Additional Details: pt felt dizzy so we called the paramedics immediately. Even though her symptoms were resolve after 5 minutes, we still waited for the paramedic to make sure she was clear to leave. EMT cleared her after their assessment

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2037921

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
NC
Alter
34,0
Geschlecht
M
Eingang
15.01.2022
Impfdatum
15.01.2022
Beginn
15.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Urticaria

Symptomtext

Patient had previously received Pfizer for his primary 2 shots. Today 1/15/2022 the patient came in for a booster shot and elected for Moderna. Patient waited the recommended 15 minutes and at the end of this time he reported to pharmacy staff "I think I am having a reaction". When asked what type of reaction he pulled up his shirt and showed that a patch of hives was developing on the right side of his abdomen. Liquid diphenhydramine was administered and the patient waited on the pharmacy bench for a few minutes. After a few more minutes he said I think I am good and prepared to leave. The patient denied any other symptoms or any history of allergic reactions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
N/A
Allergien
NKA
Vorherige Impfungen
-

VAERS 2036159

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

mild
Staat
IL
Alter
24,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
14.01.2022
Beginn
14.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness

Symptomtext

Patient reported feeling dizzy and lightheaded a few minutes after receiving vaccine while she was sitting in our post-vaccination waiting area. I went out to check on her, she was sitting with her eyes closed and leaning onto the back of the chair. I told her to stay still and let me know if she needed anything else. I gave her some water to drink while she was there, she stated not eating or drinking much prior to vaccine. She sat for about 10 minutes after that taking some sips of water until she reported feeling better. I asked her to wait about 5 more minutes before she got up just to make sure, and finally she was feeling all the way better and able to leave on her own. No medical treatment was needed, just water and time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2032862

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

mild
Staat
OK
Alter
22,0
Geschlecht
F
Eingang
13.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling

Symptomtext

Red, swollen around injection site

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2653851

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
ND
Alter
66,0
Geschlecht
M
Eingang
08.07.2023
Impfdatum
06.05.2022
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

THE SHOT WAS GIVEN 05/06/22.. BUT ON 6/28/23 WE WERE NOTIFIED THAT THE EXPIRATION DATE OF THE VACCINE REPORTED TO BE GIVEN WAS 4/17/22?? THE PHARMACY HAS NO WAY TO PROVE THAT THIS WAS OR WAS NOT CORRECT SINCE IT HAPPENED 1 AND 1/2 YEARS AGO

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2645288

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
MI
Alter
81,0
Geschlecht
M
Eingang
14.06.2023
Impfdatum
07.03.2022
Beginn
11.08.2022
Tage bis Beginn
157,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Moderna 2/15/21 lot# 031L20A; Moderna 3/15/21 lot# 030A21A; Moderna 3/7/22 lot# 016J212A

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2621834

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CO
Alter
62,0
Geschlecht
M
Eingang
26.04.2023
Impfdatum
23.10.2021
Beginn
23.10.2021
Tage bis Beginn
0,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 immunisation Off label use Suspected COVID-19

Symptomtext

SUSPECTED COVID-19 INFECTION; REVACCINATION WITH DIFFERENT COVID-19 VACCINE; OFF LABEL DOSING FREQUENCY; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 62 year old male. The patient's height, and weight were not reported. The patient's concurrent conditions included: allergy. The patient was previously treated with Pfizer BionTech (tozinameran) (Dose number in series 1) (form of admin, route of admin were not reported, batch number:1805020 expiry: UNKNOWN) dose was not reported, administered on 18-MAR-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with Pfizer BionTech (tozinameran) (Dose number in series 1). The patient was previously treated with covid-19 vaccine ad26. cov2. s (Dose number in series 2) (suspension for injection, route of admin not reported, batch number: 1805020 expiry: UNKNOWN) dose was not reported, 1 total administered on 13-MAY-2021 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with covid-19 vaccine ad26. cov2. s (Dose number in series 2). The patient received covid-19 vaccine ad26.cov2.s (Dose number in series 3) (suspension for injection, route of admin not reported, batch number: 1822809 expiry: UNKNOWN) dose was not reported, 1 total administered on 23-OCT-2021 for covid-19 prophylaxis which was associated with off label dosing frequency. The product was associated with Off label use (Dose number in series 3). Age at time of vaccination 62 years old. No concomitant medications were reported. The patient also received non-company suspect vaccine Moderna (elasomeran) (Dose number in series 4) (form of admin, route of admin were not reported, batch number: 016J21-2A expiry: UNKNOWN) dose was not reported, administered on 01-APR-2022 for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with Moderna (elasomeran) (Dose number in series 4). The patient additionaly received non-company suspect vaccine Moderna (elasomeran) (Dose number in series 5) (form of admin, route of admin were not reported, batch number: AS7162B expiry: UNKNOWN) dose was not reported, administered on 22-SEP-2022 for covid-19 prophylaxis which was revaccination with different covid-19 vaccine (Dose number in series 5). On an unspecified date in 2023, the patient experienced suspected covid-19 infection (Dose number in series 5) for which the patient was treated with non-company suspect drug Paxlovid (nirmatrelvir/ritonavir) (form of admin, route of admin, batch number and expiry date were not reported) dose and frequency were not reported from 05-APR-2023 to 09-APR-2023 for covid-19 treatment. On 15-APR-2023, the patient experienced rebound covid after paxlovid (Dose number in series 5). The action taken with covid-19 vaccine ad26.cov2.s, elasomeran, and elasomeran was not applicable; and action taken with nirmatrelvir/ritonavir was not reported. The outcome of the suspected covid-19 infection, off label dosing frequency and revaccination with different covid-19 vaccine was not reported. This report was non-serious.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19 immunisation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Allergy
Vorgeschichte
-
Andere Medikamente
PAXLOVID
Allergien
-
Vorherige Impfungen
-

VAERS 2543569

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MI
Alter
67,0
Geschlecht
M
Eingang
27.12.2022
Impfdatum
14.01.2021
Beginn
09.11.2022
Tage bis Beginn
664,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
Blood glucose increased COVID-19 Mental status changes SARS-CoV-2 test positive

Symptomtext

11/09/22 presents to ED for "altered mental status" "high blood sugar". PMHx of "HTN, and DM II"

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood glucose increased
Hospital-Tage
-
Labordaten
11/09/22 SARS-CoV-2 (COVID-19) by NAA detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2539073

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MI
Alter
53,0
Geschlecht
M
Eingang
21.12.2022
Impfdatum
07.05.2021
Beginn
01.10.2022
Tage bis Beginn
512,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja
COVID-19 Gastrointestinal haemorrhage

Symptomtext

ADMISSION DIAGNOSIS: 1. COVID-19. 2. Gastrointestinal bleed. GI has deferred endoscopy to outpatient. 3. End-stage renal disease via left arm AV fistula Monday, Wednesday, Friday, ??. 4. Coronary artery disease, sees Dr. 5. Hypertension. 6. Diabetes. 7. Hyperlipidemia. 8. Ex-smoker. DISCHARGE DIAGNOSIS: 1. COVID-19. 2. Gastrointestinal bleed. GI has deferred endoscopy to outpatient. 3. End-stage renal disease via left arm AV fistula Monday, Wednesday, Friday, ?. 4. Coronary artery disease, sees Dr. 5. Hypertension. 6. Diabetes. 7. Hyperlipidemia. 8. Ex-smoker. The patient feels well. The patient completed his 3-day of remdesivir. If the patient is non hypoxic, the patient can be discharged after dialysis today.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
10/1 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2519972

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MI
Alter
83,0
Geschlecht
M
Eingang
30.11.2022
Impfdatum
08.02.2022
Beginn
28.11.2022
Tage bis Beginn
293,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 3 vaccines Unknown type 3/19/21 Lot# 046A21A; Moderna 4/16/21 Lot# 043B21A; Moderna 2/8/22 LOt# 016J21-2A

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
COVID +
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2493922

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MI
Alter
67,0
Geschlecht
M
Eingang
31.10.2022
Impfdatum
18.06.2021
Beginn
23.10.2022
Tage bis Beginn
492,0
Dosis
3
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt
COVID-19

Symptomtext

Pt admitted to hospital with COVID-19

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2423824

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
CA
Alter
28,0
Geschlecht
M
Eingang
30.08.2022
Impfdatum
28.01.2022
Beginn
10.08.2022
Tage bis Beginn
194,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cough Inappropriate schedule of product administration SARS-CoV-2 antibody test

Symptomtext

Dry cough/Persistent dry cough; received 2 dose more than 35 days after 1st dose; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Dry cough/Persistent dry cough) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2 dose more than 35 days after 1st dose) in a 28-year-old male patient who received mRNA-1273 (Spikevax) (batch nos. 052BZZA and 016J212A) for COVID-19 prophylaxis. Patient had no known allergies. No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine. The patient's past medical history included COVID-19 in 2021 and Skin disorder. Concomitant products included PARACETAMOL (TYLENOL) and NAPROXEN SODIUM (ALEVE) for Headache. On 28-Jan-2022, the patient received first dose of mRNA-1273 (Spikevax) (Intramuscular) .5 milliliter. On 10-Aug-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to .5 milliliter. On 10-Aug-2022, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2 dose more than 35 days after 1st dose). On 11-Aug-2022, the patient experienced COUGH (Dry cough/Persistent dry cough). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, COUGH (Dry cough/Persistent dry cough) had not resolved and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received 2 dose more than 35 days after 1st dose) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, SARS-CoV-2 antibody test: (Positive) Positive. It was reported that they tried to get patient vaccinated sooner but were not able to. Patient had COVID test before vaccines in Summer of 2021. Not hospitalized, was sick for 2 weeks. Symptoms lasted 2 weeks, however, cough lingered for 1 month.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cough
Hospital-Tage
-
Labordaten
Test Date: 2021; Test Name: COVID test; Test Result: Positive ; Result Unstructured Data: Positive
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: COVID-19; Skin disorder; Comments: Patient had no known allergies. No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine.
Andere Medikamente
TYLENOL; ALEVE
Allergien
-
Vorherige Impfungen
-

VAERS 2386901

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
CA
Alter
71,0
Geschlecht
M
Eingang
23.07.2022
Impfdatum
13.02.2022
Beginn
14.07.2022
Tage bis Beginn
151,0
Dosis
4
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered

Symptomtext

Caller got a 3rd booster today 14Jul2022 of Moderna.; This spontaneous case was reported by a patient and describes the occurrence of EXTRA DOSE ADMINISTERED (Caller got a 3rd booster today 14Jul2022 of Moderna.) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 0171322A and 016J212A) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Pfizer (Dose 1), Pfizer (1st booster dose) and Pfizer (Dose 2). Past adverse reactions to the above products included No adverse event with Pfizer, Pfizer and Pfizer. Concurrent medical conditions included Immunocompromised. On 13-Feb-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jul-2022, received fifth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 14-Jul-2022, the patient experienced EXTRA DOSE ADMINISTERED (Caller got a 3rd booster today 14Jul2022 of Moderna.). At the time of the report, EXTRA DOSE ADMINISTERED (Caller got a 3rd booster today 14Jul2022 of Moderna.) outcome was unknown. No concomitant medications were reported. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Immunocompromised
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2374961

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
WA
Alter
30,0
Geschlecht
M
Eingang
20.07.2022
Impfdatum
18.01.2022
Beginn
07.07.2022
Tage bis Beginn
170,0
Dosis
3
Route/Site
IM / AR
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Conjunctivitis Eye irritation Lacrimation increased Ophthalmological examination normal Photophobia

Symptomtext

Bilateral eye irritation, photophobia, increased lacrimation and conjunctivitis without discharge. Lasted 72 hours. Resolved with ophthalmologic steroid drops.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Conjunctivitis
Hospital-Tage
-
Labordaten
Eye examination: Negative for foreign bodies, corneal abrasions or lacerations.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Flonase, Claritin
Allergien
Codeine, cat dander, hay fever
Vorherige Impfungen
-

VAERS 2372479

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
WA
Alter
32,0
Geschlecht
F
Eingang
18.07.2022
Impfdatum
14.01.2022
Beginn
01.03.2022
Tage bis Beginn
46,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Cyst Dysmenorrhoea Heavy menstrual bleeding Ultrasound scan abnormal

Symptomtext

Normally I don't have a period and it started to come back heavy in March, Now it comes for 2 weeks at a time very heavy and painful and they are not on track to when they should be. I have had pain the last cycle, I went in and they told me there was a cyst and I have to see a gyno.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Cyst
Hospital-Tage
-
Labordaten
Ultrasound, cyst.
Aktuelle Erkrankungen
COVID-19
Vorgeschichte
N/A
Andere Medikamente
NEXPLANON
Allergien
N/A
Vorherige Impfungen
-

VAERS 2334959

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
25.06.2022
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product temperature excursion issue

Symptomtext

This spontaneous case was reported by a consumer and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine after having two excursion for a total of 29 hours and 30 minutes) and PRODUCT TEMPERATURE EXCURSION ISSUE (The first temperature excursion lasted for 9 hours 45 minutes/The total amount of the excursion is 29 hours 30 minutes.) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine after having two excursion for a total of 29 hours and 30 minutes). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (The first temperature excursion lasted for 9 hours 45 minutes/The total amount of the excursion is 29 hours 30 minutes.). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine after having two excursion for a total of 29 hours and 30 minutes) and PRODUCT TEMPERATURE EXCURSION ISSUE (The first temperature excursion lasted for 9 hours 45 minutes/The total amount of the excursion is 29 hours 30 minutes.) outcome was unknown. Concomitant products were not provided. The vial was first punctured on 04-Mar-2022. The vial were not exposed to room temperature. The vial was stored only in freezer. The vial did undergo temperature excursion. The maximum 10.8 degree Fahrenheit and minimum 5.5 degree Fahrenheit were reached. The vial was not moved from freezer to refrigerator. The vial was found to be refrozen in the visual inspection. At least 1 vial was impacted. No previous excursions were seen. Treatment medications were not reported. This case was linked to MOD-2022-592504 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2318994

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
IL
Alter
52,0
Geschlecht
F
Eingang
25.06.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine given 37days after refrigerator shelf life; Vaccine given 37days after refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 37days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 37days after refrigerator shelf life) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 prophylaxis. It was reported that patient had no known drug allergy. Concurrent medical conditions included Depressive disorder, Hypertensive (Hypertensive disorder), Osteoporosis, Lung cancer (malignant tumor of lung), Mental disorder, Osteoarthritis, Alcoholism and Bipolar disorder. Concomitant products included CLONAZEPAM, DULOXETINE, ERGOCALCIFEROL (VITAMIN D [ERGOCALCIFEROL]), FUROSEMID [FUROSEMIDE], METFORMIN HYDROCHLORIDE (METFORMIN ER), SULFADIAZINE SILVER (SSD), TRAMADOL and WARFARIN SODIUM (WARFARIN [WARFARIN SODIUM]) for an unknown indication. On 18-Mar-2022 at 2:43 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2022 at 2:43 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 37days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 37days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 37days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 37days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Alcoholism; Bipolar disorder; Depressive disorder; Hypertensive (Hypertensive disorder); Lung cancer (malignant tumor of lung); Mental disorder; Osteoarthritis; Osteoporosis
Vorgeschichte
Comments: It was reported that patient had no known drug allergy.
Andere Medikamente
CLONAZEPAM; DULOXETINE; VITAMIN D [ERGOCALCIFEROL]; FUROSEMID [FUROSEMIDE]; METFORMIN ER; SSD; TRAMADOL; WARFARIN [WARFARIN SODIUM]
Allergien
-
Vorherige Impfungen
-

VAERS 2318994

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
IL
Alter
52,0
Geschlecht
F
Eingang
25.06.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine given 37days after refrigerator shelf life; Vaccine given 37days after refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine given 37days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 37days after refrigerator shelf life) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 prophylaxis. It was reported that patient had no known drug allergy. Concurrent medical conditions included Depressive disorder, Hypertensive (Hypertensive disorder), Osteoporosis, Lung cancer (malignant tumor of lung), Mental disorder, Osteoarthritis, Alcoholism and Bipolar disorder. Concomitant products included CLONAZEPAM, DULOXETINE, ERGOCALCIFEROL (VITAMIN D [ERGOCALCIFEROL]), FUROSEMID [FUROSEMIDE], METFORMIN HYDROCHLORIDE (METFORMIN ER), SULFADIAZINE SILVER (SSD), TRAMADOL and WARFARIN SODIUM (WARFARIN [WARFARIN SODIUM]) for an unknown indication. On 18-Mar-2022 at 2:43 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2022 at 2:43 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine given 37days after refrigerator shelf life). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine given 37days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine given 37days after refrigerator shelf life) and PRODUCT STORAGE ERROR (Vaccine given 37days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medication reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Alcoholism; Bipolar disorder; Depressive disorder; Hypertensive (Hypertensive disorder); Lung cancer (malignant tumor of lung); Mental disorder; Osteoarthritis; Osteoporosis
Vorgeschichte
Comments: It was reported that patient had no known drug allergy.
Andere Medikamente
CLONAZEPAM; DULOXETINE; VITAMIN D [ERGOCALCIFEROL]; FUROSEMID [FUROSEMIDE]; METFORMIN ER; SSD; TRAMADOL; WARFARIN [WARFARIN SODIUM]
Allergien
-
Vorherige Impfungen
-

VAERS 2318991

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
IL
Alter
26,0
Geschlecht
M
Eingang
25.06.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product use issue

Symptomtext

Vaccine was given 37 days after refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was given 37 days after refrigerator shelf life) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 prophylaxis. NKDA (no known drug allergies). Concurrent medical conditions included Depressive disorder and ADHD (Attention deficit hyperactivity disorder). Concomitant products included AMOXICILLIN, NAPROXEN and TRAZODONE for an unknown indication. On 18-Mar-2022 at 1:23 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2022 at 1:23 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was given 37 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was given 37 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product use issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
ADHD (Attention deficit hyperactivity disorder); Depressive disorder
Vorgeschichte
Comments: NKDA (no known drug allergies)
Andere Medikamente
AMOXICILLIN; NAPROXEN; TRAZODONE
Allergien
-
Vorherige Impfungen
-

VAERS 2318991

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
IL
Alter
26,0
Geschlecht
M
Eingang
25.06.2022
Impfdatum
18.03.2022
Beginn
18.03.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product use issue

Symptomtext

Vaccine was given 37 days after refrigerator shelf life; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was given 37 days after refrigerator shelf life) in a 26-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 prophylaxis. NKDA (no known drug allergies). Concurrent medical conditions included Depressive disorder and ADHD (Attention deficit hyperactivity disorder). Concomitant products included AMOXICILLIN, NAPROXEN and TRAZODONE for an unknown indication. On 18-Mar-2022 at 1:23 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2022 at 1:23 PM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was given 37 days after refrigerator shelf life). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was given 37 days after refrigerator shelf life) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product use issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
ADHD (Attention deficit hyperactivity disorder); Depressive disorder
Vorgeschichte
Comments: NKDA (no known drug allergies)
Andere Medikamente
AMOXICILLIN; NAPROXEN; TRAZODONE
Allergien
-
Vorherige Impfungen
-

VAERS 2329083

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
NM
Alter
61,0
Geschlecht
M
Eingang
23.06.2022
Impfdatum
18.01.2022
Beginn
01.02.2022
Tage bis Beginn
14,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Fluid retention Imaging procedure

Symptomtext

Per pt they got the first booster on 1/18/22 and since then they have had fluid retention in arm. pt stated he needed a report because his doctor and lawyer told him he needed surgery due to water in arm and that it was caused by the covid shot.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fluid retention
Hospital-Tage
-
Labordaten
Per pt he had imaging done a couple of weeks ago and has water in arm.
Aktuelle Erkrankungen
unknown
Vorgeschichte
diabetes
Andere Medikamente
unknown
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2328333

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
48,0
Geschlecht
F
Eingang
23.06.2022
Impfdatum
04.03.2022
Beginn
04.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product temperature excursion issue

Symptomtext

The first temperature excursion lasted for 9 hours 45 minutes/The total amount of the excursion is 29 hours 30 minutes.; Administered vaccine after having two excursion for a total of 29 hours and 30 minutes; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine after having two excursion for a total of 29 hours and 30 minutes) and PRODUCT TEMPERATURE EXCURSION ISSUE (The first temperature excursion lasted for 9 hours 45 minutes/The total amount of the excursion is 29 hours 30 minutes.) in a 48-year-old female patient who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 prophylaxis. No Medical History information was reported. On 04-Mar-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 04-Mar-2022, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine after having two excursion for a total of 29 hours and 30 minutes). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (The first temperature excursion lasted for 9 hours 45 minutes/The total amount of the excursion is 29 hours 30 minutes.). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine after having two excursion for a total of 29 hours and 30 minutes) and PRODUCT TEMPERATURE EXCURSION ISSUE (The first temperature excursion lasted for 9 hours 45 minutes/The total amount of the excursion is 29 hours 30 minutes.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was first punctured on 04-Mar-2022. The vial were not exposed to room temperature. The vial was stored only in freezer. The vial did undergo temperature excursion. The maximum 10.8 degree Fahrenheit and minimum 5.5 degree Fahrenheit were reached. The vial was not moved from freezer to refrigerator. The vial was found to be refrozen in the visual inspection. At least 1 vial was impacted. No previous excursions were seen. This case was linked to MOD-2022-592557 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2314247

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NY
Alter
40,0
Geschlecht
F
Eingang
09.06.2022
Impfdatum
10.05.2022
Beginn
10.05.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Expired Vaccine given. No adverse events occurred

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2314235

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NY
Alter
87,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
03.05.2022
Beginn
01.05.2022
Tage bis Beginn
-
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Expired vaccine given. No adverse events

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
Htn, Hyperlipidemia
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2314205

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NY
Alter
18,0
Geschlecht
M
Eingang
09.06.2022
Impfdatum
22.04.2022
Beginn
01.04.2022
Tage bis Beginn
-
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered No adverse event

Symptomtext

Expired vaccine given to patient. No adverse events

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2313712

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
09.06.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product temperature excursion issue

Symptomtext

The vials were frozen and underwent 4 temperature excursions total; 7 doses given from 5 vials were eventually punctured and used after the 2nd excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (The vials were frozen and underwent 4 temperature excursions total) and POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials were eventually punctured and used after the 2nd excursion) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (The vials were frozen and underwent 4 temperature excursions total) and POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials were eventually punctured and used after the 2nd excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (The vials were frozen and underwent 4 temperature excursions total) and POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials were eventually punctured and used after the 2nd excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. On 13-Jan-2022 the freezer got to 5.4F for 15 minutes, then returned to the appropriate temperature range. On 20-Jan-2022 the freezer got to 6.1F for 15 minutes, then returned to the appropriate temperature range. On 11-Feb-2022 the freezer got to 10.8F for 10 hours and 15 minutes overnight into 12-Feb-2022, then returned to the appropriate temperature range. On 25-Feb-2022 the freezer got to 22.6F and was out of range for 20 hours total into 26-Feb-2022 then returned to the appropriate temperature range. The storage condition at the time of the excursion was frozen. The vials were moved from freezer to refrigerator on 1 dose/vial on 30-Jan-2022. No visual inspection was done, noting any vaccine state change. Treatment information was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2313711

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
09.06.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product temperature excursion issue

Symptomtext

Vials were frozen & underwent 4 temperature excursions; 7 doses given from 5 vials that underwent more than 1 temperature excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Vials were frozen & underwent 4 temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials that underwent more than 1 temperature excursion) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Vials were frozen & underwent 4 temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials that underwent more than 1 temperature excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Vials were frozen & underwent 4 temperature excursions) and POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials that underwent more than 1 temperature excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were provided. On 13Jan2022 the freezer got to 5.4F for 15 minutes, then returned to the appropriate temperature range. On 20Jan2022 the freezer got to 6.1F for 15 minutes, then returned to the appropriate temperature range. On 11Feb2022 the freezer got to 10.8F for 10 hours and 15 minutes overnight into 12Feb2022, then returned to the appropriate temperature range. On 25Feb2022 the freezer got to 22.6F & was out of range for 20 hours total into 26Feb2022 then returned to the appropriate temperature range. Date vial moved from freezer to refrigerator was 1dose/vial on 25Jan2022. Number of vials/doses impacted was 7 doses/5 vials. 5 vials were eventually punctured & used after the 2nd excursion. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2313708

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
U
Eingang
09.06.2022
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Poor quality product administered Product temperature excursion issue

Symptomtext

The vials were frozen and underwent 4 temperature excursions total; 7 doses given from 5 vials were eventually punctured and used after the 2nd excursion; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (The vials were frozen and underwent 4 temperature excursions total) and POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials were eventually punctured and used after the 2nd excursion) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (The vials were frozen and underwent 4 temperature excursions total). an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials were eventually punctured and used after the 2nd excursion). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (The vials were frozen and underwent 4 temperature excursions total) and POOR QUALITY PRODUCT ADMINISTERED (7 doses given from 5 vials were eventually punctured and used after the 2nd excursion) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. On 13-Jan-2022 the freezer got to 5.4F for 15 minutes, then returned to the appropriate temperature range. On 20-Jan-2022 the freezer got to 6.1F for 15 minutes, then returned to the appropriate temperature range. On 11-Feb-2022 the freezer got to 10.8F for 10 hours and 15 minutes overnight into 12-Feb-2022, then returned to the appropriate temperature range. On 25-Feb-2022 the freezer got to 22.6F and was out of range for 20 hours total into 26-Feb-2022 then returned to the appropriate temperature range. The storage condition at the time of the excursion was frozen. The vials were moved from freezer to refrigerator on 1 dose/vial on 20-Jan-2022. No visual inspection was done, noting any vaccine state change. No treatment medication reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Poor quality product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2292895

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
WA
Alter
70,0
Geschlecht
M
Eingang
24.05.2022
Impfdatum
01.04.2022
Beginn
02.05.2022
Tage bis Beginn
31,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
COVID-19 Cough Rhinorrhoea SARS-CoV-2 test positive

Symptomtext

Tested Postive for Covid on May 3, 2022. Had running nose and cough. SLight symptoms have persisted. Retested positive, May 24, 2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
COVID-19
Hospital-Tage
-
Labordaten
May 3, 2022, May 24, 2022.
Aktuelle Erkrankungen
None
Vorgeschichte
Coronary Disease
Andere Medikamente
Lipitor, Lisingopril, Aspirin, Etymibe
Allergien
None
Vorherige Impfungen
-

VAERS 2284508

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
63,0
Geschlecht
U
Eingang
19.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Patient administered vaccine on 29-Apr-2022, which was expired on 17-Apr-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 29-Apr-2022, which was expired on 17-Apr-2022) in a 63-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 29-Apr-2022, which was expired on 17-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient administered vaccine on 29-Apr-2022, which was expired on 17-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Patient received the booster dose of Moderna vaccine (Expiry date: 17-Apr-2022). The vial was initially stored in the refrigerator on 29-Apr-2022. Vial did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282761

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
86,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

25 doses of expired Moderna COVID-19 vaccine were administered to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna COVID-19 vaccine were administered to patients.) in an 86-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna COVID-19 vaccine were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna COVID-19 vaccine were administered to patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. The vial was initially stored in refrigerator on 04-May-2022. The vial didn't undergone any temperature excursion. No treatment medications was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282760

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
79,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Expired vaccine was stored in the refrigerator; Expired Moderna COVID-19 vaccine was administered to the patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna COVID-19 vaccine was administered to the patient) and PRODUCT STORAGE ERROR (Expired vaccine was stored in the refrigerator) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna COVID-19 vaccine was administered to the patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Expired vaccine was stored in the refrigerator). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna COVID-19 vaccine was administered to the patient) and PRODUCT STORAGE ERROR (Expired vaccine was stored in the refrigerator) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication of the patient was not reported. The patient received the booster dose. It was reported that the vials were initially stored in the refrigerator was on 29-Apr-2022 and on 04-May-2022. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282759

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
75,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine expired on 17-Apr-2022 and on 04-May-2022 moved to refrigeration and was administered on same day; 25 doses of expired Moderna Covid-19 vaccine were administered to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) and PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 and on 04-May-2022 moved to refrigeration and was administered on same day) in a 75-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 and on 04-May-2022 moved to refrigeration and was administered on same day). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) and PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 and on 04-May-2022 moved to refrigeration and was administered on same day) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The vial was initially stored in refrigerator on 04-May-2022. The vial didn't undergone any temperature excursion. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282758

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
67,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

25 doses of expired Moderna Covid-19 vaccine were administered to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. Patient received Moderna Covid-19 vaccine as booster dose The vaccine was expired on 17-Apr-2022 .The vial was initially stored in the refrigerator on 29-Apr-2022 and 04-May-2022. Treatment information was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282757

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
64,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine expired on 17-Apr-2022 and date moved to refrigeration on 29-Apr-2022 and 04-may2022 vaccine was administered; Expired Moderna Covid-19 vaccine was administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered to patient) and PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 and date moved to refrigeration on 29-Apr-2022 and 04-may2022 vaccine was administered) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 and date moved to refrigeration on 29-Apr-2022 and 04-may2022 vaccine was administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered to patient) and PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 and date moved to refrigeration on 29-Apr-2022 and 04-may2022 vaccine was administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was reported. The vial was initially stored in the refrigerator on 29-Apr-2022 and 04-May-2022. The vial did not undergo any temperature excursions. No treatment medications was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282756

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
65,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. The vial did not undergo any temperature excursions. The vial was initially stored in the refrigerator on 04-May-2022. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282755

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
72,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator 29Apr2022 & 04May2022; 25 doses of expired Moderna Covid-19 vaccine were administered to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator 29Apr2022 & 04May2022) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator 29Apr2022 & 04May2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator 29Apr2022 & 04May2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant product was provided by the reporter. No treatment medication was provided by the reporter. The vial was initially stored in refrigerator on 4may2022. The patient received third full dose. The vial did not undergo any temperature excursion .

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282753

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
50,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

The vaccine expired on 17-Apr-2022 was administered on 04-May-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 04-May-2022) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 04-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 04-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medications details were not reported by the reporter. The patient received booster dose. The vial did not undergo any temperature excursion. The vial was stored in refrigerator on 04-May-2022. Treatment details was not reported by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282752

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
57,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

The vaccine expired on 17-Apr-2022 was administered on 04-May-2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 04-May-2022) in a 57-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 04-May-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 04-May-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient received booster dose. Date the vial was initially stored in the refrigerator was on 04-May-2022. The vial did not undergo any temperature excursion. No treatment medications were provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282749

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
50,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
04.05.2022
Beginn
04.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

The vaccine expired on 17-Apr-2022, was administered on 04-May-2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022, was administered on 04-May-2022.) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 04-May-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022, was administered on 04-May-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022, was administered on 04-May-2022.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. The patient received booster dose. The vial did not undergo any temperature excursion. The vial was stored in refrigerator on 04-May-2022. No treatment medications was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282748

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
79,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vial was initially stored in the refrigerator 29Apr2022 & 04May2022; 25 doses of expired Moderna Covid-19 vaccine were administered to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator 29Apr2022 & 04May2022) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator 29Apr2022 & 04May2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients) and PRODUCT STORAGE ERROR (Vial was initially stored in the refrigerator 29Apr2022 & 04May2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant drug was reported. The vial was initially stored in the refrigerator on 29-Apr-2022. The vial did not undergo any temperature excursions. The patient received third full dose. No treatment drug was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282747

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
79,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator on 29-Apr-2022; Patient received the vaccine on 29-Apr-2022, which had expired on 17-Apr-2022.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 29-Apr-2022, which had expired on 17-Apr-2022.) and PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator on 29-Apr-2022) in a 79-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 29-Apr-2022, which had expired on 17-Apr-2022.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator on 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received the vaccine on 29-Apr-2022, which had expired on 17-Apr-2022.) and PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator on 29-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator on 29-Apr-2022. Concomitant drugs were not reported. Treatment details were not given. The vial did not undergo any temperature excursions

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282746

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
67,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

25 doses of expired Moderna Covid-19 vaccine were administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patient) in a 67-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patient). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patient) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medication were provided. The vial was initially stored in the refrigerator on 29 Apr 2022 and 04 May 2022. The vial does not undergo any temperature excursions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282745

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
64,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

25 doses of expired Moderna Covid-19 vaccine were administered to patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant medications were provided. No treatment medications were provided. It was reported that vial was initially stored in the refrigerator on 29 Apr 2022, 04 May 2022 and did not undergo temperature excursions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282744

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
66,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 29-Apr-2022) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (The vaccine expired on 17-Apr-2022 was administered on 29-Apr-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The patient received booster dose. Date the vial was initially stored in the refrigerator on 29-Apr-2022. The vial did not undergo any temperature excursion. No treatment medications were provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282743

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
65,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

25 doses of expired Moderna Covid-19 vaccine were administered to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) in a 65-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not provided. Patient received Moderna Covid-19 vaccine as booster dose The vial was initially stored in the refrigerator on 29-Apr-2022 and 04-May-2022. Treatment information was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282740

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
64,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

25 doses of expired Moderna Covid-19 vaccine were administered to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) in a 64-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna Covid-19 vaccine were administered to patients.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Patient received Moderna Covid-19 vaccine as booster dose. The vial was initially stored in the refrigerator on 29 Apr 2022 and 04 May 2022. Vial did not undergo any temperature excursions. No treatment information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282739

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
66,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

25 doses of expired Moderna COVID-19 vaccine were administered to patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna COVID-19 vaccine were administered to patients.) in a 66-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna COVID-19 vaccine were administered to patients.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (25 doses of expired Moderna COVID-19 vaccine were administered to patients.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. The vial did not undergo any temperature excursion. The vial was stored in refrigerator on 29-Apr-2022. No treatment medications was reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282737

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
50,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Date the vial was initially stored in the refrigerator: 29Apr2022 and Date of expiry date 17Apr2022.; Expired Moderna Covid-19 vaccine were administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine were administered to patient) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator: 29Apr2022 and Date of expiry date 17Apr2022.) in a 50-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine were administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator: 29Apr2022 and Date of expiry date 17Apr2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine were administered to patient) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator: 29Apr2022 and Date of expiry date 17Apr2022.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. Date the vial was initially stored in the refrigerator was 29Apr2022 & 04May2022. The vial did not undergone any temperature excursions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282736

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
59,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired Moderna Covid-19 vaccine was administered; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered) in a 59-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine was administered) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. Patient received the booster dose of Moderna vaccine (Expiry date: 17-Apr-2022). The vial was initially stored in the refrigerator on 29-Apr-2022. Vial did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2282733

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
AL
Alter
33,0
Geschlecht
U
Eingang
18.05.2022
Impfdatum
29.04.2022
Beginn
29.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator and administered on 29-Apr-2022; dose of expired Moderna Covid-19 vaccine was administered to patient; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose of expired Moderna Covid-19 vaccine was administered to patient) and PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator and administered on 29-Apr-2022) in a 33-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 29-Apr-2022, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 29-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose of expired Moderna Covid-19 vaccine was administered to patient). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator and administered on 29-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose of expired Moderna Covid-19 vaccine was administered to patient) and PRODUCT STORAGE ERROR (Vaccine expired on 17-Apr-2022 but was initially stored in the refrigerator and administered on 29-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication were reported. The vial was initially stored in refrigerator on 29-Apr-2022. The vial did not undergo any temperature excursions. No treatment information was provided by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2278010

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
16.05.2022
Impfdatum
03.05.2022
Beginn
03.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Received Expired Vaccine beyond the manufacturer's expiration date; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine beyond the manufacturer's expiration date) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 03-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 03-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine beyond the manufacturer's expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine beyond the manufacturer's expiration date) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications information was not reported. Vial did not undergo any temperature excursions. The vial was initially stored in the refrigerator on 13 APR 2022. No treatment medications were provided. Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Live follow-up added: Reporter added, initial reporter address, the date of vial was initially stored in the refrigerator was updated

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2277928

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NY
Alter
-
Geschlecht
U
Eingang
16.05.2022
Impfdatum
10.05.2022
Beginn
10.05.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Received Expired Vaccine beyond the manufacturer's expiration date-3rd patient 10MAY2022/Two patients each received expired Moderna Covid-19 vaccine; This spontaneous case was reported by a physician assistant and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine beyond the manufacturer's expiration date-3rd patient 10MAY2022/Two patients each received expired Moderna Covid-19 vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 10-May-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 10-May-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine beyond the manufacturer's expiration date-3rd patient 10MAY2022/Two patients each received expired Moderna Covid-19 vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired Vaccine beyond the manufacturer's expiration date-3rd patient 10MAY2022/Two patients each received expired Moderna Covid-19 vaccine) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Reporter stated that two patients received Moderna Covid-19 vaccine which was expired. Date the vial was initially stored in the refrigerator was 13-APR-2022. The vial did not undergo any temperature excursions. No treatment medication was reported. Most recent FOLLOW-UP information incorporated above includes: On 12-May-2022: Live Followup included primary and secondary reporter details and the date of vial was initially stored in the refrigerator was updated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2273424

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
93,0
Geschlecht
F
Eingang
12.05.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Received Vaccine that expired on 4-17-2022, information from Moderna internal analysis: Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2273342

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
67,0
Geschlecht
F
Eingang
12.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Recieved vaccine that expired on 4-17-2022, from Moderna internal communications: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263293

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
59,0
Geschlecht
F
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263289

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
71,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263285

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
50,0
Geschlecht
F
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263278

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
76,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263274

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
68,0
Geschlecht
F
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263273

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
67,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263265

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
82,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263256

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
85,0
Geschlecht
F
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263252

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
87,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263248

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
73,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263246

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
65,0
Geschlecht
F
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263242

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
81,0
Geschlecht
F
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263237

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
75,0
Geschlecht
F
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263232

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
71,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2263226

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
78,0
Geschlecht
M
Eingang
04.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261800

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
78,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknownf
Allergien
unknownf
Vorherige Impfungen
-

VAERS 2261799

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
72,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261796

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
86,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261790

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
86,0
Geschlecht
M
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261787

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
70,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261782

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
77,0
Geschlecht
M
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261777

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
65,0
Geschlecht
M
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261775

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
76,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261772

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
79,0
Geschlecht
M
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261769

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
96,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261722

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
80,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261719

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
83,0
Geschlecht
M
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261717

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
92,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261714

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
69,0
Geschlecht
F
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2261708

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
74,0
Geschlecht
M
Eingang
03.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260491

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
82,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
Unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260490

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
53,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260487

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
75,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260485

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
68,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260482

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
72,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine Received expired on 4-17-22, reported to Moderna, information from internal audit "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260369

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
75,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260357

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
74,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260350

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
85,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260347

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
69,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260337

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
71,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
uknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260323

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
69,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260319

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
73,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260312

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
71,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260303

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
78,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260300

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
86,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260298

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
75,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260292

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
65,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260259

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
68,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine:

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260219

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
68,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260215

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
70,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260208

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
73,0
Geschlecht
M
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine received Expired on 4-17-22, report to Moderna, findings from internal review of vaccine: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2260009

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
SC
Alter
70,0
Geschlecht
F
Eingang
02.05.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022; Expired vaccine that expired on 17April2022 and they think it was administer to 6 people; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine that expired on 17April2022 and they think it was administer to 6 people) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine that expired on 17April2022 and they think it was administer to 6 people). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine that expired on 17April2022 and they think it was administer to 6 people) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications was provided. Vial did not undergo any temperature excursions. No treatment medications was not reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2259678

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
SC
Alter
29,0
Geschlecht
M
Eingang
30.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

This spontaneous case reported by a nurse, describes the occurrence of administered expired product (vaccine expired April 17, 2022, believed to be administered to 6 people) and product storage error (vaccine stored past expiry date) in a 29-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 016J212A) for COVID-19 immunization. No medical history reported. On Apr 20, 2022, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 20, 2022, patient administered expired product (vaccine expired April 17, 2022, believed to be administered to 6 people). On an unknown date, patient experienced product storage error (vaccine stored past expiry date). At the time of the report, administered expired product (vaccine expired April 17, 2022, believed to be administered to 6 people) and product storage error (vaccine stored past expiry date) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. The vial did not undergo any temperature excursions. Vial initially stored in the refrigerator on April 1, 2022. This case linked to MOD-2022-545248 (patient link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2259677

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
SC
Alter
80,0
Geschlecht
F
Eingang
30.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

This spontaneous case reported by a nurse, describes the occurrence of administered expired product (vaccine expired on April 17, 2022; given to patient) and product storage error (vaccine stored in refrigerator on Apr 1, 2022, expired on Apr 17, 2022 and administered on Apr 20, 2022) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 016J212A) for COVID-19 immunization. No medical history reported. On Apr 20, 2022, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 20, 2022, patient administered expired product (vaccine expired on April 17, 2022; given to patient). On an unknown date, patient experienced product storage error (vaccine stored in refrigerator on Apr 1, 2022, expired on Apr 17, 2022 and administered on Apr 20, 2022). At the time of the report, administered expired product (vaccine expired on April 17, 2022; given to patient) and product storage error (vaccine stored in refrigerator on Apr 1, 2022, expired on Apr 17, 2022 and administered on Apr 20, 2022) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. The patient received 2nd booster. The vial initially stored in the refrigerator on April 1, 2022. Vial did not undergo with any temperature excursions. This case linked to MOD-2022-545248 (patient link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2259676

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
SC
Alter
73,0
Geschlecht
M
Eingang
30.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

This spontaneous case reported by a nurse, describes the occurrence of administered expired product (expired vaccine given to patient) and product storage error (vial initially stored in the refrigerator on April 1, 2022; administered April 20, 2022) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 016J212A) for COVID-19 immunization. No medical history reported. On Apr 20, 2022, patient received the fourth dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Apr 20, 2022, patient administered expired product (expired vaccine given to patient). On an unknown date, patient experienced product storage error (vial initially stored in the refrigerator on April 1, 2022; administered April 20, 2022). At the time of the report, administered expired product (expired vaccine given to patient) and product storage error (vial initially stored in the refrigerator on April 1, 2022; administered April 20, 2022) outcome: unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. On April 1, 2022, vial was initially stored in the refrigerator. Vial did not undergo any temperature excursions.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2259675

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
SC
Alter
64,0
Geschlecht
M
Eingang
30.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vial expired on 17-Apr-2022, stored in refrigerator on 18-Apr-2022 and administered on 19-Apr-2022.; patient was administered an expired dose of the vaccine for the booster; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (patient was administered an expired dose of the vaccine for the booster) and PRODUCT STORAGE ERROR (Vial expired on 17-Apr-2022, stored in refrigerator on 18-Apr-2022 and administered on 19-Apr-2022.) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No medical history was provided by the reporter. Concomitant products included CARVEDILOL, VARENICLINE and VITAMIN C [ASCORBIC ACID] for an unknown indication. On 19-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (patient was administered an expired dose of the vaccine for the booster). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial expired on 17-Apr-2022, stored in refrigerator on 18-Apr-2022 and administered on 19-Apr-2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (patient was administered an expired dose of the vaccine for the booster) and PRODUCT STORAGE ERROR (Vial expired on 17-Apr-2022, stored in refrigerator on 18-Apr-2022 and administered on 19-Apr-2022.) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. It was reported that patient received 1st booster dose. Treatment medications were not provided. It was reported that the vial was stored in refrigerator after expiry on 18-Apr-2022. The vial did not undergo any temperature excursion.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Comments: No medical history was provided by the reporter.
Andere Medikamente
CARVEDILOL; VARENICLINE; VITAMIN C [ASCORBIC ACID]
Allergien
-
Vorherige Impfungen
-

VAERS 2259673

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
SC
Alter
65,0
Geschlecht
F
Eingang
30.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Date the vial was initially stored in the refrigerator on 01-April-2022 and administered on 20-April-2022; Expired vaccine given to 6 patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to 6 patients) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 01-April-2022 and administered on 20-April-2022) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to 6 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 01-April-2022 and administered on 20-April-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired vaccine given to 6 patients) and PRODUCT STORAGE ERROR (Date the vial was initially stored in the refrigerator on 01-April-2022 and administered on 20-April-2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Patient received second booster dose. The vial initially stored in the refrigerator on 01-Apr-2022. The vaccine expired on17-April-2022. The vial did not undergo any temperature excursions. No treatment information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2259631

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

gering
Staat
SC
Alter
83,0
Geschlecht
F
Eingang
30.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022; Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016j21-2a) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022) and PRODUCT STORAGE ERROR (Vaccine was stored in refrigerator on 01 Apr 2022 and was expired on 17 Apr 2022 and administered on 20 Apr 2022) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Concomitant medication was not reported. Patient received second booster dose. Date of refrigeration was 01-Apr-2022. It was reported that vial had not undergone any temperature excursions. Treatment medication was not reported. Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2022: Non-significant Follow-up appended- I narrative updated. On 25-Apr-2022: Follow-up ? No New Information received On 27-Apr-2022: Follow up received contains reporters details and I narrative with information regarding the 6 patient was updated. On 27-Apr-2022: Report type changed from invalid to spontaneous. Added patient demographics and suspect product dose number. Updated I narrative.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2257126

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
66,0
Geschlecht
M
Eingang
28.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, results from internal testing: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257079

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
66,0
Geschlecht
M
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257066

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
60,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257064

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
62,0
Geschlecht
M
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257060

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
87,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257055

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
77,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257052

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
79,0
Geschlecht
M
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257048

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
68,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257045

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
SD
Alter
69,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257040

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
60,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257039

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
75,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
Unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257033

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
76,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257030

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
60,0
Geschlecht
M
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Vaccine expired on 4-17-22, reported to Moderna, internal testing done and this was the result: "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2257016

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
86,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Received expired vaccine, vaccine expired on 4-17-22, Moderna contacted, and this was the report "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2256999

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
82,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered Product storage error

Symptomtext

Received expired vaccine, vaccine expired on 4-17-22, Moderna contacted, and this was the report "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2256985

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
59,0
Geschlecht
F
Eingang
28.04.2022
Impfdatum
21.04.2022
Beginn
21.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Received expired vaccine, Moderna contacted, and this was the report "Analysis of the vials associated with your storage excursion is complete. The vaccine administered on April 19, 20, 21, 2022 from lot number 016J21-2A maintained the activity necessary to protect against the SARS-CoV-2 (COVID-19) virus at time of administration."

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unkown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2255077

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
AZ
Alter
61,0
Geschlecht
F
Eingang
27.04.2022
Impfdatum
21.01.2022
Beginn
01.02.2022
Tage bis Beginn
11,0
Dosis
3
Route/Site
SYR / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Flushing Hot flush Hyperhidrosis Nasal congestion Nasopharyngitis Rhinorrhoea SARS-CoV-2 test Sneezing Tinnitus Vision blurred Visual impairment

Symptomtext

Stuffy nose, blurry vision, ringing in my ears. It was mainly like cold symptoms. I had sneezing and running nose. I still have those issues. I'm not sure if its allergy related or not. Every now and then I become flushed and you sweat a lot. It's like having a hot flash. The ringing in the ears and blurry vision is on and off. It happens every once in a while.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Flushing
Hospital-Tage
-
Labordaten
COVID-19 test
Aktuelle Erkrankungen
None
Vorgeschichte
Hypertension
Andere Medikamente
Lisinopril
Allergien
Codeine
Vorherige Impfungen
-

VAERS 2251498

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
26.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine was placed in refrigerator on 23-Mar-2022, Beyond use date on 17-Apr-2022 administration date on 19-Apr-2022; Past beyond use date Moderna Covid-19 vaccine given to 6 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.) and PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 23-Mar-2022, Beyond use date on 17-Apr-2022 administration date on 19-Apr-2022) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 23-Mar-2022, Beyond use date on 17-Apr-2022 administration date on 19-Apr-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.) and PRODUCT STORAGE ERROR (Vaccine was placed in refrigerator on 23-Mar-2022, Beyond use date on 17-Apr-2022 administration date on 19-Apr-2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was reported. Date the vial was initially stored in the refrigerator on 23 Mar 2022. Beyond use date was on 17 Apr 2022. The vial did not undergo any temperature excursions. The treatment information was unknown. This case was linked to MOD-2022-546561, MOD-2022-546566, MOD-2022-546544, MOD-2022-546563, MOD-2022-546559 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2022: Follow-up received contains Significant information date of administration of vaccine was updated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2251496

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
26.04.2022
Impfdatum
19.04.2022
Beginn
19.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine was stored past its use beyond date.; past beyond use date Moderna Covid-19 vaccine given to 6 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (past beyond use date Moderna Covid-19 vaccine given to 6 patients.) and PRODUCT STORAGE ERROR (Vaccine was stored past its use beyond date.) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (past beyond use date Moderna Covid-19 vaccine given to 6 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was stored past its use beyond date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (past beyond use date Moderna Covid-19 vaccine given to 6 patients.) and PRODUCT STORAGE ERROR (Vaccine was stored past its use beyond date.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. Vial was initially stored in the refrigerator on 23 March 2022 and the vial didn't undergo any temperature excursions. It was reported that dose administered after 30-day use By date or after manufacturer date of expiry and beyond use date was 17-APR-2022. No treatment medication information was provided. This case was linked to MOD-2022-546563, MOD-2022-546566, MOD-2022-546561, MOD-2022-546544 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2022: Follow-up received included date of administration of expired vaccine and event onset date updated.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2249858

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
25.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

Expired Moderna Covid-19 vaccine given to 6 patients/beyond use date is 17APR2022 and administration date 20 Apr 2022; This spontaneous case was reported by a health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine given to 6 patients/beyond use date is 17APR2022 and administration date 20 Apr 2022) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine given to 6 patients/beyond use date is 17APR2022 and administration date 20 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Expired Moderna Covid-19 vaccine given to 6 patients/beyond use date is 17APR2022 and administration date 20 Apr 2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were mentioned. No treatment details were reported. The vaccine vial was initially stored in the refrigerator on 23-Mar-2022 and was administered on 20-Apr-2022. The vial did not undergo any temperature excursions. The vaccine was given to 3 Males and 3 Females. Patient's age was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2249806

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
25.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vaccine beyond use date 17APR2022; Past beyond use date Moderna Covid-19 vaccine given to 6 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.) and PRODUCT STORAGE ERROR (Vaccine beyond use date 17APR2022) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine beyond use date 17APR2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.) and PRODUCT STORAGE ERROR (Vaccine beyond use date 17APR2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. Vial was initially stored in the refrigerator on 23-MAR-2022. Vial did not undergo any temperature excursion. No relevant concomitant medications were reported. No treatment information was provided. This case was linked to MOD-2022-546559, MOD-2022-546563, MOD-2022-546567, MOD-2022-546561 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2249805

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
M
Eingang
25.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

The vial was initially stored in refrigerator on 23 Mar 2022, beyong use date was 17 Apr 2022 and administered on 20 Apr 2022.; past beyond use date Moderna Covid-19 vaccine given to 6 patients; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (past beyond use date Moderna Covid-19 vaccine given to 6 patients) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 23 Mar 2022, beyong use date was 17 Apr 2022 and administered on 20 Apr 2022.) in a male patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (past beyond use date Moderna Covid-19 vaccine given to 6 patients). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 23 Mar 2022, beyong use date was 17 Apr 2022 and administered on 20 Apr 2022.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (past beyond use date Moderna Covid-19 vaccine given to 6 patients) and PRODUCT STORAGE ERROR (The vial was initially stored in refrigerator on 23 Mar 2022, beyong use date was 17 Apr 2022 and administered on 20 Apr 2022.) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No concomitant medication information was provided. The vial was initially stored in the refrigerator on 23-Mar-2022. The vial did not undergo any temperature excursions. The vaccine's beyond use date was reported as 17-Apr-2022. No treatment medications were provided. This case was linked to MOD-2022-546559, MOD-2022-546567, MOD-2022-546561, MOD-2022-546566, MOD-2022-546544 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2249804

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
-
Geschlecht
F
Eingang
25.04.2022
Impfdatum
20.04.2022
Beginn
20.04.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Vial initially stored in refrigerator on 23 Mar 2022, Vaccine beyond use date 17APR2022, Administration date was 20 Apr 2022; Past beyond use date Moderna Covid-19 vaccine given to 6 patients.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.) and PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 23 Mar 2022, Vaccine beyond use date 17APR2022, Administration date was 20 Apr 2022) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 20-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 23 Mar 2022, Vaccine beyond use date 17APR2022, Administration date was 20 Apr 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Past beyond use date Moderna Covid-19 vaccine given to 6 patients.) and PRODUCT STORAGE ERROR (Vial initially stored in refrigerator on 23 Mar 2022, Vaccine beyond use date 17APR2022, Administration date was 20 Apr 2022) outcome was unknown. For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments. No relevant concomitant medications were reported. Vial was initially stored in the refrigerator on 23 Mar 2022. The beyond use date was 17 Apr 2022. Vial did not undergo any temperature excursion. No treatment information was provided. This case was linked to MOD-2022-546559, MOD-2022-546563, MOD-2022-546567, MOD-2022-546561, MOD-2022-546566, MOD-2022-546561 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223985

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
77,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the Beyond Use Date of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223984

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
77,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the Beyond Use Date of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223982

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
78,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223980

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
WV
Alter
77,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the Beyond Use Date of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223979

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
76,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
06.04.2022
Beginn
06.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223978

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
90,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223976

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
80,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223973

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
79,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223971

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
81,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223970

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
50,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
05.04.2022
Beginn
05.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223969

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
78,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Moderna was administered after the Beyond Use Date of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223968

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
64,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223967

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
64,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
03.04.2022
Beginn
03.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Moderna was administered after the BUD of 3/30/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223965

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
69,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223964

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
70,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223963

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
70,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
04.04.2022
Beginn
04.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223962

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
66,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
03.04.2022
Beginn
03.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223960

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
78,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
03.04.2022
Beginn
03.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223958

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
77,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
03.04.2022
Beginn
03.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product storage error

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product storage error
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223957

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
77,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
03.04.2022
Beginn
03.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223956

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
57,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223955

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
81,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
02.04.2022
Beginn
02.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223954

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
81,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
02.04.2022
Beginn
02.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223953

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
64,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
02.04.2022
Beginn
02.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223952

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
60,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
02.04.2022
Beginn
02.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223951

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
51,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223949

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
79,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223948

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
85,0
Geschlecht
M
Eingang
08.04.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223945

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
64,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the BUD of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2223944

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
VA
Alter
60,0
Geschlecht
F
Eingang
08.04.2022
Impfdatum
01.04.2022
Beginn
01.04.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered

Symptomtext

Moderna was administered after the Beyond use date of 3/30/2022

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2214719

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MD
Alter
39,0
Geschlecht
M
Eingang
04.04.2022
Impfdatum
01.01.2022
Beginn
01.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tinnitus

Symptomtext

Tinnitus in both left and right ears starting shortly after booster vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tinnitus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
None
Allergien
None
Vorherige Impfungen
-

VAERS 2214222

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge 016j21-2a

gering
Staat
PA
Alter
26,0
Geschlecht
M
Eingang
04.04.2022
Impfdatum
01.03.2022
Beginn
03.03.2022
Tage bis Beginn
2,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Parosmia

Symptomtext

Sense of smell changed, onions, feces, bad breath, gasoline; all smell to me like antifreeze

Weitere VAERSDATA-Felder
Praegender Schweregrund
Parosmia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
N/a
Vorgeschichte
Asthma, gerd
Andere Medikamente
None
Allergien
Mucunex, dogs, cats,horses, hay, cockroaches, bees, polin
Vorherige Impfungen
-

VAERS 2206748

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
CA
Alter
37,0
Geschlecht
F
Eingang
30.03.2022
Impfdatum
27.01.2022
Beginn
28.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Electrocardiogram Heart rate increased

Symptomtext

High heart rate (130s-140s)

Weitere VAERSDATA-Felder
Praegender Schweregrund
Electrocardiogram
Hospital-Tage
-
Labordaten
EKG
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Prenatal vitamins, cetirizine, and vitamin d3 2000 IU
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2203985

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j212a

gering
Staat
SC
Alter
64,0
Geschlecht
M
Eingang
29.03.2022
Impfdatum
28.03.2022
Beginn
28.03.2022
Tage bis Beginn
0,0
Dosis
4
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered No adverse event

Symptomtext

Patient was incorrectly administered a second booster following the completion of the primary series and approved booster. Vaccination was given approximately 5 months after booster dose. No adverse symptoms have been observed at this point.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Neomycin, Tetracycline
Vorherige Impfungen
-

VAERS 2202424

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
AK
Alter
17,0
Geschlecht
F
Eingang
28.03.2022
Impfdatum
25.03.2022
Beginn
25.03.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

The patient believed to be 18 by the person who administered the vaccination; therefore a Moderna dose given at the request of the patient and patient's parent. It was discovered immediately after administration the patient will not be 18 until May.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2168890

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
-
Alter
32,0
Geschlecht
M
Eingang
09.03.2022
Impfdatum
01.02.2022
Beginn
07.02.2022
Tage bis Beginn
6,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event

Symptomtext

Administered wrong COVID19 booster to pt. Provider ordered Pfizer booster and pt was given moderna booster instead. Writer did not verify the order prior to administration because the pharmacist was in the pt chart at the same time. When documenting the administration, writer realized the error and reported to RN and Dr. Dr. instructed RN to notify patient who was still in the room. Patient had no other concerns.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165543

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
-
Alter
12,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
12.01.2022
Beginn
12.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
- / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

12 year old patient received a dose of the Moderna COVID-19 vaccine on 2 separate dates as dose 1 and dose 2 in their vaccination series. No adverse events have been documented as a result of the administrations to date.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165100

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MA
Alter
32,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022; Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The healthcare professional (HCP) wanted to know whether the patient should revaccinate or not. The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022. The vials did not undergo any temperature excursions. No treatment medications were reported. This case was linked to MOD-2022-500959 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165099

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MA
Alter
21,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022; Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) and PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the vial had not undergone any temperature excursions. No treatment medications were reported. This case was linked to MOD-2022-500959 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165098

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MA
Alter
53,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022; Patient received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date; This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022) and EXPIRED PRODUCT ADMINISTERED (Patient received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022). At the time of the report, PRODUCT STORAGE ERROR (The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022) and EXPIRED PRODUCT ADMINISTERED (Patient received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. No treatment medications were reported. The vial was initially stored in the refrigerator on 10-Jan-2022 and administered on 18-Feb-2022. It was reported that the vial had not undergone any temperature excursions. This case was linked to MOD-2022-500959 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2165097

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MA
Alter
46,0
Geschlecht
M
Eingang
08.03.2022
Impfdatum
18.02.2022
Beginn
01.02.2022
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date; Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) and PRODUCT STORAGE ERROR (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) in a 46-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced PRODUCT STORAGE ERROR (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date). On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) and PRODUCT STORAGE ERROR (Received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day use-by-date) outcome was unknown. Not Provided For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. The healthcare professional (HCP) wanted to know whether the patient should revaccinate or not. The vial was initially stored in the refrigerator on 10-Jan-2022. The vials did not undergo any temperature excursions. No treatment medications were reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2164967

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
MA
Alter
88,0
Geschlecht
F
Eingang
08.03.2022
Impfdatum
18.02.2022
Beginn
01.02.2022
Tage bis Beginn
-
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered Product storage error

Symptomtext

Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day; vial initially stored in the refrigerator was 10-Jan-2022 but patients received vaccine 10 days after the 30-day; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day) and PRODUCT STORAGE ERROR (vial initially stored in the refrigerator was 10-Jan-2022 but patients received vaccine 10 days after the 30-day) in an 88-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 18-Feb-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2022, the patient experienced PRODUCT STORAGE ERROR (vial initially stored in the refrigerator was 10-Jan-2022 but patients received vaccine 10 days after the 30-day). On 18-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patients received a booster dose of the Moderna COVID19 vaccine 10 days after the 30-day) and PRODUCT STORAGE ERROR (vial initially stored in the refrigerator was 10-Jan-2022 but patients received vaccine 10 days after the 30-day) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No Concomitant medications were reported It was reported that the vial did not undergo any temperature excursions. It was reported that there was a correction only 1 bottle of Moderna Lot Number 016J21-2A that was opened and administered on 18-Feb-2022 to 5 people. No Treatments were reported. This case was linked to MOD-2022-501758, MOD-2022-501759 (Patient Link). Most recent FOLLOW-UP information incorporated above includes: On 03-Mar-2022: Follow up information received, case updated to spontaneous from invalid, patient information added.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151623

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
MD
Alter
61,0
Geschlecht
F
Eingang
02.03.2022
Impfdatum
25.02.2022
Beginn
26.02.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Muscle spasms

Symptomtext

Patient is complaining of spasms in her back, claims to have had no symptoms after 1st 2 vaccinations but experienced the spasms after her booster dose.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Muscle spasms
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
rosuvastatin 10mg, Risperdal 1mg, Bupropion SR 150mg, Clindamycin 1% lotion
Allergien
N/A
Vorherige Impfungen
-

VAERS 2150682

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
43,0
Geschlecht
F
Eingang
01.03.2022
Impfdatum
31.01.2022
Beginn
31.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Feeling abnormal Head titubation Lymphadenopathy

Symptomtext

tremor started on her head, with no motion from left to right; she felt cranky; extreme swelling of the lymph nodes on her right arm and armpit after the injection; This spontaneous case was reported by a consumer and describes the occurrence of HEAD TITUBATION (tremor started on her head, with no motion from left to right), FEELING ABNORMAL (she felt cranky) and LYMPHADENOPATHY (extreme swelling of the lymph nodes on her right arm and armpit after the injection) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. The patient's past medical history included Cancer (There was no recent change in status (such as improvement or worsening)) from 2016 to 2017. Previously administered products included for Drug use for unknown indication: chicken pox vaccine (The patient received chicken pox vaccine around both first 2 doses of COVID-19 vaccine). Past adverse reactions to the above products included No adverse event with chicken pox vaccine. Concurrent medical conditions included Neck discomfort (Start date: 25 years ago and there was no recent change in status (such as improvement or worsening)), Arthritis (Start date: 15 years ago and there was no recent change in status (such as improvement or worsening)) and Scoliosis (Start date: since the patient was born and there was no recent change in status (such as improvement or worsening)). Concomitant products included IBUPROFEN for Neck discomfort, ACYCLOVIR [ACICLOVIR] and VITAMINS NOS for an unknown indication. On 31-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2022, the patient experienced FEELING ABNORMAL (she felt cranky) and LYMPHADENOPATHY (extreme swelling of the lymph nodes on her right arm and armpit after the injection). On 01-Feb-2022, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HEAD TITUBATION (tremor started on her head, with no motion from left to right). On 03-Feb-2022, FEELING ABNORMAL (she felt cranky) and LYMPHADENOPATHY (extreme swelling of the lymph nodes on her right arm and armpit after the injection) had resolved. At the time of the report, HEAD TITUBATION (tremor started on her head, with no motion from left to right) had not resolved. The extreme swelling of the lymph nodes was lasted for 2 to 3 days. The patient thought that the tremor might be related to previous neck issues. The patient visited to her doctor because of tremor and no treatment was given, but doctor told her that they would watch the symptom for a while. The tremor was still ongoing and worsened as well. Treatment information for the events feeling abnormal and swollen lymph nodes were not reported by the reporter. This case was linked to MOD-2022-495240, MOD-2022-495173 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Feeling abnormal
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Arthritis (Start date: 15 years ago and there was no recent change in status (such as improvement or worsening)); Neck discomfort (Start date: 25 years ago and there was no recent change in status (such as improvement or worsening)); Scoliosis (Start date: since the patient was born and there was no recent change in status (such as improvement or worsening))
Vorgeschichte
Medical History/Concurrent Conditions: Cancer (There was no recent change in status (such as improvement or worsening))
Andere Medikamente
ACYCLOVIR [ACICLOVIR]; IBUPROFEN; VITAMINS NOS
Allergien
-
Vorherige Impfungen
-

VAERS 2140487

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CO
Alter
16,0
Geschlecht
F
Eingang
25.02.2022
Impfdatum
27.01.2022
Beginn
27.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / UN
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Product administered to patient of inappropriate age

Symptomtext

Patient is outside of the vaccine age recommendation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2138006

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
OH
Alter
80,0
Geschlecht
M
Eingang
24.02.2022
Impfdatum
15.01.2022
Beginn
15.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products No adverse event

Symptomtext

No adverse event. Patient given Moderna booster outside of recommended guidelines.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
None.
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 2129735

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
57,0
Geschlecht
M
Eingang
21.02.2022
Impfdatum
15.01.2022
Beginn
12.02.2022
Tage bis Beginn
28,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Accidental underdose

Symptomtext

booster given instead of second dose; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL UNDERDOSE (booster given instead of second dose) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 045L21A and 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 15-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2022, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .25 milliliter. On 12-Feb-2022, the patient experienced ACCIDENTAL UNDERDOSE (booster given instead of second dose). On 12-Feb-2022, ACCIDENTAL UNDERDOSE (booster given instead of second dose) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided. No treatment information was provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2129051

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
AL
Alter
33,0
Geschlecht
F
Eingang
21.02.2022
Impfdatum
18.02.2022
Beginn
18.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Booster vaccine given two months early.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
-
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2123535

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
61,0
Geschlecht
F
Eingang
18.02.2022
Impfdatum
15.02.2022
Beginn
17.02.2022
Tage bis Beginn
2,0
Dosis
4
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Full blood count Joint range of motion decreased Laboratory test normal Periarthritis Platelet count decreased Sensory disturbance Skin discolouration

Symptomtext

I went in to get my CBC done just because the last times I got my vaccines, my platelet counts really dropped. It?s like a protocol now to go before, after, and monitor for 6 weeks. Since I have ITT, I already have low platelet count anyway. Got my CBC done yesterday and the platelet count was at 68,000 on Monday and it was at 30,000 yesterday after the vaccine. Now I will just be monitoring to see that it goes back up. Still ongoing since 2nd vaccination and still being treated for the following: Bottoms of feet turn purple. Every test done and nothing in relation to circulation. Tests cannot determine the problem. There's just this sensation and I check my feet and they're purple. Noted with dermatologist. Thought that it would go away and it's been since the 2nd vaccine and that was back in April 2021. Around the same time where I began having shoulder issues. Seems to be frozen shoulder. Was going to PT and that never helped. Finally got a steroid injection in January 2022, but I still have limited mobility and going to PT again. They said it should be another year or so until I get some mobility.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Full blood count
Hospital-Tage
-
Labordaten
CBC Panel 02/17/2022- Indicated 30,000 platelet count Tests for foot, circulation, etc. - nothing indicated
Aktuelle Erkrankungen
None
Vorgeschichte
SLE, ITT
Andere Medikamente
Mycophenolate sodium Multivitamin Calcium Vitamin D3 Probiotic Hydroxychloroquine
Allergien
Shellfish Plankton
Vorherige Impfungen
All previous Moderna COVID vaccines- platelet counts have dropped significantly after vaccines.

VAERS 2118440

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
-
Alter
22,0
Geschlecht
F
Eingang
17.02.2022
Impfdatum
14.02.2022
Beginn
14.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered

Symptomtext

This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered after vial being punctured and left at room temperature for almost 23 hours) in a 22-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 14-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered after vial being punctured and left at room temperature for almost 23 hours). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Administered after vial being punctured and left at room temperature for almost 23 hours) outcome was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medication was provided by the reporter. It was reported that the vial was initially stored in refrigerator on 28-Jan-2022 and the vial was first punctured on 13-Feb-2022 at 11:11 AM. The vial was punctured and then left at room temperature range (8 Degree Celsius to 25 Degree Celsius) for about 23 hours. Patient was administered with the vaccine on 14-Feb-2022. The vial did not undergo any temperature excursions. Reporter stated that they gave the patient two doses at their facility but was not sure if this is their booster or second dose. No treatment medication was provided by the reporter.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2116880

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
PA
Alter
15,0
Geschlecht
M
Eingang
16.02.2022
Impfdatum
16.02.2022
Beginn
16.02.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Patient was given the wrong vaccine since he is under the age of 18.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
None known.
Vorgeschichte
Leukocytopenia, Down's syndrome, Expressive speech
Andere Medikamente
Brevoxyl, Zyrtec, Metrogel, Elocon
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2101810

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TN
Alter
53,0
Geschlecht
M
Eingang
11.02.2022
Impfdatum
08.02.2022
Beginn
08.02.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration

Symptomtext

Administered booster dose of Moderna twenty two days early from second dose as a result of mistaking the second dose written date as 8/30/2021 instead 9/30/2021.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None reported
Vorgeschichte
None reported
Andere Medikamente
Unknown
Allergien
ASA and Codeine
Vorherige Impfungen
-

VAERS 2099171

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
WI
Alter
21,0
Geschlecht
F
Eingang
09.02.2022
Impfdatum
29.01.2022
Beginn
29.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Underdose

Symptomtext

On Saturday, January 29, 2022, the patient presented to the clinic to receive a Moderna vaccine. She told administrative assistant "I'm here for my booster vaccine". The administrative assistant retrieved the patient's vaccination record where she saw the patient's 1st dose logged. The administrative assistant applied a green sticker - which we use indicating a Moderna Booster dose - to the recipient's intake form and wrote a "2" on the sticker. The administrative assistant also applied a green sticker to the patient's vaccination card indicating she was receiving her booster dose even though the recipient never received a 2nd dose of Moderna. Register nurse (RN)vaccinated the patient with a booster dose of Moderna 0.25 ml. Later, the RN realized that the patient should have received a 2nd full dose and that she gave the recipient the booster dose - half of the recommended dose of 0.5 mL Moderna. Observation staff caught the error and brought it to the attention of the draw team lead. Usual practice is that vaccinators present the intake form with the sticker indicating the desired vaccine and dose to the draw team which distributes the appropriate vaccine syringe to the vaccine applicator. Regional Lead was notified. He phoned and spoke with the patient at about 3:30 pm inviting her to return to receive the remainder of her vaccine regimen and told her that our clinic would close at 6 pm. The patient did not return that day. The regional lead again attempted to contact and left a voicemail with the patient's phone on Tuesday, Feb 1st, 2022, which was the next day the clinic was open. As of today, February 9th, the patient still has not returned to the clinic for the additional half-dose and the registry does not indicate she has received the remainder elsewhere. The incident was reviewed with above staff. Today, February 9th, the patient's account in the Registry still incorrectly states that she received the 0.5 mL dose of Moderna instead of 0.25 mL. Assistant Site Lead.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Underdose
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2097317

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TX
Alter
-
Geschlecht
U
Eingang
09.02.2022
Impfdatum
07.02.2022
Beginn
07.02.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered Product storage error

Symptomtext

product storage error; Patient were given dose of the Moderna COVID 19 after 30-day Use By Date; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient were given dose of the Moderna COVID 19 after 30-day Use By Date) and PRODUCT STORAGE ERROR (product storage error) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 07-Feb-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Feb-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient were given dose of the Moderna COVID 19 after 30-day Use By Date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (product storage error). On 07-Feb-2022, EXPIRED PRODUCT ADMINISTERED (Patient were given dose of the Moderna COVID 19 after 30-day Use By Date) had resolved. At the time of the report, PRODUCT STORAGE ERROR (product storage error) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Treatment medication was not provided. Concomitant medication was not provided.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2096696

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
AZ
Alter
85,0
Geschlecht
M
Eingang
08.02.2022
Impfdatum
01.01.2022
Beginn
01.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Contusion

Symptomtext

Bruising on his arm to the elbow a few days after the booster shot was administered.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Contusion
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
Had Covid
Vorgeschichte
Only has one kidney
Andere Medikamente
Warfarin
Allergien
None
Vorherige Impfungen
-

VAERS 2076142

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

gering
Staat
TX
Alter
24,0
Geschlecht
F
Eingang
31.01.2022
Impfdatum
29.01.2022
Beginn
29.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

Patient received second dose of primary series at day 21

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
none known
Vorgeschichte
none
Andere Medikamente
none listed
Allergien
none
Vorherige Impfungen
-

VAERS 2073101

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
TX
Alter
11,0
Geschlecht
M
Eingang
28.01.2022
Impfdatum
28.01.2022
Beginn
28.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

Gave a pediatric patient a 0.25mL dose of Moderna. No adverse effects as of now.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2071517

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NE
Alter
35,0
Geschlecht
F
Eingang
28.01.2022
Impfdatum
25.01.2022
Beginn
25.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

expired Moderna COVID-19 booster dose administered greater than 12 hours post puncture; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired Moderna COVID-19 booster dose administered greater than 12 hours post puncture) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 25-Jan-2022 at 10:05 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired Moderna COVID-19 booster dose administered greater than 12 hours post puncture). On 25-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired Moderna COVID-19 booster dose administered greater than 12 hours post puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. No concomitant and treatment medications were reported. Date the vial initially stored in the refrigerator was 21 Jan 2022 at 7:00 AM. Date and time vial was first punctured was 24 Jan 2022 at 8:45 AM vial didn't undergo any temperature excursions. Total amount of time the vial was exposed to room temperature range (8? to 25?C= 46? to 77?F) 25 hours. The vial was stored post puncture at room temperature.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2067733

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
WA
Alter
66,0
Geschlecht
F
Eingang
27.01.2022
Impfdatum
20.01.2022
Beginn
20.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (3 Doses administered more than 12(US) hours post puncture) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. The patient's past medical history included Pain. Concomitant products included IBUPROFEN for Pain, ALPRAZOLAM, ASPIRIN [ACETYLSALICYLIC ACID], COLECALCIFEROL (VIT D3), GABAPENTIN, LAMOTRIGINE, METHYLPHENIDATE, MYCOPHENOLATE MOFETIL (MYCOPHENOLATE) and NAPROXEN for an unknown indication. On 20-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 20-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (3 Doses administered more than 12(US) hours post puncture). On 20-Jan-2022, EXPIRED PRODUCT ADMINISTERED (3 Doses administered more than 12(US) hours post puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No treatment medication were provided. This case was linked to MOD-2022-458512, MOD-2022-458470 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Pain
Andere Medikamente
Alprazolam; Aspirin [Acetylsalicylic Acid]; Vitamin D3; Gabapentin; Ibuprofen; Lamotrigine; Methylphenidate; Mycophenolate; Naproxen
Allergien
-
Vorherige Impfungen
-

VAERS 2062197

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
-
Alter
32,0
Geschlecht
F
Eingang
25.01.2022
Impfdatum
20.01.2022
Beginn
20.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Wrong product administered

Symptomtext

Patient requested Pfizer and was given Moderna. Records updated to show correct vaccine.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Wrong product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2060239

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
SC
Alter
58,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
24.01.2022
Beginn
24.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Inappropriate schedule of product administration No adverse event

Symptomtext

Patient was given their booster in 2.5 months instead of 5 months. Patient didn't have any kind of adverse reaction while at the pharmacy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
-
Vorgeschichte
High blood pressure
Andere Medikamente
Blood thinner, spironolactone
Allergien
None
Vorherige Impfungen
-

VAERS 2058728

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
KY
Alter
46,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
21.01.2022
Beginn
23.01.2022
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Postmenopausal haemorrhage

Symptomtext

Patient has been post-menapausal for 3 years. One day after receiving the Moderna COVID vaccine, she started menstrual bleeding which lasted about 24 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Postmenopausal haemorrhage
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
menapausal for 3 years
Andere Medikamente
unknown
Allergien
none
Vorherige Impfungen
-

VAERS 2058638

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TN
Alter
52,0
Geschlecht
M
Eingang
24.01.2022
Impfdatum
21.01.2022
Beginn
21.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Interchange of vaccine products No adverse event

Symptomtext

Patient given moderna booster (0.25 dose) after having Pfizer adult vaccine 8/20/2022. No adverse symptoms/reactions currently.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
PTSD, Major depressive disorder, Schizophrenia, schizoaffective disorder, seizure disorder
Andere Medikamente
divalproex 500mg, tegratol 200mg
Allergien
NKA
Vorherige Impfungen
-

VAERS 2058298

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
CA
Alter
40,0
Geschlecht
F
Eingang
24.01.2022
Impfdatum
18.01.2022
Beginn
18.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Accidental underdose Incorrect route of product administration Vaccination site discharge Vaccination site erythema Vaccination site warmth

Symptomtext

Hot to touch; Likely less than full dose injected; Leaked onto skin; Not injected into muscle; Red patch; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (Hot to touch), ACCIDENTAL UNDERDOSE (Likely less than full dose injected), VACCINATION SITE DISCHARGE (Leaked onto skin), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Not injected into muscle) and VACCINATION SITE ERYTHEMA (Red patch) in a 40-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 18-Jan-2022, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Jan-2022, the patient experienced VACCINATION SITE WARMTH (Hot to touch), ACCIDENTAL UNDERDOSE (Likely less than full dose injected), VACCINATION SITE DISCHARGE (Leaked onto skin), INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Not injected into muscle) and VACCINATION SITE ERYTHEMA (Red patch). On 18-Jan-2022, ACCIDENTAL UNDERDOSE (Likely less than full dose injected), VACCINATION SITE DISCHARGE (Leaked onto skin) and INCORRECT ROUTE OF PRODUCT ADMINISTRATION (Not injected into muscle) had resolved. At the time of the report, VACCINATION SITE WARMTH (Hot to touch) had not resolved and VACCINATION SITE ERYTHEMA (Red patch) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. Patient reported that ice pad application helped little. Concomitant information was not reported. Treatment information was not reported.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Accidental underdose
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2057934

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
LA
Alter
62,0
Geschlecht
F
Eingang
23.01.2022
Impfdatum
22.01.2022
Beginn
23.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein
Blood pressure fluctuation Bradycardia

Symptomtext

Patient received MOD #3 (ADD/Immuno Dose) IMZ on 01/22/2022 at 03:33 PM. Patient called on 01/23/2022 at 12:30 PM indicating fluctuating blood pressure and bradycardia. Patient indicates one reading of 148/58 with 42 BPM. Patient indicates another reading of 157/73 with 43 BPM. Patient indicates other heart rate reading ranging from 38 to 44 BPM. Recommended patient go to the emergency room for evaluation.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Blood pressure fluctuation
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
Hypertension Crohn's
Andere Medikamente
Lisinopril Furosemide Metoprolol ER Entyvio
Allergien
-
Vorherige Impfungen
"COVID ARM" after MODerna Dose #2 (03/22/2021)

VAERS 2057605

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NY
Alter
40,0
Geschlecht
F
Eingang
22.01.2022
Impfdatum
15.01.2022
Beginn
18.01.2022
Tage bis Beginn
3,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Conjunctival haemorrhage Influenza like illness Lymphadenopathy Ophthalmological examination

Symptomtext

In addition to swollen lymph nodes in left armpit and flu-like symptoms, I also experienced bilateral Subconjunctival hemorrhage. Approximately 3 days after my injection, I looked in the mirror and noticed that the blood vessels had burst on the outside of both of my eyes. It kept looking worse, even as my other side-effects improved. I went to an optometrist and had to pay out of pocket because my insurance doesn't cover it. I don't wear eye glasses or contacts and have no need for a repeated eye doctor visit normally.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Conjunctival haemorrhage
Hospital-Tage
-
Labordaten
Went to Optometrist for an exam. Had to pay out of pocket. I don't normally go to an optometrist. I do not wear eye glasses or contacts and I have never had this happen before.
Aktuelle Erkrankungen
No
Vorgeschichte
Very mild asthma. Had it as a child but grew out of it as an adult. Now only have an emergency inhaler but do not take it everyday.
Andere Medikamente
Prozac 60mg per day. Multi-vitamin
Allergien
No
Vorherige Impfungen
Swollen lymph node in armpit of injection site, flu-like symptoms

VAERS 2055541

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
WA
Alter
16,0
Geschlecht
M
Eingang
21.01.2022
Impfdatum
16.01.2022
Beginn
16.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
SYR / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

PT IS UNDER 18 Y/O AND RPH HAS GIVEN INJECTION OF (0.25 ML)MODERNA INSTEAD OF PFIZER BOOSTER

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2047537

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
SC
Alter
16,0
Geschlecht
M
Eingang
19.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

Moderna was given to a patient who was not of age to receive that vaccine. Due to the patient's age, he should have received a Pfizer vaccine. There were no known adverse effects at the time the vaccine was given or during observation following the vaccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
No current or recent illnesses reported
Vorgeschichte
No health conditions reported
Andere Medikamente
No medications reported
Allergien
No allergies reported
Vorherige Impfungen
-

VAERS 2043646

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
TX
Alter
42,0
Geschlecht
M
Eingang
18.01.2022
Impfdatum
14.01.2022
Beginn
16.01.2022
Tage bis Beginn
2,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Nerve injury

Symptomtext

Patient called and said his entire back is burning. He described the pain as "nerve damage." He said it might be shingles, but he feels it over his entire back. He has not seen a doctor yet.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Burning sensation
Hospital-Tage
-
Labordaten
None as of yet.
Aktuelle Erkrankungen
None
Vorgeschichte
None
Andere Medikamente
Unknown
Allergien
NKDA
Vorherige Impfungen
-

VAERS 2043572

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
TN
Alter
65,0
Geschlecht
F
Eingang
18.01.2022
Impfdatum
18.01.2022
Beginn
18.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Chest discomfort Cough Hiatus hernia Oropharyngeal discomfort

Symptomtext

Patient started coughing, pulse ox read 93 at that time. Pulse ox immediately went up to 97 when she stopped coughing. Patient complained of tightness in chest stating "Feels like hiatal hernia" and "nausea in throat" that was not present before vaccination. Patient vitals as follows: BP 138/72, HR 86, 02 93 Patient evaluated by APN provider in house and patient refused ER evaluation and refused EKG by provider, APN.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Chest discomfort
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None listed by patient
Vorgeschichte
Asthma, Obesity
Andere Medikamente
Unknown
Allergien
None listed by patient
Vorherige Impfungen
-

VAERS 2042105

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TN
Alter
-
Geschlecht
U
Eingang
18.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Expired product administered

Symptomtext

5 expired doses administered from a vial greater than 12 hours post puncture; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (5 expired doses administered from a vial greater than 12 hours post puncture) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016J21-2A) for COVID-19 vaccination. No Medical History information was reported. On 13-Jan-2022, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (5 expired doses administered from a vial greater than 12 hours post puncture). On 13-Jan-2022, EXPIRED PRODUCT ADMINISTERED (5 expired doses administered from a vial greater than 12 hours post puncture) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. No concomitant medications were reported. It was reported that the vial was initially stored in the refrigerator on 10-Jan-2022, it was first punctured on 12-Jan-2022 at 03:45 pm and was kept in the refrigerator after punctured until it was administered. The vial did not undergo any temperature excursions. Total amount of time the vial was exposed to the room temperature was 8? to 25?C= 46? to 77?F. It was reported that 4 doses were booster doses and 1 dose was 2nd Moderna vaccine. No treatment medications were reported This case was linked to MOD-2022-451915 (Patient Link).

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2039477

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J212A

gering
Staat
CA
Alter
17,0
Geschlecht
M
Eingang
17.01.2022
Impfdatum
15.01.2022
Beginn
15.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

NO ADVERSE PATIENT 17 YEARS OLD

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
NOT AVAILABLE
Aktuelle Erkrankungen
NOT AVAILABLE
Vorgeschichte
NOT AVAILABLE
Andere Medikamente
NOT AVAILABLE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2038472

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

gering
Staat
CA
Alter
37,0
Geschlecht
M
Eingang
16.01.2022
Impfdatum
16.01.2022
Beginn
16.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Interchange of vaccine products

Symptomtext

The patient presented his vaccine card to the technician which he got his first and second dose of Moderna so he filled out his card for moderna booster and so it was typed up for the Moderna booster, the patient stated he signed up for the Pfizer vaccine for his booster shot instead.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Interchange of vaccine products
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
no
Vorgeschichte
no
Andere Medikamente
no
Allergien
no
Vorherige Impfungen
-

VAERS 2036151

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TN
Alter
71,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

There were NO adverse patient reactions. Continually refrigerated Moderna vaccine was given past, recommended 12 hours of opening multi dose vial. Moderna manufacturer contacted regarding issue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2036146

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TN
Alter
66,0
Geschlecht
M
Eingang
14.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

There were NO adverse patient reactions. Continually refrigerated Moderna vaccine was given past, recommended 12 hours of opening multi dose vial. Moderna manufacturer contacted regarding issue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2036140

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TN
Alter
77,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

There were NO adverse patient reactions. Continually refrigerated Moderna vaccine was given past, recommended 12 hours of opening multi dose vial. Moderna manufacturer contacted regarding issue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2036125

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TN
Alter
89,0
Geschlecht
F
Eingang
14.01.2022
Impfdatum
13.01.2022
Beginn
13.01.2022
Tage bis Beginn
0,0
Dosis
3
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Expired product administered No adverse event

Symptomtext

There were NO adverse patient reactions. Continually refrigerated Moderna vaccine was given past, recommended 12 hours of opening multi dose vial. Moderna manufacturer notified of issue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2028152

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TN
Alter
17,0
Geschlecht
M
Eingang
12.01.2022
Impfdatum
12.01.2022
Beginn
12.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

there was no adverse affect at the time of vaccine

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2025492

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
NY
Alter
61,0
Geschlecht
F
Eingang
11.01.2022
Impfdatum
08.01.2022
Beginn
09.01.2022
Tage bis Beginn
1,0
Dosis
3
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Heart rate increased

Symptomtext

Patient stating having unexplained elevated heart rate/ high pulse that has not returned to normal yet

Weitere VAERSDATA-Felder
Praegender Schweregrund
Heart rate increased
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none reported
Vorgeschichte
none reported
Andere Medikamente
unknown
Allergien
none reported
Vorherige Impfungen
-

VAERS 2021250

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TX
Alter
11,0
Geschlecht
F
Eingang
10.01.2022
Impfdatum
09.01.2022
Beginn
09.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

MODERNA VACCINE WAS ADMINISTERED TO A PATIENT AGE 11YEARS OLD. The vaccine is only indicated for individuals age 18 and above.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
NONE
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
NONE
Allergien
NONE
Vorherige Impfungen
-

VAERS 2021074

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016j21-2a

gering
Staat
PA
Alter
32,0
Geschlecht
M
Eingang
10.01.2022
Impfdatum
10.01.2022
Beginn
10.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Extra dose administered Interchange of vaccine products

Symptomtext

Patient had admitted to already receiving 3 doses of Pfizer after receiving the first dose of Moderna for a total of 4 COVID vaccines. Patient received a full dose of Moderna as it was assumed it was the first COVID vacccination.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2018345

MODERNA · COVID19 (COVID19 (MODERNA)) · Charge 016J21-2A

gering
Staat
TX
Alter
17,0
Geschlecht
M
Eingang
08.01.2022
Impfdatum
07.01.2022
Beginn
07.01.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

No adverse event observed after 15 minute of injection.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
not known
Allergien
none
Vorherige Impfungen
-